##fileformat=VCFv4.2
##GENOME_BUILD=GRCh38
##CREATION_DATE=2025-01-30
##CALLING_DATE=2025-01-30
##SOURCE=freebayes v1.3.6
##ANALYSISTYPE=GERMLINE_SINGLESAMPLE
##PIPELINE=megSAP 2024_09-172-g959cf54d
##SAMPLE=<ID=NA12878_58,Gender=female,ExternalSampleName=Coriell-DNA,IsTumor=no,IsFFPE=no,DiseaseGroup=Neoplasms,DiseaseStatus=Affected>
##INFO=<ID=NA12878_58,Number=.,Type=String,Description="Genotype of variant in sample.">
##INFO=<ID=filter,Number=.,Type=String,Description="Annotations for filtering and ranking variants.">
##INFO=<ID=quality,Number=.,Type=String,Description="Quality parameters - variant quality (QUAL), depth (DP), quality divided by depth (QD), allele frequency (AF), mean mapping quality of alternate allele (MQM), probability of strand bias for alternate bases as phred score (SAP), probability of allele ballance as phred score (ABP)">
##INFO=<ID=gene,Number=.,Type=String,Description="Affected gene list (comma-separated).">
##INFO=<ID=variant_type,Number=.,Type=String,Description="Variant type.">
##INFO=<ID=coding_and_splicing,Number=.,Type=String,Description="Coding and splicing details (Gene, ENST number, type, impact, exon/intron number, HGVS.c, HGVS.p, Pfam domain).">
##INFO=<ID=regulatory,Number=.,Type=String,Description="Regulatory consequence details.">
##INFO=<ID=OMIM,Number=.,Type=String,Description="OMIM database annotation.">
##INFO=<ID=ClinVar,Number=.,Type=String,Description="ClinVar database annotation.">
##INFO=<ID=HGMD,Number=.,Type=String,Description="HGMD database annotation.">
##INFO=<ID=RepeatMasker,Number=.,Type=String,Description="RepeatMasker annotation.">
##INFO=<ID=dbSNP,Number=.,Type=String,Description="Identifier in dbSNP database.">
##INFO=<ID=gnomAD,Number=.,Type=String,Description="Allele frequency in gnomAD project.">
##INFO=<ID=gnomAD_sub,Number=.,Type=String,Description="Sub-population allele frequenciens (AFR,AMR,EAS,NFE,SAS) in gnomAD project.">
##INFO=<ID=gnomAD_hom_hemi,Number=.,Type=String,Description="Homoyzgous/hemizygous case count of gnomAD project (genome data).">
##INFO=<ID=gnomAD_het,Number=.,Type=String,Description="Heterozygous allele count of the gnomAD project (genome data).">
##INFO=<ID=gnomAD_wt,Number=.,Type=String,Description="Wildtype allele count of the gnomAD project (genome data).">
##INFO=<ID=phyloP,Number=.,Type=String,Description="phyloP (100way vertebrate) annotation. Deleterious threshold > 1.6.">
##INFO=<ID=CADD,Number=.,Type=String,Description="CADD pathogenicity prediction scores (scaled phred-like). Deleterious threshold > 10-20.">
##INFO=<ID=REVEL,Number=.,Type=String,Description="REVEL pathogenicity prediction score. Deleterious threshold > 0.5.">
##INFO=<ID=AlphaMissense,Number=.,Type=String,Description="AlphaMissense pathogenicity score. Deleterious threshold > 0.564.">
##INFO=<ID=MaxEntScan,Number=.,Type=String,Description="MaxEntScan reference score and alternate score for (1) native splice site, (2) acceptor gain and (3) donor gain. Comma-separated list if there are different predictions for several transcripts.">
##INFO=<ID=COSMIC,Number=.,Type=String,Description="COSMIC somatic variant database anntotation.">
##INFO=<ID=SpliceAI,Number=.,Type=String,Description="SpliceAI prediction. These include delta scores (DS) and delta positions (DP) for acceptor gain (AG), acceptor loss (AL), donor gain (DG), and donor loss (DL). Format: GENE|DS_AG|DS_AL|DS_DG|DS_DL|DP_AG|DP_AL|DP_DG|DP_DL.">
##INFO=<ID=PubMed,Number=.,Type=String,Description="PubMed ids to publications on the given variant.">
##INFO=<ID=NGSD_hom,Number=.,Type=String,Description="Homozygous variant count in NGSD.">
##INFO=<ID=NGSD_het,Number=.,Type=String,Description="Heterozygous variant count in NGSD.">
##INFO=<ID=NGSD_mosaic,Number=.,Type=String,Description="Mosaic variant count in NGSD.">
##INFO=<ID=NGSD_group,Number=.,Type=String,Description="Homozygous / heterozygous variant count in NGSD with the same disease group.">
##INFO=<ID=classification,Number=.,Type=String,Description="Classification from the NGSD.">
##INFO=<ID=classification_comment,Number=.,Type=String,Description="Classification comment from the NGSD.">
##INFO=<ID=validation,Number=.,Type=String,Description="Validation information from the NGSD. Validation results of other samples are listed in brackets!">
##INFO=<ID=comment,Number=.,Type=String,Description="Variant comments from the NGSD.">
##INFO=<ID=gene_info,Number=.,Type=String,Description="Gene information from NGSD (inheritance mode, gnomAD o/e scores).">
##FILTER=<ID=low_conf_region,Description="Low confidence region for small variant calling based on gnomAD AC0/RF filters and IMGAG trio/twin data.">
##FILTER=<ID=low_mappability,Description="Variants in reads with low mapping score.">
##FILTER=<ID=mosaic,Description="Putative mosaic variants.">
##FILTER=<ID=off-target,Description="Variant marked as 'off-target'.">
##FORMAT=<ID=GT,Number=1,Type=String,Description="Genotype">
#CHROM	POS	ID	REF	ALT	QUAL	FILTER	INFO	FORMAT	NA12878_58
chr1	2408634	.	C	G	2361	.	quality=DP%3D163%3BQD%3D14.48%3BAF%3D0.55%3BMQM%3D60%3BSAP%3D3%3BABP%3D7%3BSAR%3D47%3BSAF%3D43;gene=PEX10%2CRER1;variant_type=missense%2Cdownstream_gene;coding_and_splicing=PEX10:ENST00000288774.8:missense_variant:MODERATE:exon3/6:c.418G>C:p.Gly140Arg:PF04757%20[Pex2%20/%20Pex12%20amino%20terminal%20region]%2CPEX10:ENST00000447513.7:missense_variant:MODERATE:exon3/6:c.418G>C:p.Gly140Arg:PF04757%20[Pex2%20/%20Pex12%20amino%20terminal%20region]%2CPEX10:ENST00000507596.5:missense_variant:MODERATE:exon3/6:c.418G>C:p.Gly140Arg:PF04757%20[Pex2%20/%20Pex12%20amino%20terminal%20region]%2CRER1:ENST00000378513.7:downstream_gene_variant:MODIFIER::::%2CRER1:ENST00000605895.6:downstream_gene_variant:MODIFIER::::%2CRER1:ENST00000378512.5:downstream_gene_variant:MODIFIER::::;regulatory=regulatory_region_variant:CTCF_binding_site%2Cregulatory_region_variant:TF_binding_site;OMIM=602859_[GENE%3DPEX10_PHENOS%3DPeroxisome%20biogenesis%20disorder%206A%20(Zellweger)%2C%20614870%20(3)%2C%20Autosomal%20recessive%3B%20Peroxisome%20biogenesis%20disorder%206B%2C%20614871%20(3)%2C%20Autosomal%20recessive];ClinVar=296280%20[uncertain%20significance(replaced%20by%20megSAP%20based%20on%20classifications:2x2%2C5x3)%20DISEASE%3DPeroxisome%20biogenesis%20disorder%2C%20complementation%20group%207%2CPeroxisome%20biogenesis%20disorder%206A%20(Zellweger)%2CPEX10-related%20disorder%2CZellweger%20spectrum%20disorders%2CInborn%20genetic%20diseases%2CPeroxisome%20biogenesis%20disorder%206B%2Cnot%20provided%20GENE%3DPEX10]%3B;dbSNP=rs76530653;gnomAD=0.00046;gnomAD_sub=0.00017%2C0.00150%2C0.00000%2C0.00056%2C0.00000;gnomAD_hom_hemi=0%2C;gnomAD_het=70;gnomAD_wt=152266;phyloP=0.5320;CADD=7.57;REVEL=0.064;AlphaMissense=0.09;MaxEntScan=/0.6>0.0/1.5>0.0;SpliceAI=PEX10|0.00|0.00|0.00|0.00|33|-1|-16|18;NGSD_hom=0;NGSD_het=35;NGSD_mosaic=0;NGSD_group=0%20/%204;comment="GS140615_01:%20GS140615%3B%20only%20in%20rev%20reads%3B%2010.10.2014%3B%20FH";gene_info=RER1%20(inh%3Dn/a%20oe_syn%3D1.20%20oe_mis%3D0.46%20oe_lof%3D0.22)%2C%20PEX10%20(inh%3DAR%20oe_syn%3D1.00%20oe_mis%3D1.06%20oe_lof%3D0.48)	GT	1/0
chr1	11046878	.	G	A	685	.	quality=DP%3D89%3BQD%3D7.70%3BAF%3D0.40%3BMQM%3D60%3BSAP%3D18%3BABP%3D10%3BSAR%3D10%3BSAF%3D26;gene=MASP2;variant_type=splice_region&intron;coding_and_splicing=MASP2:ENST00000700088.1:splice_region_variant&intron_variant:LOW:intron2/11:c.234+13C>T::%2CMASP2:ENST00000700091.1:splice_region_variant&intron_variant:LOW:intron2/8:c.234+13C>T::%2CMASP2:ENST00000700092.1:splice_region_variant&intron_variant:LOW:intron2/10:c.234+13C>T::%2CMASP2:ENST00000700093.1:splice_region_variant&intron_variant:LOW:intron2/10:c.234+13C>T::%2CMASP2:ENST00000700095.1:splice_region_variant&intron_variant:LOW:intron2/10:c.234+13C>T::%2CMASP2:ENST00000400897.8:splice_region_variant&intron_variant:LOW:intron2/10:c.234+13C>T::%2CMASP2:ENST00000699958.1:splice_region_variant&intron_variant:LOW:intron2/10:c.234+13C>T::%2CMASP2:ENST00000700097.1:splice_region_variant&intron_variant:LOW:intron2/10:c.234+13C>T::%2CMASP2:ENST00000400898.3:splice_region_variant&intron_variant:LOW:intron2/4:c.234+13C>T::;OMIM=605102_[GENE%3DMASP2_PHENOS%3DMASP2%20deficiency%2C%20613791%20(3)%2C%20Autosomal%20recessive];ClinVar=291809%20[likely%20benign%20DISEASE%3Dnot%20provided%2CImmunodeficiency%20due%20to%20MASP-2%20deficiency%20GENE%3DMASP2]%3B;dbSNP=rs72647262;gnomAD=0.00549;gnomAD_sub=0.00178%2C0.00653%2C0.00000%2C0.00750%2C0.00166;gnomAD_hom_hemi=7%2C;gnomAD_het=823;gnomAD_wt=151489;phyloP=-2.2500;CADD=0.06;MaxEntScan=/0.0>0.0/0.0>0.0;SpliceAI=MASP2|0.00|0.00|0.00|0.00|45|-22|11|29;NGSD_hom=3;NGSD_het=534;NGSD_mosaic=1;NGSD_group=0%20/%2060;gene_info=MASP2%20(inh%3DAR%20oe_syn%3D1.07%20oe_mis%3D0.99%20oe_lof%3D0.81)	GT	1/0
chr1	16050868	.	G	A	746	.	quality=DP%3D261%3BQD%3D2.86%3BAF%3D0.23%3BMQM%3D44%3BSAP%3D3%3BABP%3D164%3BSAR%3D30%3BSAF%3D31;gene=CLCNKB;variant_type=splice_region&intron;coding_and_splicing=CLCNKB:ENST00000684324.1:splice_region_variant&intron_variant:LOW:intron14/22:c.1054-7G>A::%2CCLCNKB:ENST00000684545.1:splice_region_variant&intron_variant:LOW:intron11/19:c.1054-7G>A::%2CCLCNKB:ENST00000683578.1:splice_region_variant&intron_variant:LOW:intron12/20:c.1054-7G>A::%2CCLCNKB:ENST00000682338.1:splice_region_variant&intron_variant:LOW:intron13/21:c.1054-7G>A::%2CCLCNKB:ENST00000682793.1:splice_region_variant&intron_variant:LOW:intron11/19:c.1054-7G>A::%2CCLCNKB:ENST00000375679.9:splice_region_variant&intron_variant:LOW:intron11/19:c.1054-7G>A::%2CCLCNKB:ENST00000375667.7:splice_region_variant&intron_variant:LOW:intron4/12:c.547-7G>A::;regulatory=regulatory_region_variant:open_chromatin_region;OMIM=602023_[GENE%3DCLCNKB_PHENOS%3DBartter%20syndrome%2C%20type%203%2C%20607364%20(3)%2C%20Autosomal%20recessive%3B%20Bartter%20syndrome%2C%20type%204b%2C%20digenic%2C%20613090%20(3)%2C%20Digenic%20recessive];ClinVar=1222788%20[benign%20DISEASE%3Dnot%20provided%20GENE%3DCLCNKB]%3B;dbSNP=rs185451420;gnomAD=0.00200;gnomAD_sub=0.00201%2C0.00101%2C0.00019%2C0.00234%2C0.00148;gnomAD_hom_hemi=0%2C;gnomAD_het=292;gnomAD_wt=145832;phyloP=-0.9160;CADD=1.95;MaxEntScan=6.5>6.8/6.5>6.8/0.0>0.0;COSMIC=COSV65160244;SpliceAI=CLCNKB|0.01|0.00|0.00|0.00|22|-14|22|35;NGSD_hom=0;NGSD_het=3779;NGSD_mosaic=156;NGSD_group=0%20/%20367;gene_info=CLCNKB%20(inh%3DAR%20oe_syn%3D1.21%20oe_mis%3D1.08%20oe_lof%3D0.93)	GT	1/0
chr1	35901980	.	C	T	1350	.	quality=DP%3D113%3BQD%3D11.95%3BAF%3D0.49%3BMQM%3D60%3BSAP%3D28%3BABP%3D3%3BSAR%3D15%3BSAF%3D40;gene=AGO1;variant_type=synonymous;coding_and_splicing=AGO1:ENST00000373206.5:synonymous_variant:LOW:exon10/19:c.948C>T:p.Tyr316%3D:PF16488%20[Argonaute%20linker%202%20domain]%2CAGO1:ENST00000373204.6:synonymous_variant:LOW:exon10/19:c.1173C>T:p.Tyr391%3D:PF16488%20[Argonaute%20linker%202%20domain]%2CAGO1:ENST00000674426.1:synonymous_variant:LOW:exon10/19:c.1173C>T:p.Tyr391%3D:PF16488%20[Argonaute%20linker%202%20domain];OMIM=606228_[GENE%3DAGO1_PHENOS%3DNeurodevelopmental%20disorder%20with%20language%20delay%20and%20behavioral%20abnormalities%2C%20with%20or%20without%20seizures%2C%20620292%20(3)%2C%20Autosomal%20dominant];ClinVar=708164%20[likely%20benign%20DISEASE%3Dnot%20provided%20GENE%3DAGO1]%3B;dbSNP=rs72661614;gnomAD=0.00138;gnomAD_sub=0.00067%2C0.00131%2C0.00000%2C0.00226%2C0.00000;gnomAD_hom_hemi=1%2C;gnomAD_het=208;gnomAD_wt=152148;phyloP=1.0540;CADD=7.78;MaxEntScan=/4.7>4.5/0.0>0.0;SpliceAI=AGO1|0.00|0.00|0.00|0.00|7|-32|-2|42;NGSD_hom=0;NGSD_het=166;NGSD_mosaic=0;NGSD_group=0%20/%2016;gene_info=AGO1%20(inh%3DAD%20oe_syn%3D1.00%20oe_mis%3D0.31%20oe_lof%3D0.00)	GT	1/0
chr1	39387318	.	T	C	1796	.	quality=DP%3D145%3BQD%3D12.39%3BAF%3D0.50%3BMQM%3D60%3BSAP%3D3%3BABP%3D3%3BSAR%3D36%3BSAF%3D36;gene=MACF1;variant_type=synonymous;coding_and_splicing=MACF1:ENST00000361689.7:synonymous_variant:LOW:exon53/94:c.8290T>C:p.Leu2764%3D:PF00435%20[Spectrin%20repeat]%2CMACF1:ENST00000567887.5:synonymous_variant:LOW:exon58/101:c.14587T>C:p.Leu4863%3D:PF00435%20[Spectrin%20repeat]%2CMACF1:ENST00000372915.8:synonymous_variant:LOW:exon57/96:c.14491T>C:p.Leu4831%3D:PF00435%20[Spectrin%20repeat]%2CMACF1:ENST00000564288.6:synonymous_variant:LOW:exon58/101:c.14476T>C:p.Leu4826%3D:PF00435%20[Spectrin%20repeat]%2CMACF1:ENST00000671089.2:synonymous_variant:LOW:exon52/93:c.8137T>C:p.Leu2713%3D:PF00435%20[Spectrin%20repeat];regulatory=regulatory_region_variant:enhancer;OMIM=608271_[GENE%3DMACF1_PHENOS%3DLissencephaly%209%20with%20complex%20brainstem%20malformation%2C%20618325%20(3)%2C%20Autosomal%20dominant];ClinVar=1701102%20[benign%20DISEASE%3DMACF1-related%20disorder%2CLissencephaly%209%20with%20complex%20brainstem%20malformation%2Cnot%20provided%20GENE%3DMACF1]%3B;dbSNP=rs72661966;gnomAD=0.00278;gnomAD_sub=0.00393%2C0.00759%2C0.00000%2C0.00090%2C0.00000;gnomAD_hom_hemi=5%2C;gnomAD_het=413;gnomAD_wt=151785;phyloP=0.2210;CADD=4.09;REVEL=0.409;MaxEntScan=/0.0>0.0/0.0>0.0;SpliceAI=MACF1|0.00|0.00|0.00|0.00|-1|6|20|-1;NGSD_hom=1;NGSD_het=128;NGSD_mosaic=0;NGSD_group=0%20/%2013;gene_info=MACF1%20(inh%3DAD%20oe_syn%3D0.97%20oe_mis%3D0.93%20oe_lof%3D0.29)	GT	1/0
chr1	63323417	.	C	T	1773	.	quality=DP%3D122%3BQD%3D14.53%3BAF%3D0.57%3BMQM%3D60%3BSAP%3D24%3BABP%3D9%3BSAR%3D22%3BSAF%3D48;gene=FOXD3%2CFOXD3-AS1%2CMIR6068;variant_type=missense%2Cupstream_gene%2Cdownstream_gene;coding_and_splicing=FOXD3:ENST00000371116.4:missense_variant:MODERATE:exon1/1:c.359C>T:p.Pro120Leu:%2CFOXD3-AS1:ENST00000689015.1:upstream_gene_variant:MODIFIER::::%2CFOXD3-AS1:ENST00000686639.1:upstream_gene_variant:MODIFIER::::%2CFOXD3-AS1:ENST00000690254.1:upstream_gene_variant:MODIFIER::::%2CFOXD3-AS1:ENST00000691303.1:upstream_gene_variant:MODIFIER::::%2CMIR6068:ENST00000615405.1:downstream_gene_variant:MODIFIER::::;regulatory=regulatory_region_variant:open_chromatin_region;OMIM=611539_[GENE%3DFOXD3_PHENOS%3D{Autoimmune%20disease%2C%20susceptibility%20to%2C%201}%2C%20607836%20(3)%2C%20Autosomal%20dominant];dbSNP=rs202186939;gnomAD=0.00088;gnomAD_sub=0.00014%2C0.00007%2C0.00000%2C0.00169%2C0.00000;gnomAD_hom_hemi=0%2C;gnomAD_het=134;gnomAD_wt=151720;phyloP=0.9660;CADD=21.20;REVEL=0.230;AlphaMissense=0.09;MaxEntScan=/2.1>1.6/0.0>0.0;SpliceAI=FOXD3|0.00|0.00|0.00|0.00|-2|-11|-40|43;NGSD_hom=0;NGSD_het=132;NGSD_mosaic=1;NGSD_group=0%20/%2017;gene_info=FOXD3-AS1%20(inh%3Dn/a%20oe_syn%3Dn/a%20oe_mis%3Dn/a%20oe_lof%3Dn/a)%2C%20FOXD3%20(inh%3DAD%20oe_syn%3D1.10%20oe_mis%3D0.81%20oe_lof%3D0.14)%2C%20MIR6068%20(inh%3Dn/a%20oe_syn%3Dn/a%20oe_mis%3Dn/a%20oe_lof%3Dn/a)	GT	1/0
chr1	115705205	.	T	C	1557	.	quality=DP%3D123%3BQD%3D12.66%3BAF%3D0.51%3BMQM%3D60%3BSAP%3D25%3BABP%3D3%3BSAR%3D19%3BSAF%3D44;gene=CASQ2;variant_type=missense;coding_and_splicing=CASQ2:ENST00000713711.1:missense_variant:MODERATE:exon10/12:c.1067A>G:p.Asp356Gly:PF01216%20[Calsequestrin]%2CCASQ2:ENST00000261448.6:missense_variant:MODERATE:exon9/11:c.926A>G:p.Asp309Gly:PF01216%20[Calsequestrin]%2CCASQ2:ENST00000713728.1:missense_variant:MODERATE:exon10/12:c.650A>G:p.Asp217Gly:PF01216%20[Calsequestrin];regulatory=regulatory_region_variant:enhancer%2Cregulatory_region_variant:CTCF_binding_site;OMIM=114251_[GENE%3DCASQ2_PHENOS%3DVentricular%20tachycardia%2C%20catecholaminergic%20polymorphic%2C%202%2C%20611938%20(3)%2C%20Autosomal%20recessive];ClinVar=292129%20[uncertain%20significance%20DISEASE%3DCatecholaminergic%20polymorphic%20ventricular%20tachycardia%202%20GENE%3DCASQ2]%3B;dbSNP=rs72703607;gnomAD=0.00001;gnomAD_sub=0.00000%2C0.00000%2C0.00000%2C0.00001%2C0.00000;gnomAD_hom_hemi=0%2C;gnomAD_het=1;gnomAD_wt=152335;phyloP=7.6670;CADD=27.90;REVEL=0.750;AlphaMissense=0.44;MaxEntScan=/0.0>0.0/0.0>0.0;SpliceAI=CASQ2|0.00|0.00|0.00|0.00|-13|-3|-17|-13;NGSD_hom=0;NGSD_het=11;NGSD_mosaic=0;NGSD_group=0%20/%201;gene_info=CASQ2%20(inh%3DAR+AD%20oe_syn%3D1.07%20oe_mis%3D1.04%20oe_lof%3D0.94)	GT	1/0
chr1	117994519	.	T	C	824	.	quality=DP%3D87%3BQD%3D9.47%3BAF%3D0.41%3BMQM%3D60%3BSAP%3D23%3BABP%3D9%3BSAR%3D27%3BSAF%3D9;gene=SPAG17;variant_type=missense;coding_and_splicing=SPAG17:ENST00000336338.10:missense_variant:MODERATE:exon35/49:c.5065A>G:p.Ile1689Val:;OMIM=616554_[GENE%3DSPAG17_PHENOS%3D?Spermatogenic%20failure%2055%2C%20619380%20(3)%2C%20Autosomal%20recessive];dbSNP=rs72697565;gnomAD=0.00001;gnomAD_sub=0.00000%2C0.00000%2C0.00000%2C0.00001%2C0.00000;gnomAD_hom_hemi=0%2C;gnomAD_het=1;gnomAD_wt=152271;phyloP=3.3890;CADD=23.90;REVEL=0.185;AlphaMissense=0.12;MaxEntScan=/1.8>1.3/0.0>0.0;SpliceAI=SPAG17|0.00|0.00|0.01|0.00|11|-28|-37|11;NGSD_hom=0;NGSD_het=11;NGSD_mosaic=0;NGSD_group=0%20/%201;gene_info=SPAG17%20(inh%3DAR%20oe_syn%3D0.98%20oe_mis%3D0.99%20oe_lof%3D0.50)	GT	1/0
chr1	119422310	.	T	C	1982	.	quality=DP%3D168%3BQD%3D11.80%3BAF%3D0.48%3BMQM%3D59%3BSAP%3D32%3BABP%3D3%3BSAR%3D24%3BSAF%3D57;gene=HSD3B2;variant_type=missense;coding_and_splicing=HSD3B2:ENST00000543831.5:missense_variant:MODERATE:exon4/4:c.809T>C:p.Ile270Thr:PF01073%20[3-beta%20hydroxysteroid%20dehydrogenase/isomerase%20family]%2CHSD3B2:ENST00000369416.4:missense_variant:MODERATE:exon4/4:c.809T>C:p.Ile270Thr:PF01073%20[3-beta%20hydroxysteroid%20dehydrogenase/isomerase%20family];OMIM=613890_[GENE%3DHSD3B2_PHENOS%3DAdrenal%20hyperplasia%2C%20congenital%2C%20due%20to%203-beta-hydroxysteroid%20dehydrogenase%202%20deficiency%2C%20201810%20(3)%2C%20Autosomal%20recessive];ClinVar=874298%20[uncertain%20significance%20DISEASE%3Dnot%20provided%2C3%20beta-Hydroxysteroid%20dehydrogenase%20deficiency%2CHSD3B2-related%20disorder%2Cnot%20specified%20GENE%3DHSD3B2]%3B;HGMD=CM191004%20[CLASS%3DDM?%20MUT%3DALT%20PHEN%3D"Disorder%20of%20sex%20development"%20GENE%3DHSD3B2]%3B;dbSNP=rs75429891;gnomAD=0.00040;gnomAD_sub=0.00014%2C0.00013%2C0.00000%2C0.00076%2C0.00000;gnomAD_hom_hemi=0%2C;gnomAD_het=61;gnomAD_wt=152229;phyloP=-0.5710;CADD=0.00;REVEL=0.217;AlphaMissense=0.11;MaxEntScan=/0.0>0.0/0.0>0.0;COSMIC=COSV65593543;SpliceAI=HSD3B2|0.00|0.00|0.00|0.00|1|-39|1|36;PubMed=26288759%2C30668521;NGSD_hom=0;NGSD_het=90;NGSD_mosaic=0;NGSD_group=0%20/%2010;gene_info=HSD3B2%20(inh%3DAR%20oe_syn%3D1.33%20oe_mis%3D0.87%20oe_lof%3D0.99)	GT	1/0
chr1	155357300	.	G	A	1571	.	quality=DP%3D122%3BQD%3D12.88%3BAF%3D0.52%3BMQM%3D60%3BSAP%3D25%3BABP%3D3%3BSAR%3D19%3BSAF%3D44;gene=ASH1L%2CRNU6-106P;variant_type=splice_region&intron%2Cdownstream_gene;coding_and_splicing=ASH1L:ENST00000368346.7:splice_region_variant&intron_variant:LOW:intron15/27:c.7070+16C>T::%2CASH1L:ENST00000392403.8:splice_region_variant&intron_variant:LOW:intron15/27:c.7055+16C>T::%2CASH1L:ENST00000677825.1:splice_region_variant&intron_variant:LOW:intron14/26:c.7055+16C>T::%2CASH1L:ENST00000679333.1:splice_region_variant&intron_variant:LOW:intron14/26:c.6875+16C>T::%2CASH1L:ENST00000679097.1:splice_region_variant&intron_variant:LOW:intron16/28:c.7055+16C>T::%2CASH1L:ENST00000678117.1:splice_region_variant&intron_variant:LOW:intron16/28:c.7055+16C>T::%2CASH1L:ENST00000677213.1:splice_region_variant&intron_variant:LOW:intron15/27:c.7055+16C>T::%2CASH1L:ENST00000679133.1:splice_region_variant&intron_variant:LOW:intron15/27:c.7055+16C>T::%2CRNU6-106P:ENST00000384405.1:downstream_gene_variant:MODIFIER::::;OMIM=607999_[GENE%3DASH1L_PHENOS%3DIntellectual%20developmental%20disorder%2C%20autosomal%20dominant%2052%2C%20617796%20(3)%2C%20Autosomal%20dominant];dbSNP=rs41264233;gnomAD=0.00861;gnomAD_sub=0.00210%2C0.01168%2C0.00019%2C0.01069%2C0.03674;gnomAD_hom_hemi=10%2C;gnomAD_het=1290;gnomAD_wt=150772;phyloP=0.4300;CADD=4.73;MaxEntScan=/0.0>0.0/0.0>0.0;SpliceAI=ASH1L|0.00|0.00|0.00|0.00|43|41|16|-16;NGSD_hom=33;NGSD_het=1306;NGSD_mosaic=0;NGSD_group=2%20/%20127;gene_info=ASH1L%20(inh%3DAD%20oe_syn%3D0.93%20oe_mis%3D0.75%20oe_lof%3D0.02)%2C%20RNU6-106P%20(inh%3Dn/a%20oe_syn%3Dn/a%20oe_mis%3Dn/a%20oe_lof%3Dn/a)	GT	1/0
chr1	156134501	.	G	A	2252	.	quality=DP%3D164%3BQD%3D13.73%3BAF%3D0.56%3BMQM%3D60%3BSAP%3D49%3BABP%3D8%3BSAR%3D68%3BSAF%3D24;gene=LMNA;variant_type=synonymous;coding_and_splicing=LMNA:ENST00000368301.6:synonymous_variant:LOW:exon6/13:c.612G>A:p.Leu204%3D:PF00038%20[Intermediate%20filament%20protein]%2CLMNA:ENST00000676385.2:synonymous_variant:LOW:exon5/13:c.612G>A:p.Leu204%3D:PF00038%20[Intermediate%20filament%20protein]%2CLMNA:ENST00000675939.1:synonymous_variant:LOW:exon4/13:c.612G>A:p.Leu204%3D:PF00038%20[Intermediate%20filament%20protein]%2CLMNA:ENST00000675667.1:synonymous_variant:LOW:exon4/12:c.612G>A:p.Leu204%3D:PF00038%20[Intermediate%20filament%20protein]%2CLMNA:ENST00000683032.1:synonymous_variant:LOW:exon4/13:c.612G>A:p.Leu204%3D:PF00038%20[Intermediate%20filament%20protein]%2CLMNA:ENST00000682650.1:synonymous_variant:LOW:exon4/12:c.612G>A:p.Leu204%3D:PF00038%20[Intermediate%20filament%20protein]%2CLMNA:ENST00000361308.9:synonymous_variant:LOW:exon4/13:c.612G>A:p.Leu204%3D:PF00038%20[Intermediate%20filament%20protein]%2CLMNA:ENST00000677389.1:synonymous_variant:LOW:exon3/10:c.612G>A:p.Leu204%3D:PF00038%20[Intermediate%20filament%20protein]%2CLMNA:ENST00000368300.9:synonymous_variant:LOW:exon3/12:c.612G>A:p.Leu204%3D:PF00038%20[Intermediate%20filament%20protein]%2CLMNA:ENST00000368299.7:synonymous_variant:LOW:exon3/12:c.612G>A:p.Leu204%3D:PF00038%20[Intermediate%20filament%20protein]%2CLMNA:ENST00000448611.6:synonymous_variant:LOW:exon3/13:c.276G>A:p.Leu92%3D:PF00038%20[Intermediate%20filament%20protein]%2CLMNA:ENST00000368297.5:synonymous_variant:LOW:exon4/11:c.369G>A:p.Leu123%3D:PF00038%20[Intermediate%20filament%20protein]%2CLMNA:ENST00000504687.7:synonymous_variant:LOW:exon3/12:c.54G>A:p.Leu18%3D:PF00038%20[Intermediate%20filament%20protein]%2CLMNA:ENST00000473598.6:synonymous_variant:LOW:exon4/13:c.315G>A:p.Leu105%3D:PF00038%20[Intermediate%20filament%20protein];regulatory=regulatory_region_variant:promoter;OMIM=150330_[GENE%3DLMNA_PHENOS%3DMandibuloacral%20dysplasia%2C%20248370%20(3)%2C%20Autosomal%20recessive%3B%20Heart-hand%20syndrome%2C%20Slovenian%20type%2C%20610140%20(3)%2C%20Autosomal%20dominant%3B%20Cardiomyopathy%2C%20dilated%2C%201A%2C%20115200%20(3)%2C%20Autosomal%20dominant%3B%20Emery-Dreifuss%20muscular%20dystrophy%203%2C%20autosomal%20recessive%2C%20616516%20(3)%2C%20Autosomal%20recessive%3B%20Restrictive%20dermopathy%202%2C%20619793%20(3)%3B%20Charcot-Marie-Tooth%20disease%2C%20type%202B1%2C%20605588%20(3)%2C%20Autosomal%20recessive%3B%20Emery-Dreifuss%20muscular%20dystrophy%202%2C%20autosomal%20dominant%2C%20181350%20(3)%2C%20Autosomal%20dominant%3B%20Hutchinson-Gilford%20progeria%2C%20176670%20(3)%2C%20Autosomal%20dominant%3B%20Lipodystrophy%2C%20familial%20partial%2C%20type%202%2C%20151660%20(3)%2C%20Autosomal%20dominant%3B%20Muscular%20dystrophy%2C%20congenital%2C%20613205%20(3)%2C%20Autosomal%20dominant%3B%20Malouf%20syndrome%2C%20212112%20(3)%2C%20Autosomal%20dominant];ClinVar=48071%20[benign/likely%20benign%20DISEASE%3DCharcot-Marie-Tooth%20disease%2CEmery-Dreifuss%20muscular%20dystrophy%2Cnot%20specified%2CEmery-Dreifuss%20muscular%20dystrophy%202%2C%20autosomal%20dominant%2CFamilial%20partial%20lipodystrophy%2C%20Dunnigan%20type%2CCardiovascular%20phenotype%2CDilated%20cardiomyopathy%201A%2CLipoatrophy%20with%20Diabetes%2C%20Hepatic%20Steatosis%2C%20Hypertrophic%20Cardiomyopathy%2C%20and%20Leukomelanodermic%20Papules%2CPrimary%20dilated%20cardiomyopathy%2CLethal%20tight%20skin%20contracture%20syndrome%2CCharcot-Marie-Tooth%20disease%20type%202%2CCongenital%20muscular%20dystrophy%20due%20to%20LMNA%20mutation%2CHutchinson-Gilford%20syndrome%2CCharcot-Marie-Tooth%20disease%20type%202B1%2CMandibuloacral%20dysplasia%20with%20type%20A%20lipodystrophy%2CLimb-girdle%20muscular%20dystrophy%2C%20recessive%2CCardiomyopathy%2Cnot%20provided%20GENE%3DLMNA]%3B;dbSNP=rs12117552;gnomAD=0.00706;gnomAD_sub=0.00231%2C0.00438%2C0.00000%2C0.00841%2C0.02755;gnomAD_hom_hemi=6%2C;gnomAD_het=1064;gnomAD_wt=151278;phyloP=2.3390;CADD=10.29;MaxEntScan=/0.0>0.0/0.0>0.0;SpliceAI=LMNA|0.00|0.00|0.00|0.00|2|-24|30|22;PubMed=25741868%2C24033266%2C22340368%2C28785654%2C18414213%2C23757202%2C27841901%2C15998779%2C27923400%2C27896052%2C15475483%2C24721642;NGSD_hom=21;NGSD_het=1022;NGSD_mosaic=1;NGSD_group=1%20/%2097;classification=2;classification_comment="[2]%20old%20entry%20-%20no%20details%20available";gene_info=LMNA%20(inh%3DAR+AD%20oe_syn%3D0.95%20oe_mis%3D0.67%20oe_lof%3D0.07)	GT	1/0
chr1	156158429	.	T	C	2743	.	quality=DP%3D214%3BQD%3D12.82%3BAF%3D0.50%3BMQM%3D60%3BSAP%3D4%3BABP%3D3%3BSAR%3D56%3BSAF%3D51;gene=SEMA4A;variant_type=synonymous%2Cintron;coding_and_splicing=SEMA4A:ENST00000355014.6:synonymous_variant:LOW:exon5/15:c.405T>C:p.Asn135%3D:%2CSEMA4A:ENST00000368284.5:intron_variant:MODIFIER:intron3/12:c.67-290T>C::%2CSEMA4A:ENST00000368285.8:synonymous_variant:LOW:exon5/15:c.405T>C:p.Asn135%3D:%2CSEMA4A:ENST00000368282.1:synonymous_variant:LOW:exon4/14:c.405T>C:p.Asn135%3D:;regulatory=regulatory_region_variant:open_chromatin_region;OMIM=607292_[GENE%3DSEMA4A_PHENOS%3DRetinitis%20pigmentosa%2035%2C%20610282%20(3)%2C%20Autosomal%20recessive%3B%20Cone-rod%20dystrophy%2010%2C%20610283%20(3)%2C%20Autosomal%20recessive];ClinVar=292845%20[likely%20benign(replaced%20by%20megSAP%20based%20on%20classifications:3x2%2C2x3)%20DISEASE%3DRetinitis%20Pigmentosa%2C%20Recessive%2Cnot%20provided%2CRetinitis%20pigmentosa%2CCone-rod%20dystrophy%2010%20GENE%3DSEMA4A]%3B;dbSNP=rs56271605;gnomAD=0.00041;gnomAD_sub=0.00000%2C0.00072%2C0.00000%2C0.00075%2C0.00000;gnomAD_hom_hemi=0%2C;gnomAD_het=63;gnomAD_wt=151951;phyloP=-1.5520;CADD=0.46;MaxEntScan=/0.6>1.5/0.0>0.0;SpliceAI=SEMA4A|0.04|0.00|0.00|0.00|-35|39|46|0;NGSD_hom=0;NGSD_het=57;NGSD_mosaic=0;NGSD_group=0%20/%208;gene_info=SEMA4A%20(inh%3DAR+AD%20oe_syn%3D0.96%20oe_mis%3D0.97%20oe_lof%3D0.41)	GT	1/0
chr1	156860987	.	G	A	1246	.	quality=DP%3D115%3BQD%3D10.83%3BAF%3D0.46%3BMQM%3D60%3BSAP%3D15%3BABP%3D5%3BSAR%3D18%3BSAF%3D35;gene=NTRK1%2CINSRR;variant_type=intron%2Cmissense%2Cupstream_gene;coding_and_splicing=NTRK1:ENST00000674537.2:intron_variant:MODIFIER:intron3/17:c.51-3367G>A::%2CNTRK1:ENST00000392302.7:intron_variant:MODIFIER:intron2/16:c.51-3367G>A::%2CNTRK1:ENST00000368196.7:missense_variant:MODERATE:exon1/16:c.53G>A:p.Gly18Glu:%2CNTRK1:ENST00000524377.7:missense_variant:MODERATE:exon1/17:c.53G>A:p.Gly18Glu:%2CNTRK1:ENST00000358660.3:missense_variant:MODERATE:exon1/16:c.53G>A:p.Gly18Glu:%2CNTRK1:ENST00000675461.1:missense_variant:MODERATE:exon1/4:c.53G>A:p.Gly18Glu:%2CINSRR:ENST00000368195.4:upstream_gene_variant:MODIFIER::::;regulatory=regulatory_region_variant:open_chromatin_region;OMIM=191315_[GENE%3DNTRK1_PHENOS%3DInsensitivity%20to%20pain%2C%20congenital%2C%20with%20anhidrosis%2C%20256800%20(3)%2C%20Autosomal%20recessive];ClinVar=193129%20[benign/likely%20benign%20DISEASE%3Dnot%20provided%2Cnot%20specified%2CHereditary%20insensitivity%20to%20pain%20with%20anhidrosis%20GENE%3DNTRK1]%3B;HGMD=CM2014107%20[CLASS%3DDM?%20MUT%3DALT%20PHEN%3D"Uveitis"%20GENE%3DNTRK1]%3B;dbSNP=rs1007211;gnomAD=0.00908;gnomAD_sub=0.00274%2C0.00653%2C0.00019%2C0.01557%2C0.00062;gnomAD_hom_hemi=11%2C;gnomAD_het=1361;gnomAD_wt=150913;phyloP=0.2220;CADD=20.10;REVEL=0.130;AlphaMissense=0.13;MaxEntScan=/0.0>0.0/0.0>0.0;COSMIC=COSV62325362;SpliceAI=NTRK1|0.00|0.00|0.00|0.00|2|10|21|-43;PubMed=11748840%2C22397633%2C23241418%2C16373086%2C18179783%2C27544236%2C19598235;NGSD_hom=7;NGSD_het=1108;NGSD_mosaic=0;NGSD_group=2%20/%20119;classification=1;classification_comment="[1]%20ahbuchr1%2023.09.2016%20MAF>1%25";gene_info=NTRK1%20(inh%3DAR%20oe_syn%3D1.00%20oe_mis%3D0.87%20oe_lof%3D0.43)%2C%20INSRR%20(inh%3Dn/a%20oe_syn%3D1.00%20oe_mis%3D0.92%20oe_lof%3D0.74)	GT	1/0
chr1	171636247	.	T	C	4275	.	quality=DP%3D363%3BQD%3D11.78%3BAF%3D0.47%3BMQM%3D60%3BSAP%3D9%3BABP%3D6%3BSAR%3D74%3BSAF%3D96;gene=MYOCOS%2CMYOC;variant_type=intron%2Cmissense;coding_and_splicing=MYOCOS:ENST00000637303.1:intron_variant:MODIFIER:intron3/3:c.235-2383T>C::%2CMYOC:ENST00000037502.11:missense_variant:MODERATE:exon3/3:c.1193A>G:p.Lys398Arg:PF02191%20[Olfactomedin-like%20domain];OMIM=601652_[GENE%3DMYOC_PHENOS%3DGlaucoma%201A%2C%20primary%20open%20angle%2C%20137750%20(3)%2C%20Autosomal%20dominant];ClinVar=403218%20[likely%20benign%20DISEASE%3DGlaucoma%2CGlaucoma%20of%20childhood%2CMYOC-related%20disorder%2CGlaucoma%201%2C%20open%20angle%2C%20A%2Cnot%20provided%2Cnot%20specified%20GENE%3DMYOC]%3B;HGMD=CM004363%20[CLASS%3DDM?%20MUT%3DALT%20PHEN%3D"Glaucoma%201%20open%20angle"%20GENE%3DMYOC]%3B;dbSNP=rs56314834;gnomAD=0.00396;gnomAD_sub=0.00142%2C0.00458%2C0.00000%2C0.00670%2C0.00000;gnomAD_hom_hemi=6%2C;gnomAD_het=591;gnomAD_wt=151663;phyloP=0.5380;CADD=11.57;REVEL=0.207;AlphaMissense=0.08;MaxEntScan=/0.0>0.0/0.0>0.0%2C/0.0>0.0/3.4>1.4;COSMIC=COSV99078735;SpliceAI=MYOC|0.00|0.00|0.00|0.00|14|-33|5|-2;PubMed=24033266%2C20668460%2C22933836%2C11004290%2C25524706%2C30816137%2C11152659%2C10196380%2C16466712%2C10545602;NGSD_hom=2;NGSD_het=324;NGSD_mosaic=0;NGSD_group=1%20/%2041;gene_info=MYOCOS%20(inh%3Dn/a%20oe_syn%3Dn/a%20oe_mis%3Dn/a%20oe_lof%3Dn/a)%2C%20MYOC%20(inh%3DAR+AD%20oe_syn%3D1.01%20oe_mis%3D0.91%20oe_lof%3D0.85)	GT	1/0
chr1	186977737	.	A	G	862	.	quality=DP%3D87%3BQD%3D9.91%3BAF%3D0.43%3BMQM%3D60%3BSAP%3D29%3BABP%3D7%3BSAR%3D29%3BSAF%3D8;gene=PLA2G4A;variant_type=missense;coding_and_splicing=PLA2G4A:ENST00000367466.4:missense_variant:MODERATE:exon16/18:c.1909A>G:p.Ile637Val:PF01735%20[Lysophospholipase%20catalytic%20domain];OMIM=600522_[GENE%3DPLA2G4A_PHENOS%3DGastrointestinal%20ulceration%2C%20recurrent%2C%20with%20dysfunctional%20platelets%2C%20618372%20(3)%2C%20Autosomal%20recessive];ClinVar=770331%20[benign%20DISEASE%3Dnot%20provided%20GENE%3DPLA2G4A]%3B;dbSNP=rs28395831;gnomAD=0.00706;gnomAD_sub=0.00205%2C0.00706%2C0.00019%2C0.00942%2C0.01407;gnomAD_hom_hemi=4%2C;gnomAD_het=1068;gnomAD_wt=151228;phyloP=3.2590;CADD=16.52;REVEL=0.035;AlphaMissense=0.06;MaxEntScan=/0.0>0.0/0.0>0.0;COSMIC=COSV100820786;SpliceAI=PLA2G4A|0.00|0.00|0.00|0.00|-30|35|37|-3;NGSD_hom=21;NGSD_het=1031;NGSD_mosaic=1;NGSD_group=2%20/%2094;gene_info=PLA2G4A%20(inh%3DAR%20oe_syn%3D1.01%20oe_mis%3D0.67%20oe_lof%3D0.38)	GT	1/0
chr1	201361940	.	A	G	1754	.	quality=DP%3D137%3BQD%3D12.80%3BAF%3D0.51%3BMQM%3D60%3BSAP%3D39%3BABP%3D3%3BSAR%3D18%3BSAF%3D52;gene=TNNT2;variant_type=missense;coding_and_splicing=TNNT2:ENST00000455702.7:missense_variant:MODERATE:exon13/16:c.677T>C:p.Ile226Thr:PF00992%20[Troponin]%2CTNNT2:ENST00000660295.1:missense_variant:MODERATE:exon14/17:c.662T>C:p.Ile221Thr:PF00992%20[Troponin]%2CTNNT2:ENST00000714312.1:missense_variant:MODERATE:exon12/15:c.485T>C:p.Ile162Thr:PF00992%20[Troponin]%2CTNNT2:ENST00000367318.10:missense_variant:MODERATE:exon13/16:c.662T>C:p.Ile221Thr:PF00992%20[Troponin]%2CTNNT2:ENST00000422165.6:missense_variant:MODERATE:exon13/16:c.683T>C:p.Ile228Thr:PF00992%20[Troponin]%2CTNNT2:ENST00000656932.1:missense_variant:MODERATE:exon14/17:c.692T>C:p.Ile231Thr:PF00992%20[Troponin]%2CTNNT2:ENST00000714313.1:missense_variant:MODERATE:exon11/14:c.530T>C:p.Ile177Thr:PF00992%20[Troponin]%2CTNNT2:ENST00000714314.1:missense_variant:MODERATE:exon15/18:c.692T>C:p.Ile231Thr:PF00992%20[Troponin]%2CTNNT2:ENST00000367322.6:missense_variant:MODERATE:exon12/15:c.650T>C:p.Ile217Thr:PF00992%20[Troponin]%2CTNNT2:ENST00000658476.1:missense_variant:MODERATE:exon12/15:c.662T>C:p.Ile221Thr:PF00992%20[Troponin]%2CTNNT2:ENST00000412633.3:missense_variant:MODERATE:exon12/15:c.653T>C:p.Ile218Thr:PF00992%20[Troponin]%2CTNNT2:ENST00000714316.2:missense_variant:MODERATE:exon13/16:c.659T>C:p.Ile220Thr:PF00992%20[Troponin]%2CTNNT2:ENST00000367320.6:missense_variant:MODERATE:exon12/15:c.563T>C:p.Ile188Thr:PF00992%20[Troponin]%2CTNNT2:ENST00000509001.5:missense_variant:MODERATE:exon13/16:c.662T>C:p.Ile221Thr:PF00992%20[Troponin]%2CTNNT2:ENST00000714317.1:missense_variant:MODERATE:exon12/15:c.485T>C:p.Ile162Thr:PF00992%20[Troponin]%2CTNNT2:ENST00000438742.6:missense_variant:MODERATE:exon12/15:c.641T>C:p.Ile214Thr:PF00992%20[Troponin];regulatory=regulatory_region_variant:CTCF_binding_site;OMIM=191045_[GENE%3DTNNT2_PHENOS%3DCardiomyopathy%2C%20dilated%2C%201D%2C%20601494%20(3)%2C%20Autosomal%20dominant%3B%20Cardiomyopathy%2C%20hypertrophic%2C%202%2C%20115195%20(3)%2C%20Autosomal%20dominant%3B%20Cardiomyopathy%2C%20familial%20restrictive%2C%203%2C%20612422%20(3)%2C%20Autosomal%20dominant%3B%20Left%20ventricular%20noncompaction%206%2C%20601494%20(3)%2C%20Autosomal%20dominant];ClinVar=181604%20[uncertain%20significance(replaced%20by%20megSAP%20based%20on%20classifications:1x1%2C3x2%2C9x3)%20DISEASE%3DHypertrophic%20cardiomyopathy%202%2CCardiomyopathy%2C%20familial%20restrictive%2C%203%2CDilated%20cardiomyopathy%201D%2CCardiomyopathy%2CDilated%20Cardiomyopathy%2C%20Dominant%2Cnot%20provided%2CCardiovascular%20phenotype%2Cnot%20specified%2CLeft%20ventricular%20noncompaction%20cardiomyopathy%20GENE%3DTNNT2]%3B;HGMD=CM1310647%20[CLASS%3DDM%20MUT%3DALT%20PHEN%3D"Cardiomyopathy%20hypertrophic"%20GENE%3DTNNT2]%3B;dbSNP=rs45520032;gnomAD=0.00014;gnomAD_sub=0.00007%2C0.00039%2C0.00000%2C0.00018%2C0.00000;gnomAD_hom_hemi=0%2C;gnomAD_het=22;gnomAD_wt=152274;phyloP=7.3940;CADD=25.50;REVEL=0.906;AlphaMissense=0.25;MaxEntScan=/0.0>0.0/0.0>0.0;SpliceAI=TNNT2|0.00|0.00|0.00|0.00|10|11|-29|11;PubMed=24033266%2C18414213%2C24093860%2C22958901%2C30763825%2C32880476%2C26507537%2C28255936%2C33025817%2C30297972;NGSD_hom=0;NGSD_het=19;NGSD_mosaic=0;NGSD_group=0%20/%202;gene_info=TNNT2%20(inh%3DAD%20oe_syn%3D0.99%20oe_mis%3D0.74%20oe_lof%3D0.37)	GT	1/0
chr1	204954892	.	C	T	3880	.	quality=DP%3D316%3BQD%3D12.28%3BAF%3D0.48%3BMQM%3D60%3BSAP%3D8%3BABP%3D4%3BSAR%3D67%3BSAF%3D86;gene=NFASC;variant_type=missense;coding_and_splicing=NFASC:ENST00000339876.11:missense_variant:MODERATE:exon7/30:c.476C>T:p.Thr159Met:PF00047%20[Immunoglobulin%20domain]%2CNFASC:ENST00000680427.1:missense_variant:MODERATE:exon6/16:c.458C>T:p.Thr153Met:PF00047%20[Immunoglobulin%20domain]%2CNFASC:ENST00000403080.5:missense_variant:MODERATE:exon7/16:c.476C>T:p.Thr159Met:PF00047%20[Immunoglobulin%20domain]%2CNFASC:ENST00000513543.6:missense_variant:MODERATE:exon6/27:c.458C>T:p.Thr153Met:PF00047%20[Immunoglobulin%20domain]%2CNFASC:ENST00000430393.7:missense_variant:MODERATE:exon6/28:c.458C>T:p.Thr153Met:PF00047%20[Immunoglobulin%20domain]%2CNFASC:ENST00000404076.5:missense_variant:MODERATE:exon6/27:c.458C>T:p.Thr153Met:PF00047%20[Immunoglobulin%20domain]%2CNFASC:ENST00000539706.6:missense_variant:MODERATE:exon5/28:c.458C>T:p.Thr153Met:PF00047%20[Immunoglobulin%20domain]%2CNFASC:ENST00000401399.5:missense_variant:MODERATE:exon6/29:c.476C>T:p.Thr159Met:PF00047%20[Immunoglobulin%20domain];OMIM=609145_[GENE%3DNFASC_PHENOS%3DNeurodevelopmental%20disorder%20with%20central%20and%20peripheral%20motor%20dysfunction%2C%20618356%20(3)%2C%20Autosomal%20recessive];ClinVar=709848%20[benign/likely%20benign%20DISEASE%3Dnot%20provided%20GENE%3DNFASC]%3B;dbSNP=rs3795564;gnomAD=0.00908;gnomAD_sub=0.00147%2C0.00353%2C0.01003%2C0.00806%2C0.01036;gnomAD_hom_hemi=32%2C;gnomAD_het=1318;gnomAD_wt=150890;phyloP=3.2810;CADD=25.00;REVEL=0.108;MaxEntScan=/4.6>5.5/0.0>0.0;SpliceAI=NFASC|0.00|0.00|0.00|0.00|-43|8|-43|37;NGSD_hom=3;NGSD_het=739;NGSD_mosaic=1;NGSD_group=0%20/%2077;gene_info=NFASC%20(inh%3DAR%20oe_syn%3D0.98%20oe_mis%3D0.74%20oe_lof%3D0.12)	GT	1/0
chr1	204975313	.	G	A	2758	.	quality=DP%3D212%3BQD%3D13.01%3BAF%3D0.52%3BMQM%3D60%3BSAP%3D45%3BABP%3D4%3BSAR%3D32%3BSAF%3D78;gene=NFASC;variant_type=missense;coding_and_splicing=NFASC:ENST00000339876.11:missense_variant:MODERATE:exon15/30:c.1601G>A:p.Arg534Lys:PF07679%20[Immunoglobulin%20I-set%20domain]%2CNFASC:ENST00000680427.1:missense_variant:MODERATE:exon15/16:c.1634G>A:p.Arg545Lys:PF07679%20[Immunoglobulin%20I-set%20domain]%2CNFASC:ENST00000403080.5:missense_variant:MODERATE:exon15/16:c.1601G>A:p.Arg534Lys:PF07679%20[Immunoglobulin%20I-set%20domain]%2CNFASC:ENST00000513543.6:missense_variant:MODERATE:exon15/27:c.1634G>A:p.Arg545Lys:PF07679%20[Immunoglobulin%20I-set%20domain]%2CNFASC:ENST00000430393.7:missense_variant:MODERATE:exon15/28:c.1634G>A:p.Arg545Lys:PF07679%20[Immunoglobulin%20I-set%20domain]%2CNFASC:ENST00000404076.5:missense_variant:MODERATE:exon14/27:c.1583G>A:p.Arg528Lys:PF07679%20[Immunoglobulin%20I-set%20domain]%2CNFASC:ENST00000539706.6:missense_variant:MODERATE:exon14/28:c.1634G>A:p.Arg545Lys:PF07679%20[Immunoglobulin%20I-set%20domain]%2CNFASC:ENST00000401399.5:missense_variant:MODERATE:exon14/29:c.1601G>A:p.Arg534Lys:PF07679%20[Immunoglobulin%20I-set%20domain];regulatory=regulatory_region_variant:enhancer%2Cregulatory_region_variant:CTCF_binding_site;OMIM=609145_[GENE%3DNFASC_PHENOS%3DNeurodevelopmental%20disorder%20with%20central%20and%20peripheral%20motor%20dysfunction%2C%20618356%20(3)%2C%20Autosomal%20recessive];ClinVar=723068%20[benign/likely%20benign%20DISEASE%3Dnot%20provided%20GENE%3DNFASC]%3B;dbSNP=rs56223230;gnomAD=0.00578;gnomAD_sub=0.00243%2C0.00307%2C0.00522%2C0.00591%2C0.01014;gnomAD_hom_hemi=11%2C;gnomAD_het=858;gnomAD_wt=151446;phyloP=1.3060;CADD=15.37;REVEL=0.091;MaxEntScan=/0.0>0.0/0.0>0.0;SpliceAI=NFASC|0.00|0.00|0.00|0.00|20|-32|-8|31;NGSD_hom=1;NGSD_het=520;NGSD_mosaic=0;NGSD_group=0%20/%2058;gene_info=NFASC%20(inh%3DAR%20oe_syn%3D0.98%20oe_mis%3D0.74%20oe_lof%3D0.12)	GT	1/0
chr1	204975326	.	G	A	3096	.	quality=DP%3D228%3BQD%3D13.58%3BAF%3D0.54%3BMQM%3D60%3BSAP%3D16%3BABP%3D6%3BSAR%3D48%3BSAF%3D75;gene=NFASC;variant_type=synonymous;coding_and_splicing=NFASC:ENST00000339876.11:synonymous_variant:LOW:exon15/30:c.1614G>A:p.Thr538%3D:PF07679%20[Immunoglobulin%20I-set%20domain]%2CNFASC:ENST00000680427.1:synonymous_variant:LOW:exon15/16:c.1647G>A:p.Thr549%3D:PF07679%20[Immunoglobulin%20I-set%20domain]%2CNFASC:ENST00000403080.5:synonymous_variant:LOW:exon15/16:c.1614G>A:p.Thr538%3D:PF07679%20[Immunoglobulin%20I-set%20domain]%2CNFASC:ENST00000513543.6:synonymous_variant:LOW:exon15/27:c.1647G>A:p.Thr549%3D:PF07679%20[Immunoglobulin%20I-set%20domain]%2CNFASC:ENST00000430393.7:synonymous_variant:LOW:exon15/28:c.1647G>A:p.Thr549%3D:PF07679%20[Immunoglobulin%20I-set%20domain]%2CNFASC:ENST00000404076.5:synonymous_variant:LOW:exon14/27:c.1596G>A:p.Thr532%3D:PF07679%20[Immunoglobulin%20I-set%20domain]%2CNFASC:ENST00000539706.6:synonymous_variant:LOW:exon14/28:c.1647G>A:p.Thr549%3D:PF07679%20[Immunoglobulin%20I-set%20domain]%2CNFASC:ENST00000401399.5:synonymous_variant:LOW:exon14/29:c.1614G>A:p.Thr538%3D:PF07679%20[Immunoglobulin%20I-set%20domain];regulatory=regulatory_region_variant:enhancer%2Cregulatory_region_variant:CTCF_binding_site;OMIM=609145_[GENE%3DNFASC_PHENOS%3DNeurodevelopmental%20disorder%20with%20central%20and%20peripheral%20motor%20dysfunction%2C%20618356%20(3)%2C%20Autosomal%20recessive];ClinVar=723069%20[benign/likely%20benign%20DISEASE%3Dnot%20provided%20GENE%3DNFASC]%3B;dbSNP=rs55969362;gnomAD=0.00562;gnomAD_sub=0.00180%2C0.00307%2C0.00542%2C0.00591%2C0.01036;gnomAD_hom_hemi=11%2C;gnomAD_het=834;gnomAD_wt=151426;phyloP=-2.0240;CADD=0.89;REVEL=0.070;MaxEntScan=/0.0>0.0/1.9>0.0;SpliceAI=NFASC|0.00|0.00|0.00|0.00|2|-45|18|0;NGSD_hom=1;NGSD_het=520;NGSD_mosaic=0;NGSD_group=0%20/%2058;gene_info=NFASC%20(inh%3DAR%20oe_syn%3D0.98%20oe_mis%3D0.74%20oe_lof%3D0.12)	GT	1/0
chr1	204975408	.	A	G	2705	.	quality=DP%3D221%3BQD%3D12.24%3BAF%3D0.48%3BMQM%3D60%3BSAP%3D43%3BABP%3D4%3BSAR%3D75%3BSAF%3D31;gene=NFASC;variant_type=missense;coding_and_splicing=NFASC:ENST00000339876.11:missense_variant:MODERATE:exon15/30:c.1696A>G:p.Ile566Val:PF07679%20[Immunoglobulin%20I-set%20domain]%2CNFASC:ENST00000680427.1:missense_variant:MODERATE:exon15/16:c.1729A>G:p.Ile577Val:PF07679%20[Immunoglobulin%20I-set%20domain]%2CNFASC:ENST00000403080.5:missense_variant:MODERATE:exon15/16:c.1696A>G:p.Ile566Val:PF07679%20[Immunoglobulin%20I-set%20domain]%2CNFASC:ENST00000513543.6:missense_variant:MODERATE:exon15/27:c.1729A>G:p.Ile577Val:PF07679%20[Immunoglobulin%20I-set%20domain]%2CNFASC:ENST00000430393.7:missense_variant:MODERATE:exon15/28:c.1729A>G:p.Ile577Val:PF07679%20[Immunoglobulin%20I-set%20domain]%2CNFASC:ENST00000404076.5:missense_variant:MODERATE:exon14/27:c.1678A>G:p.Ile560Val:PF07679%20[Immunoglobulin%20I-set%20domain]%2CNFASC:ENST00000539706.6:missense_variant:MODERATE:exon14/28:c.1729A>G:p.Ile577Val:PF07679%20[Immunoglobulin%20I-set%20domain]%2CNFASC:ENST00000401399.5:missense_variant:MODERATE:exon14/29:c.1696A>G:p.Ile566Val:PF07679%20[Immunoglobulin%20I-set%20domain];regulatory=regulatory_region_variant:enhancer%2Cregulatory_region_variant:CTCF_binding_site;OMIM=609145_[GENE%3DNFASC_PHENOS%3DNeurodevelopmental%20disorder%20with%20central%20and%20peripheral%20motor%20dysfunction%2C%20618356%20(3)%2C%20Autosomal%20recessive];ClinVar=723070%20[benign/likely%20benign%20DISEASE%3Dnot%20provided%20GENE%3DNFASC]%3B;dbSNP=rs55778126;gnomAD=0.00545;gnomAD_sub=0.00118%2C0.00307%2C0.00541%2C0.00591%2C0.01036;gnomAD_hom_hemi=11%2C;gnomAD_het=808;gnomAD_wt=151448;phyloP=0.0650;CADD=14.59;REVEL=0.068;MaxEntScan=/4.3>5.6/0.0>0.0;COSMIC=COSV58374492;SpliceAI=NFASC|0.00|0.00|0.01|0.02|39|11|-1|10;NGSD_hom=1;NGSD_het=520;NGSD_mosaic=1;NGSD_group=0%20/%2058;gene_info=NFASC%20(inh%3DAR%20oe_syn%3D0.98%20oe_mis%3D0.74%20oe_lof%3D0.12)	GT	1/0
chr1	204976686	.	C	T	2035	.	quality=DP%3D209%3BQD%3D9.74%3BAF%3D0.42%3BMQM%3D60%3BSAP%3D24%3BABP%3D16%3BSAR%3D29%3BSAF%3D58;gene=NFASC;variant_type=synonymous;coding_and_splicing=NFASC:ENST00000339876.11:synonymous_variant:LOW:exon16/30:c.1722C>T:p.Asp574%3D:PF07679%20[Immunoglobulin%20I-set%20domain]%2CNFASC:ENST00000680427.1:synonymous_variant:LOW:exon16/16:c.1755C>T:p.Asp585%3D:PF07679%20[Immunoglobulin%20I-set%20domain]%2CNFASC:ENST00000403080.5:synonymous_variant:LOW:exon16/16:c.1722C>T:p.Asp574%3D:PF07679%20[Immunoglobulin%20I-set%20domain]%2CNFASC:ENST00000513543.6:synonymous_variant:LOW:exon16/27:c.1755C>T:p.Asp585%3D:PF07679%20[Immunoglobulin%20I-set%20domain]%2CNFASC:ENST00000430393.7:synonymous_variant:LOW:exon16/28:c.1755C>T:p.Asp585%3D:PF07679%20[Immunoglobulin%20I-set%20domain]%2CNFASC:ENST00000404076.5:synonymous_variant:LOW:exon15/27:c.1704C>T:p.Asp568%3D:PF07679%20[Immunoglobulin%20I-set%20domain]%2CNFASC:ENST00000539706.6:synonymous_variant:LOW:exon15/28:c.1755C>T:p.Asp585%3D:PF07679%20[Immunoglobulin%20I-set%20domain]%2CNFASC:ENST00000401399.5:synonymous_variant:LOW:exon15/29:c.1722C>T:p.Asp574%3D:PF07679%20[Immunoglobulin%20I-set%20domain];regulatory=regulatory_region_variant:enhancer;OMIM=609145_[GENE%3DNFASC_PHENOS%3DNeurodevelopmental%20disorder%20with%20central%20and%20peripheral%20motor%20dysfunction%2C%20618356%20(3)%2C%20Autosomal%20recessive];ClinVar=723071%20[benign/likely%20benign%20DISEASE%3Dnot%20provided%20GENE%3DNFASC]%3B;dbSNP=rs55726173;gnomAD=0.00550;gnomAD_sub=0.00130%2C0.00301%2C0.00541%2C0.00592%2C0.01035;gnomAD_hom_hemi=12%2C;gnomAD_het=814;gnomAD_wt=151496;phyloP=-4.5860;CADD=0.16;REVEL=0.182;MaxEntScan=/0.0>0.0/0.0>0.0;SpliceAI=NFASC|0.00|0.00|0.00|0.00|29|-15|21|50;NGSD_hom=1;NGSD_het=520;NGSD_mosaic=0;NGSD_group=0%20/%2058;gene_info=NFASC%20(inh%3DAR%20oe_syn%3D0.98%20oe_mis%3D0.74%20oe_lof%3D0.12)	GT	1/0
chr1	210683919	.	C	T	2816	.	quality=DP%3D245%3BQD%3D11.49%3BAF%3D0.46%3BMQM%3D60%3BSAP%3D24%3BABP%3D6%3BSAR%3D73%3BSAF%3D40;gene=KCNH1;variant_type=missense;coding_and_splicing=KCNH1:ENST00000367007.5:missense_variant:MODERATE:exon11/12:c.2251G>A:p.Ala751Thr:%2CKCNH1:ENST00000638498.1:missense_variant:MODERATE:exon11/12:c.2332G>A:p.Ala778Thr:%2CKCNH1:ENST00000271751.10:missense_variant:MODERATE:exon11/11:c.2332G>A:p.Ala778Thr:%2CKCNH1:ENST00000639952.1:missense_variant:MODERATE:exon11/11:c.2251G>A:p.Ala751Thr:%2CKCNH1:ENST00000640044.1:missense_variant:MODERATE:exon7/7:c.1180G>A:p.Ala394Thr:%2CKCNH1:ENST00000640566.1:missense_variant:MODERATE:exon5/5:c.727G>A:p.Ala243Thr:;OMIM=603305_[GENE%3DKCNH1_PHENOS%3DZimmermann-Laband%20syndrome%201%2C%20135500%20(3)%2C%20Autosomal%20dominant%3B%20Temple-Baraitser%20syndrome%2C%20611816%20(3)%2C%20Autosomal%20dominant];ClinVar=1634135%20[likely%20benign%20DISEASE%3Dnot%20provided%2CKCNH1-related%20disorder%20GENE%3DKCNH1]%3B;dbSNP=rs72751436;gnomAD=0.00018;gnomAD_sub=0.00002%2C0.00105%2C0.00000%2C0.00016%2C0.00000;gnomAD_hom_hemi=0%2C;gnomAD_het=28;gnomAD_wt=152264;phyloP=-0.0050;CADD=14.93;REVEL=0.157;AlphaMissense=0.06;MaxEntScan=/5.2>4.8/0.0>0.0;SpliceAI=KCNH1|0.00|0.00|0.00|0.00|-11|11|-20|-35;NGSD_hom=0;NGSD_het=22;NGSD_mosaic=1;NGSD_group=0%20/%202;gene_info=KCNH1%20(inh%3DAD%20oe_syn%3D0.99%20oe_mis%3D0.55%20oe_lof%3D0.21)	GT	1/0
chr1	214657249	.	A	G	1301	.	quality=DP%3D123%3BQD%3D10.58%3BAF%3D0.44%3BMQM%3D60%3BSAP%3D3%3BABP%3D7%3BSAR%3D28%3BSAF%3D26;gene=CENPF;variant_type=synonymous;coding_and_splicing=CENPF:ENST00000706765.1:synonymous_variant:LOW:exon17/19:c.8625A>G:p.Arg2875%3D:%2CCENPF:ENST00000366955.8:synonymous_variant:LOW:exon18/20:c.8802A>G:p.Arg2934%3D:;OMIM=600236_[GENE%3DCENPF_PHENOS%3DStromme%20syndrome%2C%20243605%20(3)%2C%20Autosomal%20recessive];ClinVar=735749%20[likely%20benign%20DISEASE%3Dnot%20provided%20GENE%3DCENPF]%3B;dbSNP=rs72759668;gnomAD=0.00016;gnomAD_sub=0.00005%2C0.00000%2C0.00000%2C0.00032%2C0.00000;gnomAD_hom_hemi=0%2C;gnomAD_het=25;gnomAD_wt=152275;phyloP=1.7800;CADD=7.81;MaxEntScan=/0.0>0.0/0.0>0.0;SpliceAI=CENPF|0.00|0.00|0.00|0.00|50|-44|-1|22;NGSD_hom=0;NGSD_het=34;NGSD_mosaic=0;NGSD_group=0%20/%205;gene_info=CENPF%20(inh%3DAR%20oe_syn%3D1.02%20oe_mis%3D1.00%20oe_lof%3D0.61)	GT	1/0
chr1	215671031	.	C	T	1646	.	quality=DP%3D141%3BQD%3D11.67%3BAF%3D0.48%3BMQM%3D60%3BSAP%3D11%3BABP%3D3%3BSAR%3D26%3BSAF%3D42;gene=USH2A;variant_type=missense;coding_and_splicing=USH2A:ENST00000307340.8:missense_variant:MODERATE:exon64/72:c.14074G>A:p.Gly4692Arg:%2CUSH2A:ENST00000674083.1:missense_variant:MODERATE:exon64/73:c.14074G>A:p.Gly4692Arg:;regulatory=regulatory_region_variant:enhancer;OMIM=608400_[GENE%3DUSH2A_PHENOS%3DUsher%20syndrome%2C%20type%202A%2C%20276901%20(3)%2C%20Autosomal%20recessive%3B%20Retinitis%20pigmentosa%2039%2C%20613809%20(3)%2C%20Autosomal%20recessive];ClinVar=48427%20[benign/likely%20benign%20DISEASE%3DUsher%20syndrome%20type%202A%2Cnot%20provided%2CRetinitis%20pigmentosa%2039%2Cnot%20specified%20GENE%3DUSH2A]%3B%20560515%20[pathogenic%20DISEASE%3DRetinitis%20pigmentosa%2039%20GENE%3DUSH2A]%3B;HGMD=CM095516%20[CLASS%3DDM?%20MUT%3DALT%20PHEN%3D"Usher%20syndrome%202A"%20GENE%3DUSH2A]%3B;dbSNP=rs45549044;gnomAD=0.00421;gnomAD_sub=0.00149%2C0.00137%2C0.00000%2C0.00745%2C0.00353;gnomAD_hom_hemi=2%2C;gnomAD_het=637;gnomAD_wt=151563;phyloP=3.4840;CADD=23.90;REVEL=0.433;AlphaMissense=0.34;MaxEntScan=/0.1>4.5/0.0>0.0;COSMIC=COSV56323371;SpliceAI=USH2A|0.00|0.00|0.00|0.00|-22|-10|-46|13;PubMed=24033266%2C20507924%2C22004887%2C25333064%2C19129697%2C25262649%2C22952768%2C31101089%2C26075083%2C28224992%2C29551606%2C26927203;NGSD_hom=2;NGSD_het=602;NGSD_mosaic=1;NGSD_group=0%20/%2060;classification=3;classification_comment="[3]%20ahmazzp1%2008.02.2023%202x%20hom%20in-house%20und%202x%20hom%20in%20gnomAD%2C%201x%20pathogen%2C%207x%20benign%2C%205x%20likely%20benign%20in%20ClinVar%2C%20beschrieben%20bei%20Patient%20mit%20Usher%20Syndrom%20in%20PMID%2019129697%20und%20mit%20nicht-syndromaler%20RP%20in%20PMID%2026927203%3B%20aufgrund%20der%20Hï¿½ufigkeit%20auch%20als%20(wahrscheinlich)%20benigne%20eingestuft%20in%20PMID%2030245029%2C%2022004887%2C%2025262649";gene_info=USH2A%20(inh%3DAR%20oe_syn%3D1.16%20oe_mis%3D1.13%20oe_lof%3D0.76)	GT	1/0
chr1	225877491	.	G	C	3736	.	quality=DP%3D259%3BQD%3D14.42%3BAF%3D0.55%3BMQM%3D60%3BSAP%3D10%3BABP%3D9%3BSAR%3D82%3BSAF%3D61;gene=TMEM63A;variant_type=synonymous;coding_and_splicing=TMEM63A:ENST00000366835.8:synonymous_variant:LOW:exon3/25:c.90C>G:p.Ser30%3D:;regulatory=regulatory_region_variant:CTCF_binding_site%2Cregulatory_region_variant:promoter%2CTF_binding_site_variant;OMIM=618685_[GENE%3DTMEM63A_PHENOS%3DLeukodystrophy%2C%20hypomyelinating%2C%2019%2C%20transient%20infantile%2C%20618688%20(3)%2C%20Autosomal%20dominant];ClinVar=2639967%20[likely%20benign%20DISEASE%3Dnot%20provided%20GENE%3DTMEM63A]%3B;dbSNP=rs72754986;gnomAD=0.00008;gnomAD_sub=0.00002%2C0.00000%2C0.00000%2C0.00016%2C0.00000;gnomAD_hom_hemi=0%2C;gnomAD_het=12;gnomAD_wt=152320;phyloP=0.4390;CADD=7.33;MaxEntScan=/0.0>0.0/0.0>0.0;SpliceAI=TMEM63A|0.00|0.00|0.00|0.00|29|-27|1|-42;NGSD_hom=0;NGSD_het=11;NGSD_mosaic=0;NGSD_group=0%20/%201;gene_info=TMEM63A%20(inh%3DAD%20oe_syn%3D0.94%20oe_mis%3D0.84%20oe_lof%3D0.60)	GT	1/0
chr1	235677195	.	G	T	1213	.	quality=DP%3D74%3BQD%3D16.39%3BAF%3D0.64%3BMQM%3D60%3BSAP%3D42%3BABP%3D15%3BSAR%3D38%3BSAF%3D9;gene=LYST;variant_type=splice_region&intron;coding_and_splicing=LYST:ENST00000389793.7:splice_region_variant&intron_variant:LOW:intron49/52:c.10941-7C>A::;OMIM=606897_[GENE%3DLYST_PHENOS%3DChediak-Higashi%20syndrome%2C%20214500%20(3)%2C%20Autosomal%20recessive];ClinVar=235367%20[likely%20benign(replaced%20by%20megSAP%20based%20on%20classifications:4x1%2C3x2%2C1x3)%20DISEASE%3Dnot%20specified%2CAutoinflammatory%20syndrome%2CChediak-Higashi%20syndrome%2Cnot%20provided%20GENE%3DLYST]%3B;dbSNP=rs72761794;gnomAD=0.00626;gnomAD_sub=0.00142%2C0.00406%2C0.00019%2C0.00981%2C0.01039;gnomAD_hom_hemi=4%2C;gnomAD_het=943;gnomAD_wt=151085;phyloP=0.4940;CADD=8.47;MaxEntScan=12.2>10.7/12.2>10.7/0.0>0.0;SpliceAI=LYST|0.00|0.01|0.00|0.00|-25|-7|-7|-16;PubMed=25741868;NGSD_hom=8;NGSD_het=850;NGSD_mosaic=0;NGSD_group=1%20/%2091;classification=2;classification_comment="[2]%20old%20entry%20-%20no%20details%20available";gene_info=LYST%20(inh%3DAR%20oe_syn%3D1.01%20oe_mis%3D0.91%20oe_lof%3D0.24)	GT	1/0
chr2	1477583	.	G	A	786	.	quality=DP%3D95%3BQD%3D8.27%3BAF%3D0.40%3BMQM%3D60%3BSAP%3D11%3BABP%3D11%3BSAR%3D25%3BSAF%3D13;gene=TPO;variant_type=synonymous%2Cintron;coding_and_splicing=TPO:ENST00000345913.8:synonymous_variant:LOW:exon8/17:c.1317G>A:p.Lys439%3D:PF03098%20[Animal%20haem%20peroxidase]%2CTPO:ENST00000329066.9:synonymous_variant:LOW:exon8/17:c.1317G>A:p.Lys439%3D:PF03098%20[Animal%20haem%20peroxidase]%2CTPO:ENST00000382201.7:synonymous_variant:LOW:exon8/16:c.1317G>A:p.Lys439%3D:PF03098%20[Animal%20haem%20peroxidase]%2CTPO:ENST00000346956.7:synonymous_variant:LOW:exon7/15:c.1317G>A:p.Lys439%3D:PF03098%20[Animal%20haem%20peroxidase]%2CTPO:ENST00000382198.5:intron_variant:MODIFIER:intron6/14:c.820-7013G>A::;OMIM=606765_[GENE%3DTPO_PHENOS%3DThyroid%20dyshormonogenesis%202A%2C%20274500%20(3)%2C%20Autosomal%20recessive];ClinVar=331317%20[likely%20benign(replaced%20by%20megSAP%20based%20on%20classifications:1x1%2C1x2%2C1x3)%20DISEASE%3Dnot%20provided%2CDeficiency%20of%20iodide%20peroxidase%20GENE%3DTPO]%3B;dbSNP=rs28910598;gnomAD=0.00164;gnomAD_sub=0.00070%2C0.00026%2C0.00000%2C0.00288%2C0.00000;gnomAD_hom_hemi=1%2C;gnomAD_het=248;gnomAD_wt=152110;phyloP=1.4200;CADD=8.30;REVEL=0.012;MaxEntScan=/0.0>0.0/0.0>0.0;SpliceAI=TPO|0.00|0.00|0.00|0.00|-11|0|21|0;NGSD_hom=1;NGSD_het=150;NGSD_mosaic=0;NGSD_group=0%20/%2021;gene_info=TPO%20(inh%3DAR%20oe_syn%3D1.07%20oe_mis%3D1.00%20oe_lof%3D0.84)	GT	1/0
chr2	21002628	.	A	G	1131	.	quality=DP%3D118%3BQD%3D9.58%3BAF%3D0.42%3BMQM%3D60%3BSAP%3D6%3BABP%3D9%3BSAR%3D29%3BSAF%3D21;gene=APOB;variant_type=missense;coding_and_splicing=APOB:ENST00000233242.5:missense_variant:MODERATE:exon29/29:c.12794T>C:p.Val4265Ala:;OMIM=107730_[GENE%3DAPOB_PHENOS%3DHypercholesterolemia%2C%20familial%2C%202%2C%20144010%20(3)%2C%20Autosomal%20dominant%3B%20Hypobetalipoproteinemia%2C%20615558%20(3)%2C%20Autosomal%20recessive];ClinVar=237738%20[likely%20benign(replaced%20by%20megSAP%20based%20on%20classifications:4x1%2C6x2%2C1x3)%20DISEASE%3DFamilial%20hypobetalipoproteinemia%201%2Cnot%20provided%2CHypercholesterolemia%2C%20familial%2C%201%2CHypercholesterolemia%2C%20autosomal%20dominant%2C%20type%20B%2CFamilial%20hypercholesterolemia%2Cnot%20specified%2CCardiovascular%20phenotype%20GENE%3DAPOB]%3B;HGMD=CM1510582%20[CLASS%3DDM?%20MUT%3DALT%20PHEN%3D"Hypercholesterolaemia"%20GENE%3DAPOB]%3B;dbSNP=rs61743502;gnomAD=0.00506;gnomAD_sub=0.00209%2C0.00242%2C0.00000%2C0.00872%2C0.00456;gnomAD_hom_hemi=1%2C;gnomAD_het=769;gnomAD_wt=151543;phyloP=0.4150;CADD=2.09;REVEL=0.024;AlphaMissense=0.16;MaxEntScan=/3.3>2.9/0.0>0.0;COSMIC=COSV99028621;SpliceAI=APOB|0.00|0.00|0.00|0.00|45|-16|-16|27;PubMed=27153395%2C26415676%2C19602640%2C31150472%2C34648354%2C33111339;NGSD_hom=1;NGSD_het=386;NGSD_mosaic=0;NGSD_group=0%20/%2043;classification=2;classification_comment="[3]%20ahschak1%2026.04.2018%20[2]%20ahfausu1%2030.12.2020";gene_info=APOB%20(inh%3DAR+AD%20oe_syn%3D1.06%20oe_mis%3D1.10%20oe_lof%3D0.37)	GT	1/0
chr2	24821548	.	G	A	2780	.	quality=DP%3D235%3BQD%3D11.83%3BAF%3D0.49%3BMQM%3D60%3BSAP%3D17%3BABP%3D3%3BSAR%3D44%3BSAF%3D71;gene=CENPO%2CADCY3;variant_type=3'UTR%2Csynonymous;coding_and_splicing=CENPO:ENST00000473706.5:3_prime_UTR_variant:MODIFIER:exon7/7:c.*2230G>A::%2CCENPO:ENST00000380834.7:3_prime_UTR_variant:MODIFIER:exon8/8:c.*2230G>A::%2CCENPO:ENST00000260662.2:3_prime_UTR_variant:MODIFIER:exon8/8:c.*2230G>A::%2CADCY3:ENST00000260600.9:synonymous_variant:LOW:exon19/21:c.3096C>T:p.Asn1032%3D:PF00211%20[Adenylate%20and%20Guanylate%20cyclase%20catalytic%20domain]%2CADCY3:ENST00000679454.1:synonymous_variant:LOW:exon20/22:c.3096C>T:p.Asn1032%3D:PF00211%20[Adenylate%20and%20Guanylate%20cyclase%20catalytic%20domain]%2CADCY3:ENST00000405392.6:synonymous_variant:LOW:exon19/21:c.3099C>T:p.Asn1033%3D:PF00211%20[Adenylate%20and%20Guanylate%20cyclase%20catalytic%20domain];regulatory=regulatory_region_variant:CTCF_binding_site;OMIM=600291_[GENE%3DADCY3_PHENOS%3D{Obesity%2C%20susceptibility%20to%2C%20BMIQ19}%2C%20617885%20(3)%2C%20Autosomal%20recessive];ClinVar=774810%20[benign/likely%20benign%20DISEASE%3Dnot%20provided%2CADCY3-related%20disorder%20GENE%3DADCY3]%3B;dbSNP=rs72792178;gnomAD=0.00572;gnomAD_sub=0.00149%2C0.00647%2C0.00019%2C0.00914%2C0.00207;gnomAD_hom_hemi=6%2C;gnomAD_het=859;gnomAD_wt=151495;phyloP=0.4810;CADD=6.17;MaxEntScan=/0.0>0.0/0.0>0.0%2C/1.6>1.1/0.0>0.0;SpliceAI=ADCY3|0.00|0.00|0.00|0.00|-4|23|23|-31%2CCENPO|0.00|0.00|0.00|0.00|50|8|50|8;NGSD_hom=4;NGSD_het=642;NGSD_mosaic=0;NGSD_group=1%20/%2086;gene_info=CENPO%20(inh%3Dn/a%20oe_syn%3D1.11%20oe_mis%3D0.91%20oe_lof%3D0.84)%2C%20ADCY3%20(inh%3DAR%20oe_syn%3D1.07%20oe_mis%3D0.73%20oe_lof%3D0.49)	GT	1/0
chr2	27233506	.	G	A	4253	.	quality=DP%3D310%3BQD%3D13.72%3BAF%3D0.52%3BMQM%3D60%3BSAP%3D7%3BABP%3D4%3BSAR%3D89%3BSAF%3D72;gene=CAD;variant_type=synonymous;coding_and_splicing=CAD:ENST00000264705.9:synonymous_variant:LOW:exon20/44:c.3186G>A:p.Gln1062%3D:PF02786%20[Carbamoyl-phosphate%20synthase%20L%20chain%20ATP%20binding%20domain]%2CCAD:ENST00000403525.5:synonymous_variant:LOW:exon19/43:c.2997G>A:p.Gln999%3D:PF02786%20[Carbamoyl-phosphate%20synthase%20L%20chain%20ATP%20binding%20domain];OMIM=114010_[GENE%3DCAD_PHENOS%3DDevelopmental%20and%20epileptic%20encephalopathy%2050%2C%20616457%20(3)%2C%20Autosomal%20recessive];ClinVar=732455%20[benign/likely%20benign%20DISEASE%3Dnot%20provided%20GENE%3DCAD]%3B;dbSNP=rs55916426;gnomAD=0.00043;gnomAD_sub=0.00012%2C0.00026%2C0.00000%2C0.00059%2C0.00269;gnomAD_hom_hemi=0%2C;gnomAD_het=66;gnomAD_wt=152274;phyloP=3.6470;CADD=8.79;MaxEntScan=/0.0>0.0/0.0>0.0;SpliceAI=CAD|0.00|0.00|0.06|0.00|7|1|-11|45;NGSD_hom=2;NGSD_het=109;NGSD_mosaic=0;NGSD_group=0%20/%2010;gene_info=CAD%20(inh%3DAR%20oe_syn%3D1.05%20oe_mis%3D0.67%20oe_lof%3D0.17)	GT	1/0
chr2	29232333	.	A	T	2928	.	quality=DP%3D218%3BQD%3D13.43%3BAF%3D0.53%3BMQM%3D60%3BSAP%3D14%3BABP%3D5%3BSAR%3D46%3BSAF%3D70;gene=ALK;variant_type=missense;coding_and_splicing=ALK:ENST00000389048.8:missense_variant:MODERATE:exon15/29:c.2603T>A:p.Leu868Gln:PF12810%20[Glycine%20rich%20protein]%2CALK:ENST00000618119.4:missense_variant:MODERATE:exon14/28:c.1472T>A:p.Leu491Gln:PF12810%20[Glycine%20rich%20protein];OMIM=105590_[GENE%3DALK_PHENOS%3D{Neuroblastoma%2C%20susceptibility%20to%2C%203}%2C%20613014%20(3)];ClinVar=335700%20[uncertain%20significance%20DISEASE%3DNeuroblastoma%2C%20susceptibility%20to%2C%203%20GENE%3DALK]%3B;dbSNP=rs55941323;gnomAD=0.00002;gnomAD_sub=0.00000%2C0.00000%2C0.00000%2C0.00004%2C0.00000;gnomAD_hom_hemi=0%2C;gnomAD_het=3;gnomAD_wt=152349;phyloP=4.2680;CADD=20.10;REVEL=0.377;AlphaMissense=0.07;MaxEntScan=/6.3>2.5/0.0>0.0;SpliceAI=ALK|0.00|0.00|0.00|0.00|27|-3|-29|5;NGSD_hom=0;NGSD_het=11;NGSD_mosaic=0;NGSD_group=0%20/%201;gene_info=ALK%20(inh%3DAD%20oe_syn%3D1.17%20oe_mis%3D1.00%20oe_lof%3D0.32)	GT	1/0
chr2	43995884	.	G	C	1313	.	quality=DP%3D100%3BQD%3D13.13%3BAF%3D0.52%3BMQM%3D60%3BSAP%3D20%3BABP%3D3%3BSAR%3D16%3BSAF%3D36;gene=LRPPRC;variant_type=missense%2Cintron;coding_and_splicing=LRPPRC:ENST00000260665.12:missense_variant:MODERATE:exon1/38:c.64C>G:p.Leu22Val:%2CLRPPRC:ENST00000682308.1:missense_variant:MODERATE:exon1/37:c.64C>G:p.Leu22Val:%2CLRPPRC:ENST00000683623.1:missense_variant:MODERATE:exon1/38:c.64C>G:p.Leu22Val:%2CLRPPRC:ENST00000683125.1:missense_variant:MODERATE:exon1/39:c.64C>G:p.Leu22Val:%2CLRPPRC:ENST00000682546.1:missense_variant:MODERATE:exon1/38:c.64C>G:p.Leu22Val:%2CLRPPRC:ENST00000683833.1:missense_variant:MODERATE:exon1/37:c.64C>G:p.Leu22Val:%2CLRPPRC:ENST00000683220.1:missense_variant:MODERATE:exon1/38:c.64C>G:p.Leu22Val:%2CLRPPRC:ENST00000683590.1:missense_variant:MODERATE:exon1/35:c.64C>G:p.Leu22Val:%2CLRPPRC:ENST00000683213.1:missense_variant:MODERATE:exon1/38:c.64C>G:p.Leu22Val:%2CLRPPRC:ENST00000682779.1:missense_variant:MODERATE:exon1/38:c.64C>G:p.Leu22Val:%2CLRPPRC:ENST00000682885.1:missense_variant:MODERATE:exon1/37:c.64C>G:p.Leu22Val:%2CLRPPRC:ENST00000682480.1:missense_variant:MODERATE:exon1/38:c.64C>G:p.Leu22Val:%2CLRPPRC:ENST00000683989.1:missense_variant:MODERATE:exon1/25:c.64C>G:p.Leu22Val:%2CLRPPRC:ENST00000447246.2:missense_variant:MODERATE:exon1/24:c.64C>G:p.Leu22Val:%2CLRPPRC:ENST00000409659.6:missense_variant:MODERATE:exon1/24:c.64C>G:p.Leu22Val:%2CLRPPRC:ENST00000682104.1:intron_variant:MODIFIER:intron1/23:c.23+256C>G::%2CLRPPRC:ENST00000409946.6:missense_variant:MODERATE:exon1/14:c.64C>G:p.Leu22Val:;regulatory=regulatory_region_variant:open_chromatin_region%2CTF_binding_site_variant;OMIM=607544_[GENE%3DLRPPRC_PHENOS%3DMitochondrial%20complex%20IV%20deficiency%2C%20nuclear%20type%205%2C%20(French-Canadian)%2C%20220111%20(3)%2C%20Autosomal%20recessive];ClinVar=138150%20[likely%20benign(replaced%20by%20megSAP%20based%20on%20classifications:3x1%2C1x2%2C3x3)%20DISEASE%3DLRPPRC-related%20disorder%2Cnot%20specified%2CCongenital%20lactic%20acidosis%2C%20Saguenay-Lac-Saint-Jean%20type%2Cnot%20provided%20GENE%3DLRPPRC]%3B;dbSNP=rs181626399;gnomAD=0.00128;gnomAD_sub=0.00046%2C0.00059%2C0.00000%2C0.00226%2C0.00000;gnomAD_hom_hemi=0%2C;gnomAD_het=195;gnomAD_wt=152127;phyloP=1.2030;CADD=14.66;REVEL=0.065;AlphaMissense=0.08;MaxEntScan=/0.2>0.0/0.0>0.0;SpliceAI=LRPPRC|0.00|0.00|0.00|0.00|0|20|1|35;NGSD_hom=0;NGSD_het=130;NGSD_mosaic=0;NGSD_group=0%20/%2014;gene_info=LRPPRC%20(inh%3DAR%20oe_syn%3D1.17%20oe_mis%3D1.20%20oe_lof%3D0.39)	GT	1/0
chr2	46905488	.	G	A	686	.	quality=DP%3D64%3BQD%3D10.72%3BAF%3D0.48%3BMQM%3D60%3BSAP%3D40%3BABP%3D3%3BSAR%3D4%3BSAF%3D27;gene=MCFD2;variant_type=missense%2C3'UTR;coding_and_splicing=MCFD2:ENST00000444761.6:missense_variant:MODERATE:exon3/3:c.359C>T:p.Ala120Val:PF13499%20[EF-hand%20domain%20pair]%2CMCFD2:ENST00000409105.5:missense_variant:MODERATE:exon5/5:c.416C>T:p.Ala139Val:PF13499%20[EF-hand%20domain%20pair]%2CMCFD2:ENST00000319466.9:missense_variant:MODERATE:exon4/4:c.416C>T:p.Ala139Val:PF13499%20[EF-hand%20domain%20pair]%2CMCFD2:ENST00000409913.5:missense_variant:MODERATE:exon3/3:c.260C>T:p.Ala87Val:PF13499%20[EF-hand%20domain%20pair]%2CMCFD2:ENST00000409800.5:missense_variant:MODERATE:exon3/3:c.260C>T:p.Ala87Val:PF13499%20[EF-hand%20domain%20pair]%2CMCFD2:ENST00000649435.1:3_prime_UTR_variant:MODIFIER:exon4/4:c.*82C>T::%2CMCFD2:ENST00000409207.5:missense_variant:MODERATE:exon4/4:c.416C>T:p.Ala139Val:PF13499%20[EF-hand%20domain%20pair]%2CMCFD2:ENST00000409973.5:missense_variant:MODERATE:exon5/5:c.416C>T:p.Ala139Val:PF13499%20[EF-hand%20domain%20pair]%2CMCFD2:ENST00000409147.1:missense_variant:MODERATE:exon3/3:c.260C>T:p.Ala87Val:PF13499%20[EF-hand%20domain%20pair]%2CMCFD2:ENST00000409218.5:missense_variant:MODERATE:exon4/4:c.416C>T:p.Ala139Val:PF13499%20[EF-hand%20domain%20pair];OMIM=607788_[GENE%3DMCFD2_PHENOS%3DFactor%20V%20and%20factor%20VIII%2C%20combined%20deficiency%20of%2C%20613625%20(3)];ClinVar=336381%20[uncertain%20significance%20DISEASE%3DFactor%205%20and%20Factor%20VIII%2C%20combined%20deficiency%20of%2C%202%2CThrombocytopenia%2CAbnormal%20bleeding%20GENE%3DMCFD2]%3B;dbSNP=rs80294301;gnomAD=0.00001;gnomAD_sub=0.00002%2C0.00000%2C0.00000%2C0.00001%2C0.00000;gnomAD_hom_hemi=0%2C;gnomAD_het=2;gnomAD_wt=152202;phyloP=7.4750;CADD=26.50;REVEL=0.594;AlphaMissense=0.45;MaxEntScan=/0.0>0.0/0.0>0.0;COSMIC=COSV60177740;SpliceAI=MCFD2|0.00|0.00|0.00|0.00|-23|36|2|-46;NGSD_hom=0;NGSD_het=11;NGSD_mosaic=0;NGSD_group=0%20/%201;gene_info=MCFD2%20(inh%3DAR%20oe_syn%3D1.12%20oe_mis%3D1.18%20oe_lof%3D0.41)	GT	1/0
chr2	55646394	.	CA	C	531	.	quality=DP%3D68%3BQD%3D7.81%3BAF%3D0.37%3BMQM%3D60%3BSAP%3D3%3BABP%3D13%3BSAR%3D13%3BSAF%3D12;gene=PNPT1;variant_type=splice_region&intron;coding_and_splicing=PNPT1:ENST00000447944.7:splice_region_variant&intron_variant:LOW:intron20/27:c.1674+20del::;OMIM=610316_[GENE%3DPNPT1_PHENOS%3DSpinocerebellar%20ataxia%2025%2C%20608703%20(3)%2C%20Autosomal%20dominant%3B%20Deafness%2C%20autosomal%20recessive%2070%2C%20with%20or%20without%20adult-onset%20neurodegeneration%2C%20614934%20(3)%2C%20Autosomal%20recessive%3B%20Combined%20oxidative%20phosphorylation%20deficiency%2013%2C%20614932%20(3)%2C%20Autosomal%20recessive];ClinVar=215002%20[benign%20DISEASE%3Dnot%20specified%2Cnot%20provided%20GENE%3DPNPT1]%3B;dbSNP=rs149526231;gnomAD=0.00158;gnomAD_sub=0.00017%2C0.00491%2C0.00000%2C0.00149%2C0.00083;gnomAD_hom_hemi=2%2C;gnomAD_het=237;gnomAD_wt=151853;phyloP=1.7950;CADD=12.78;MaxEntScan=/0.0>0.0/0.0>0.0;SpliceAI=PNPT1|0.00|0.00|0.00|0.00|20|-50|21|20;NGSD_hom=0;NGSD_het=299;NGSD_mosaic=0;NGSD_group=0%20/%2024;gene_info=PNPT1%20(inh%3DAR%20oe_syn%3D1.12%20oe_mis%3D0.94%20oe_lof%3D0.31)	GT	1/0
chr2	73449618	.	A	G	2292	.	quality=DP%3D178%3BQD%3D12.88%3BAF%3D0.52%3BMQM%3D60%3BSAP%3D3%3BABP%3D3%3BSAR%3D47%3BSAF%3D45;gene=ALMS1;variant_type=missense;coding_and_splicing=ALMS1:ENST00000484298.5:missense_variant:MODERATE:exon7/22:c.2965A>G:p.Thr989Ala:PF18727%20[Alstrom%20syndrome%20repeat]%2CALMS1:ENST00000613296.6:missense_variant:MODERATE:exon8/23:c.3091A>G:p.Thr1031Ala:PF18727%20[Alstrom%20syndrome%20repeat]%2CALMS1:ENST00000614410.4:missense_variant:MODERATE:exon8/16:c.3091A>G:p.Thr1031Ala:PF18727%20[Alstrom%20syndrome%20repeat];OMIM=606844_[GENE%3DALMS1_PHENOS%3DAlstrom%20syndrome%2C%20203800%20(3)%2C%20Autosomal%20recessive];ClinVar=1727490%20[uncertain%20significance%20DISEASE%3Dnot%20specified%2CCardiovascular%20phenotype%20GENE%3DALMS1]%3B;dbSNP=rs72811915;gnomAD=0.00003;gnomAD_sub=0.00002%2C0.00000%2C0.00000%2C0.00003%2C0.00000;gnomAD_hom_hemi=0%2C;gnomAD_het=4;gnomAD_wt=152090;phyloP=-2.9870;CADD=0.00;REVEL=0.057;AlphaMissense=0.07;MaxEntScan=/1.8>0.6/0.0>0.0;PubMed=25905921;NGSD_hom=0;NGSD_het=11;NGSD_mosaic=0;NGSD_group=0%20/%201;gene_info=ALMS1%20(inh%3DAR%20oe_syn%3D1.14%20oe_mis%3D1.19%20oe_lof%3D0.75)	GT	1/0
chr2	148483494	.	C	A	2270	.	quality=DP%3D214%3BQD%3D10.61%3BAF%3D0.43%3BMQM%3D60%3BSAP%3D3%3BABP%3D12%3BSAR%3D48%3BSAF%3D44;gene=MBD5;variant_type=intron%2Cmissense;coding_and_splicing=MBD5:ENST00000407073.5:intron_variant:MODIFIER:intron10/14:c.2845+58C>A::%2CMBD5:ENST00000642680.2:missense_variant:MODERATE:exon9/14:c.2903C>A:p.Ala968Asp:%2CMBD5:ENST00000638043.2:intron_variant:MODIFIER:intron9/13:c.2845+58C>A::;regulatory=regulatory_region_variant:enhancer;OMIM=611472_[GENE%3DMBD5_PHENOS%3DIntellectual%20developmental%20disorder%2C%20autosomal%20dominant%201%2C%20156200%20(3)%2C%20Autosomal%20dominant];ClinVar=675624%20[likely%20benign%20DISEASE%3Dnot%20provided%20GENE%3DMBD5]%3B;dbSNP=rs72861124;gnomAD=0.00284;gnomAD_sub=0.00039%2C0.00039%2C0.00000%2C0.00288%2C0.00125;gnomAD_hom_hemi=1%2C;gnomAD_het=430;gnomAD_wt=151828;phyloP=4.1410;CADD=25.20;REVEL=0.079;MaxEntScan=/6.0>5.5/0.0>0.0;SpliceAI=MBD5|0.00|0.00|0.00|0.00|19|-27|34|-11;NGSD_hom=1;NGSD_het=171;NGSD_mosaic=0;NGSD_group=0%20/%2019;gene_info=MBD5%20(inh%3DAD%20oe_syn%3D1.05%20oe_mis%3D0.91%20oe_lof%3D0.04)	GT	1/0
chr2	162279995	.	C	G	773	.	quality=DP%3D74%3BQD%3D10.45%3BAF%3D0.47%3BMQM%3D60%3BSAP%3D42%3BABP%3D3%3BSAR%3D5%3BSAF%3D30;gene=IFIH1;variant_type=splice_donor%2Cintron;coding_and_splicing=IFIH1:ENST00000649979.2:splice_donor_variant:HIGH:intron8/15:c.1641+1G>C:p.?:%2CIFIH1:ENST00000679938.1:splice_donor_variant:HIGH:intron7/14:c.1329+1G>C:p.?:%2CIFIH1:ENST00000648433.1:intron_variant:MODIFIER:intron7/14:c.1524+1333G>C::;OMIM=606951_[GENE%3DIFIH1_PHENOS%3DImmunodeficiency%2095%2C%20619773%20(3)%2C%20Autosomal%20recessive%3B%20Aicardi-Goutieres%20syndrome%207%2C%20615846%20(3)%2C%20Autosomal%20dominant%3B%20Singleton-Merten%20syndrome%201%2C%20182250%20(3)%2C%20Autosomal%20dominant];ClinVar=261563%20[likely%20benign(replaced%20by%20megSAP%20based%20on%20classifications:3x1%2C3x3)%20DISEASE%3DSingleton-Merten%20syndrome%201%2CAicardi-Goutieres%20syndrome%207%2Cnot%20specified%2CMultisystem%20inflammatory%20syndrome%20in%20children%2CImmunodeficiency%2095%2Cnot%20provided%2CSusceptibility%20to%20severe%20COVID-19%20GENE%3DIFIH1]%3B;HGMD=CS092022%20[CLASS%3DDFP%20MUT%3DALT%20PHEN%3D"Diabetes%20type%201%20reduced%20risk"%20GENE%3DIFIH1]%3B;dbSNP=rs35337543;gnomAD=0.00724;gnomAD_sub=0.00279%2C0.01173%2C0.00000%2C0.01097%2C0.00124;gnomAD_hom_hemi=5%2C;gnomAD_het=1092;gnomAD_wt=151032;phyloP=5.7900;CADD=27.60;MaxEntScan=3.5>0.0/0.0>0.0/3.5>0.0%2C/0.0>0.0/3.5>0.0;COSMIC=COSV99719009;SpliceAI=IFIH1|0.00|0.00|0.01|0.98|-48|42|-12|1;PubMed=25741868%2C20392289%2C22654555%2C21224255%2C25685889%2C25294186%2C22770979%2C19961590%2C19264985%2C20844740%2C22110759%2C23144876%2C20736039%2C34127860%2C33184476%2C29691411%2C29333267%2C36599968%2C33483996%2C32918943%2C34917078%2C36434151%2C22976083%2C32727064%2C19490597%2C20441610%2C21813454%2C34758847%2C25883954%2C35926770%2C31572372%2C28606988%2C23940698%2C33658892%2C36228008%2C32635205%2C32709702%2C33219336%2C28716935%2C16199547%2C37383588%2C37588055%2C37834254;NGSD_hom=4;NGSD_het=750;NGSD_mosaic=0;NGSD_group=1%20/%2095;gene_info=IFIH1%20(inh%3DAR+AD%20oe_syn%3D1.12%20oe_mis%3D1.10%20oe_lof%3D1.25)	GT	1/0
chr2	165137966	.	A	G	1420	.	quality=DP%3D120%3BQD%3D11.83%3BAF%3D0.49%3BMQM%3D60%3BSAP%3D7%3BABP%3D3%3BSAR%3D24%3BSAF%3D35;gene=SCN3A;variant_type=synonymous;coding_and_splicing=SCN3A:ENST00000283254.12:synonymous_variant:LOW:exon15/28:c.2304T>C:p.Ile768%3D:PF00520%20[Ion%20transport%20protein]%2CSCN3A:ENST00000639244.1:synonymous_variant:LOW:exon15/28:c.2253T>C:p.Ile751%3D:PF00520%20[Ion%20transport%20protein]%2CSCN3A:ENST00000706067.1:synonymous_variant:LOW:exon15/28:c.2253T>C:p.Ile751%3D:PF00520%20[Ion%20transport%20protein]%2CSCN3A:ENST00000409101.7:synonymous_variant:LOW:exon15/28:c.2157T>C:p.Ile719%3D:PF00520%20[Ion%20transport%20protein]%2CSCN3A:ENST00000668657.1:synonymous_variant:LOW:exon15/19:c.2166T>C:p.Ile722%3D:PF00520%20[Ion%20transport%20protein];OMIM=182391_[GENE%3DSCN3A_PHENOS%3DEpilepsy%2C%20familial%20focal%2C%20with%20variable%20foci%204%2C%20617935%20(3)%2C%20Autosomal%20dominant%3B%20Developmental%20and%20epileptic%20encephalopathy%2062%2C%20617938%20(3)%2C%20Autosomal%20dominant];ClinVar=594575%20[benign/likely%20benign%20DISEASE%3Dnot%20specified%2Cnot%20provided%20GENE%3DSCN3A]%3B;dbSNP=rs72870766;gnomAD=0.00070;gnomAD_sub=0.00014%2C0.00098%2C0.00000%2C0.00112%2C0.00000;gnomAD_hom_hemi=0%2C;gnomAD_het=107;gnomAD_wt=152135;phyloP=-0.0990;CADD=4.62;MaxEntScan=/0.0>0.0/0.0>0.0;SpliceAI=SCN3A|0.00|0.00|0.00|0.00|28|-37|3|48;NGSD_hom=0;NGSD_het=138;NGSD_mosaic=0;NGSD_group=0%20/%2017;gene_info=SCN3A%20(inh%3DAD%20oe_syn%3D1.08%20oe_mis%3D0.60%20oe_lof%3D0.10)	GT	1/0
chr2	177875895	.	A	C	1061	.	quality=DP%3D107%3BQD%3D9.92%3BAF%3D0.43%3BMQM%3D60%3BSAP%3D10%3BABP%3D8%3BSAR%3D29%3BSAF%3D17;gene=PDE11A;variant_type=missense%2C5'UTR;coding_and_splicing=PDE11A:ENST00000286063.11:missense_variant:MODERATE:exon5/20:c.1331T>G:p.Leu444Trp:PF01590%20[GAF%20domain]%2CPDE11A:ENST00000358450.8:missense_variant:MODERATE:exon6/21:c.581T>G:p.Leu194Trp:PF01590%20[GAF%20domain]%2CPDE11A:ENST00000409504.5:missense_variant:MODERATE:exon4/20:c.257T>G:p.Leu86Trp:PF01590%20[GAF%20domain]%2CPDE11A:ENST00000389683.7:5_prime_UTR_variant:MODIFIER:exon2/17:c.-2T>G::;OMIM=604961_[GENE%3DPDE11A_PHENOS%3DPigmented%20nodular%20adrenocortical%20disease%2C%20primary%2C%202%2C%20610475%20(3)%2C%20Autosomal%20dominant];dbSNP=rs72948844;gnomAD=0.00001;gnomAD_sub=0.00000%2C0.00000%2C0.00000%2C0.00001%2C0.00000;gnomAD_hom_hemi=0%2C;gnomAD_het=1;gnomAD_wt=152305;phyloP=6.0420;CADD=27.90;REVEL=0.533;AlphaMissense=0.58;MaxEntScan=/3.1>2.6/0.0>0.0;SpliceAI=PDE11A|0.00|0.00|0.03|0.00|28|-14|-36|28;NGSD_hom=0;NGSD_het=11;NGSD_mosaic=0;NGSD_group=0%20/%201;gene_info=PDE11A%20(inh%3DAD%20oe_syn%3D0.96%20oe_mis%3D1.00%20oe_lof%3D1.11)	GT	1/0
chr2	208338525	.	A	G	1241	.	quality=DP%3D85%3BQD%3D14.60%3BAF%3D0.55%3BMQM%3D60%3BSAP%3D3%3BABP%3D5%3BSAR%3D23%3BSAF%3D24;gene=PIKFYVE;variant_type=synonymous;coding_and_splicing=PIKFYVE:ENST00000264380.9:synonymous_variant:LOW:exon29/42:c.4629A>G:p.Ala1543%3D:;OMIM=609414_[GENE%3DPIKFYVE_PHENOS%3DCorneal%20fleck%20dystrophy%2C%20121850%20(3)%2C%20Autosomal%20dominant];ClinVar=333922%20[benign%20DISEASE%3DFleck%20corneal%20dystrophy%2Cnot%20provided%20GENE%3DPIKFYVE]%3B;dbSNP=rs61752190;gnomAD=0.00293;gnomAD_sub=0.00113%2C0.00046%2C0.00000%2C0.00475%2C0.00000;gnomAD_hom_hemi=2%2C;gnomAD_het=443;gnomAD_wt=151911;phyloP=-0.0360;CADD=5.90;MaxEntScan=/0.0>0.0/0.0>0.0;SpliceAI=PIKFYVE|0.00|0.00|0.00|0.00|-17|-41|43|-19;NGSD_hom=2;NGSD_het=344;NGSD_mosaic=0;NGSD_group=0%20/%2044;gene_info=PIKFYVE%20(inh%3DAD%20oe_syn%3D0.99%20oe_mis%3D0.83%20oe_lof%3D0.29)	GT	1/0
chr2	209982201	.	C	T	875	.	quality=DP%3D125%3BQD%3D7.00%3BAF%3D0.35%3BMQM%3D60%3BSAP%3D19%3BABP%3D27%3BSAR%3D13%3BSAF%3D31;gene=UNC80;variant_type=synonymous;coding_and_splicing=UNC80:ENST00000673951.2:synonymous_variant:LOW:exon59/64:c.8937C>T:p.Ser2979%3D:%2CUNC80:ENST00000673920.1:synonymous_variant:LOW:exon60/65:c.9141C>T:p.Ser3047%3D:%2CUNC80:ENST00000439458.5:synonymous_variant:LOW:exon59/64:c.8943C>T:p.Ser2981%3D:%2CUNC80:ENST00000272845.10:synonymous_variant:LOW:exon59/63:c.8928C>T:p.Ser2976%3D:;OMIM=612636_[GENE%3DUNC80_PHENOS%3DHypotonia%2C%20infantile%2C%20with%20psychomotor%20retardation%20and%20characteristic%20facies%202%2C%20616801%20(3)%2C%20Autosomal%20recessive];ClinVar=717614%20[benign/likely%20benign%20DISEASE%3Dnot%20provided%20GENE%3DUNC80]%3B;dbSNP=rs73003402;gnomAD=0.00191;gnomAD_sub=0.00048%2C0.00020%2C0.00000%2C0.00332%2C0.00000;gnomAD_hom_hemi=0%2C;gnomAD_het=291;gnomAD_wt=151871;phyloP=1.2200;CADD=11.08;MaxEntScan=/0.0>0.0/0.0>0.0;SpliceAI=UNC80|0.00|0.03|0.00|0.00|0|-22|-2|3;NGSD_hom=0;NGSD_het=261;NGSD_mosaic=1;NGSD_group=0%20/%2023;gene_info=UNC80%20(inh%3DAR%20oe_syn%3D0.81%20oe_mis%3D0.63%20oe_lof%3D0.24)	GT	1/0
chr2	214730440	.	G	A	842	.	quality=DP%3D80%3BQD%3D10.53%3BAF%3D0.45%3BMQM%3D60%3BSAP%3D23%3BABP%3D5%3BSAR%3D27%3BSAF%3D9;gene=BARD1;variant_type=missense%2C3'UTR;coding_and_splicing=BARD1:ENST00000260947.9:missense_variant:MODERATE:exon10/11:c.1972C>T:p.Arg658Cys:%2CBARD1:ENST00000619009.5:missense_variant:MODERATE:exon4/5:c.433C>T:p.Arg145Cys:%2CBARD1:ENST00000617164.5:missense_variant:MODERATE:exon9/10:c.1915C>T:p.Arg639Cys:%2CBARD1:ENST00000613374.5:missense_variant:MODERATE:exon5/6:c.562C>T:p.Arg188Cys:%2CBARD1:ENST00000613706.5:missense_variant:MODERATE:exon10/11:c.1564C>T:p.Arg522Cys:%2CBARD1:ENST00000421162.2:missense_variant:MODERATE:exon6/7:c.619C>T:p.Arg207Cys:%2CBARD1:ENST00000620057.4:3_prime_UTR_variant:MODIFIER:exon9/10:c.*638C>T::;regulatory=regulatory_region_variant:enhancer;OMIM=601593_[GENE%3DBARD1_PHENOS%3D{Breast%20cancer%2C%20susceptibility%20to}%2C%20114480%20(3)%2C%20Somatic%20mutation%2C%20Autosomal%20dominant];ClinVar=136500%20[benign/likely%20benign%20DISEASE%3Dnot%20provided%2CMalignant%20tumor%20of%20breast%2Cnot%20specified%2CHereditary%20cancer-predisposing%20syndrome%2CHereditary%20breast%20ovarian%20cancer%20syndrome%2CHereditary%20cancer%2CTriple-Negative%20Breast%20Cancer%20Finding%2CFamilial%20cancer%20of%20breast%20GENE%3DBARD1]%3B;HGMD=CM067650%20[CLASS%3DDP%20MUT%3DALT%20PHEN%3D"Lung%20cancer%20susceptibility%20to%20association%20with"%20GENE%3DBARD1]%3B;dbSNP=rs3738888;gnomAD=0.00731;gnomAD_sub=0.00219%2C0.00667%2C0.00986%2C0.00844%2C0.00374;gnomAD_hom_hemi=15%2C;gnomAD_het=1083;gnomAD_wt=151055;phyloP=5.2690;CADD=25.20;REVEL=0.104;AlphaMissense=0.10;MaxEntScan=/0.0>0.0/0.0>0.5;COSMIC=COSV53616840;SpliceAI=BARD1|0.00|0.00|0.00|0.01|46|-25|43|-29;PubMed=25741868%2C29458332%2C27153395%2C19412175%2C23056176%2C31258718%2C32708251%2C35084806%2C32039725%2C16061562%2C20077502%2C9425226%2C15342711%2C16333312%2C16741161%2C19584272%2C25994375%2C26315354%2C26350354%2C35650591%2C26307947%2C26329992%2C26010302;NGSD_hom=2;NGSD_het=577;NGSD_mosaic=0;NGSD_group=0%20/%2093;classification=2;classification_comment="[2]%20Ilnaz%20Sepahi%2029-03-2016%20batch%20import";gene_info=BARD1%20(inh%3DAD%20oe_syn%3D1.11%20oe_mis%3D1.08%20oe_lof%3D1.03)	GT	1/0
chr2	215414974	.	T	C	929	.	quality=DP%3D72%3BQD%3D12.90%3BAF%3D0.54%3BMQM%3D60%3BSAP%3D57%3BABP%3D4%3BSAR%3D35%3BSAF%3D4;gene=FN1;variant_type=splice_region&intron;coding_and_splicing=FN1:ENST00000421182.5:splice_region_variant&intron_variant:LOW:intron12/44:c.1820-16A>G::%2CFN1:ENST00000323926.10:splice_region_variant&intron_variant:LOW:intron12/46:c.1820-16A>G::%2CFN1:ENST00000336916.8:splice_region_variant&intron_variant:LOW:intron12/45:c.1820-16A>G::%2CFN1:ENST00000357867.8:splice_region_variant&intron_variant:LOW:intron12/43:c.1820-16A>G::%2CFN1:ENST00000359671.5:splice_region_variant&intron_variant:LOW:intron12/44:c.1820-16A>G::%2CFN1:ENST00000446046.5:splice_region_variant&intron_variant:LOW:intron12/45:c.1820-16A>G::%2CFN1:ENST00000443816.5:splice_region_variant&intron_variant:LOW:intron12/44:c.1820-16A>G::%2CFN1:ENST00000432072.6:splice_region_variant&intron_variant:LOW:intron12/44:c.1820-16A>G::%2CFN1:ENST00000354785.11:splice_region_variant&intron_variant:LOW:intron12/45:c.1820-16A>G::%2CFN1:ENST00000356005.8:splice_region_variant&intron_variant:LOW:intron12/43:c.1820-16A>G::%2CFN1:ENST00000426059.1:splice_region_variant&intron_variant:LOW:intron12/12:c.1820-16A>G::;regulatory=regulatory_region_variant:enhancer%2CTF_binding_site_variant;OMIM=135600_[GENE%3DFN1_PHENOS%3DSpondylometaphyseal%20dysplasia%2C%20corner%20fracture%20type%2C%20184255%20(3)%2C%20Autosomal%20dominant%3B%20Glomerulopathy%20with%20fibronectin%20deposits%202%2C%20601894%20(3)%2C%20Autosomal%20dominant];ClinVar=1621270%20[likely%20benign%20DISEASE%3Dnot%20provided%2CGlomerulopathy%20with%20fibronectin%20deposits%202%2CSpondylometaphyseal%20dysplasia%20-%20Sutcliffe%20type%20GENE%3DFN1]%3B;dbSNP=rs72943927;gnomAD=0.00016;gnomAD_sub=0.00000%2C0.00007%2C0.00000%2C0.00034%2C0.00000;gnomAD_hom_hemi=0%2C;gnomAD_het=24;gnomAD_wt=152318;phyloP=0.2590;CADD=8.04;MaxEntScan=10.2>10.4/10.2>10.4/0.0>0.0;SpliceAI=FN1|0.00|0.00|0.00|0.00|-16|-37|-35|31;NGSD_hom=0;NGSD_het=26;NGSD_mosaic=0;NGSD_group=0%20/%202;gene_info=FN1%20(inh%3DAD%20oe_syn%3D1.03%20oe_mis%3D0.87%20oe_lof%3D0.25)	GT	1/0
chr2	218640742	.	G	A	3609	.	quality=DP%3D246%3BQD%3D14.67%3BAF%3D0.56%3BMQM%3D60%3BSAP%3D9%3BABP%3D10%3BSAR%3D78%3BSAF%3D59;gene=ZNF142%2CPLCD4;variant_type=missense%2Cdownstream_gene;coding_and_splicing=ZNF142:ENST00000411696.7:missense_variant:MODERATE:exon10/11:c.5116C>T:p.Arg1706Trp:%2CZNF142:ENST00000449707.5:missense_variant:MODERATE:exon9/10:c.4516C>T:p.Arg1506Trp:%2CPLCD4:ENST00000450993.7:downstream_gene_variant:MODIFIER::::%2CPLCD4:ENST00000417849.5:downstream_gene_variant:MODIFIER::::%2CPLCD4:ENST00000432688.5:downstream_gene_variant:MODIFIER::::;OMIM=604083_[GENE%3DZNF142_PHENOS%3DNeurodevelopmental%20disorder%20with%20impaired%20speech%20and%20hyperkinetic%20movements%2C%20618425%20(3)%2C%20Autosomal%20recessive];ClinVar=1675839%20[likely%20benign%20DISEASE%3DNeurodevelopmental%20disorder%20with%20impaired%20speech%20and%20hyperkinetic%20movements%2CZNF142-related%20disorder%2Cnot%20provided%20GENE%3DZNF142]%3B;dbSNP=rs72962069;gnomAD=0.00192;gnomAD_sub=0.00077%2C0.00183%2C0.00000%2C0.00298%2C0.00021;gnomAD_hom_hemi=1%2C;gnomAD_het=290;gnomAD_wt=151976;phyloP=2.4900;CADD=29.40;REVEL=0.300;AlphaMissense=0.79;MaxEntScan=/0.0>0.0/3.1>1.0;SpliceAI=ZNF142|0.00|0.00|0.00|0.00|27|6|22|-37;NGSD_hom=1;NGSD_het=185;NGSD_mosaic=0;NGSD_group=0%20/%2016;gene_info=PLCD4%20(inh%3Dn/a%20oe_syn%3D0.82%20oe_mis%3D0.81%20oe_lof%3D0.65)%2C%20ZNF142%20(inh%3DAR%20oe_syn%3D0.97%20oe_mis%3D0.98%20oe_lof%3D0.59)	GT	1/0
chr2	219040574	.	C	T	1581	.	quality=DP%3D129%3BQD%3D12.26%3BAF%3D0.50%3BMQM%3D60%3BSAP%3D44%3BABP%3D3%3BSAR%3D50%3BSAF%3D15;gene=CFAP65;variant_type=splice_region&intron%2Cupstream_gene;coding_and_splicing=CFAP65:ENST00000341552.10:splice_region_variant&intron_variant:LOW:intron1/34:c.-48-10G>A::%2CCFAP65:ENST00000409865.7:splice_region_variant&intron_variant:LOW:intron1/12:c.26-10G>A::%2CCFAP65:ENST00000410037.5:splice_region_variant&intron_variant:LOW:intron1/11:c.-88-10G>A::%2CCFAP65:ENST00000295729.6:splice_region_variant&intron_variant:LOW:intron1/3:c.-88-10G>A::%2CCFAP65:ENST00000453220.5:upstream_gene_variant:MODIFIER::::%2CCFAP65:ENST00000441968.5:upstream_gene_variant:MODIFIER::::;regulatory=regulatory_region_variant:open_chromatin_region;OMIM=614270_[GENE%3DCFAP65_PHENOS%3DSpermatogenic%20failure%2040%2C%20618664%20(3)%2C%20Autosomal%20recessive];dbSNP=rs72966102;gnomAD=0.00515;gnomAD_sub=0.00173%2C0.00189%2C0.00000%2C0.00931%2C0.00248;gnomAD_hom_hemi=4%2C;gnomAD_het=777;gnomAD_wt=151521;phyloP=0.0520;CADD=9.36;MaxEntScan=10.6>9.1/10.6>9.1/0.0>0.0%2C/10.6>9.1/0.0>0.0;SpliceAI=CCDC108|0.00|0.10|0.00|0.00|-43|-10|19|1;NGSD_hom=4;NGSD_het=475;NGSD_mosaic=1;NGSD_group=1%20/%2057;gene_info=CFAP65%20(inh%3DAR%20oe_syn%3D1.00%20oe_mis%3D0.97%20oe_lof%3D0.63)	GT	1/0
chr2	219216753	.	C	T	2794	.	quality=DP%3D197%3BQD%3D14.18%3BAF%3D0.56%3BMQM%3D60%3BSAP%3D3%3BABP%3D9%3BSAR%3D56%3BSAF%3D54;gene=ABCB6%2CATG9A;variant_type=missense%2Cdownstream_gene;coding_and_splicing=ABCB6:ENST00000265316.9:missense_variant:MODERATE:exon3/19:c.767G>A:p.Arg256Gln:%2CABCB6:ENST00000295750.5:missense_variant:MODERATE:exon2/18:c.629G>A:p.Arg210Gln:%2CATG9A:ENST00000361242.9:downstream_gene_variant:MODIFIER::::%2CATG9A:ENST00000396761.6:downstream_gene_variant:MODIFIER::::%2CATG9A:ENST00000409618.5:downstream_gene_variant:MODIFIER::::%2CATG9A:ENST00000409422.5:downstream_gene_variant:MODIFIER::::;regulatory=regulatory_region_variant:promoter;OMIM=605452_[GENE%3DABCB6_PHENOS%3DMicrophthalmia%2C%20isolated%2C%20with%20coloboma%207%2C%20614497%20(3)%2C%20Autosomal%20dominant%3B%20Dyschromatosis%20universalis%20hereditaria%203%2C%20615402%20(3)%2C%20Autosomal%20dominant%3B%20Blood%20group%2C%20Langereis%20system%2C%20111600%20(3)%3B%20Pseudohyperkalemia%2C%20familial%2C%202%2C%20due%20to%20red%20cell%20leak%2C%20609153%20(3)%2C%20Autosomal%20dominant];dbSNP=rs72955421;gnomAD=0.00005;gnomAD_sub=0.00000%2C0.00000%2C0.00000%2C0.00012%2C0.00000;gnomAD_hom_hemi=0%2C;gnomAD_het=8;gnomAD_wt=152322;phyloP=0.3100;CADD=16.23;REVEL=0.246;AlphaMissense=0.07;MaxEntScan=/0.0>2.3/0.8>1.4;SpliceAI=ABCB6|0.00|0.00|0.00|0.00|-3|35|-20|-50;NGSD_hom=0;NGSD_het=11;NGSD_mosaic=0;NGSD_group=0%20/%201;gene_info=ABCB6%20(inh%3DAD%20oe_syn%3D1.14%20oe_mis%3D1.02%20oe_lof%3D0.74)%2C%20ATG9A%20(inh%3Dn/a%20oe_syn%3D1.04%20oe_mis%3D0.68%20oe_lof%3D0.16)	GT	1/0
chr2	219420154	.	C	T	1669	.	quality=DP%3D192%3BQD%3D8.69%3BAF%3D0.40%3BMQM%3D60%3BSAP%3D32%3BABP%3D21%3BSAR%3D22%3BSAF%3D54;gene=DES;variant_type=missense&splice_region;coding_and_splicing=DES:ENST00000373960.4:missense_variant&splice_region_variant:MODERATE:exon2/9:c.638C>T:p.Ala213Val:PF00038%20[Intermediate%20filament%20protein];regulatory=regulatory_region_variant:promoter;OMIM=125660_[GENE%3DDES_PHENOS%3DScapuloperoneal%20syndrome%2C%20neurogenic%2C%20Kaeser%20type%2C%20181400%20(3)%2C%20Autosomal%20dominant%3B%20Cardiomyopathy%2C%20dilated%2C%201I%2C%20604765%20(3)%2C%20Autosomal%20dominant%3B%20Myopathy%2C%20myofibrillar%2C%201%2C%20601419%20(3)%2C%20Autosomal%20dominant%2C%20Autosomal%20recessive];ClinVar=44265%20[benign(replaced%20by%20megSAP%20based%20on%20classifications:10x1%2C6x2%2C1x3)%20DISEASE%3DMyofibrillar%20myopathy%2Cnot%20specified%2CCardiomyopathy%2CMyofibrillar%20Myopathy%2C%20Dominant%2CCardiovascular%20phenotype%2CCongenital%20diaphragmatic%20hernia%2CNeurogenic%20scapuloperoneal%20syndrome%2C%20Kaeser%20type%2CDilated%20cardiomyopathy%201I%2Cnot%20provided%2CDesmin-related%20myofibrillar%20myopathy%20GENE%3DDES]%3B;HGMD=CM117560%20[CLASS%3DDFP%20MUT%3DALT%20PHEN%3D"Heart%20dilation%20association%20with"%20GENE%3DDES]%3B;dbSNP=rs41272699;gnomAD=0.00989;gnomAD_sub=0.00320%2C0.00934%2C0.00000%2C0.01583%2C0.00331;gnomAD_hom_hemi=12%2C;gnomAD_het=1482;gnomAD_wt=150840;phyloP=1.5140;CADD=25.20;REVEL=0.362;AlphaMissense=0.26;MaxEntScan=10.5>8.9/0.0>0.0/10.5>8.9;COSMIC=COSV99059323;SpliceAI=DES|0.00|0.00|0.03|0.00|-2|-49|-2|1;PubMed=25741868%2C24033266%2C23757202%2C23861362%2C20474083%2C25736269%2C17325244%2C14724127%2C15477095%2C16865695%2C17626518%2C22215463%2C25214167%2C23168288%2C16217025%2C16828798%2C16519886%2C23143191%2C21842594;NGSD_hom=6;NGSD_het=951;NGSD_mosaic=1;NGSD_group=1%20/%20116;classification_comment="[3]%20auto-classification%2014.09.2017%20[n/a]%20ahkleik1%2007.11.2022";gene_info=DES%20(inh%3DAR+AD%20oe_syn%3D0.87%20oe_mis%3D0.71%20oe_lof%3D0.33)	GT	1/0
chr2	219444963	.	G	A	1074	.	quality=DP%3D97%3BQD%3D11.07%3BAF%3D0.46%3BMQM%3D60%3BSAP%3D3%3BABP%3D4%3BSAR%3D23%3BSAF%3D22;gene=SPEG;variant_type=missense;coding_and_splicing=SPEG:ENST00000312358.12:missense_variant:MODERATE:exon3/41:c.617G>A:p.Arg206His:%2CSPEG:ENST00000396698.5:missense_variant:MODERATE:exon4/11:c.305G>A:p.Arg102His:;regulatory=regulatory_region_variant:promoter;OMIM=615950_[GENE%3DSPEG_PHENOS%3DCentronuclear%20myopathy%205%2C%20615959%20(3)%2C%20Autosomal%20recessive];ClinVar=1600464%20[benign%20DISEASE%3Dnot%20provided%20GENE%3DSPEG]%3B;dbSNP=rs55821435;gnomAD=0.00919;gnomAD_sub=0.00275%2C0.00229%2C0.00000%2C0.01590%2C0.00373;gnomAD_hom_hemi=10%2C;gnomAD_het=1379;gnomAD_wt=150771;phyloP=4.4810;CADD=23.80;REVEL=0.045;AlphaMissense=0.28;MaxEntScan=/6.5>5.6/0.0>0.0;COSMIC=COSV100404145;NGSD_hom=14;NGSD_het=1063;NGSD_mosaic=2;NGSD_group=3%20/%20132;gene_info=SPEG%20(inh%3DAR%20oe_syn%3D0.96%20oe_mis%3D0.82%20oe_lof%3D0.21)	GT	1/0
chr2	219557964	.	C	T	3074	.	quality=DP%3D221%3BQD%3D13.91%3BAF%3D0.55%3BMQM%3D60%3BSAP%3D63%3BABP%3D8%3BSAR%3D32%3BSAF%3D90;gene=OBSL1;variant_type=missense%2Cdownstream_gene;coding_and_splicing=OBSL1:ENST00000404537.6:missense_variant:MODERATE:exon11/21:c.3649G>A:p.Glu1217Lys:PF07679%20[Immunoglobulin%20I-set%20domain]%2COBSL1:ENST00000373876.5:missense_variant:MODERATE:exon11/20:c.3649G>A:p.Glu1217Lys:PF07679%20[Immunoglobulin%20I-set%20domain]%2COBSL1:ENST00000603926.5:missense_variant:MODERATE:exon11/14:c.3649G>A:p.Glu1217Lys:PF07679%20[Immunoglobulin%20I-set%20domain]%2COBSL1:ENST00000373873.8:downstream_gene_variant:MODIFIER::::%2COBSL1:ENST00000289656.3:downstream_gene_variant:MODIFIER::::;OMIM=610991_[GENE%3DOBSL1_PHENOS%3D3-M%20syndrome%202%2C%20612921%20(3)%2C%20Autosomal%20recessive];ClinVar=193901%20[benign/likely%20benign%20DISEASE%3Dnot%20specified%2C3M%20syndrome%202%2Cnot%20provided%20GENE%3DOBSL1]%3B;dbSNP=rs72957510;gnomAD=0.00711;gnomAD_sub=0.01378%2C0.00235%2C0.00000%2C0.00612%2C0.00269;gnomAD_hom_hemi=3%2C;gnomAD_het=1077;gnomAD_wt=151231;phyloP=0.7730;CADD=13.95;REVEL=0.032;AlphaMissense=0.07;MaxEntScan=/0.0>0.0/0.0>1.4;COSMIC=COSV105026433;SpliceAI=OBSL1|0.00|0.00|0.00|0.00|-24|6|3|17;PubMed=25741868;NGSD_hom=9;NGSD_het=609;NGSD_mosaic=0;NGSD_group=2%20/%20109;gene_info=OBSL1%20(inh%3DAR%20oe_syn%3D1.01%20oe_mis%3D1.00%20oe_lof%3D0.70)	GT	1/0
chr2	227010486	.	A	G	680	.	quality=DP%3D77%3BQD%3D8.83%3BAF%3D0.42%3BMQM%3D60%3BSAP%3D56%3BABP%3D8%3BSAR%3D30%3BSAF%3D2;gene=COL4A4;variant_type=missense;coding_and_splicing=COL4A4:ENST00000396625.5:missense_variant:MODERATE:exon46/48:c.4349T>C:p.Ile1450Thr:;OMIM=120131_[GENE%3DCOL4A4_PHENOS%3DHematuria%2C%20familial%20benign%2C%201%2C%20141200%20(3)%2C%20Autosomal%20dominant%3B%20Alport%20syndrome%202%2C%20autosomal%20recessive%2C%20203780%20(3)%2C%20Autosomal%20recessive];ClinVar=334705%20[likely%20benign(replaced%20by%20megSAP%20based%20on%20classifications:1x1%2C3x2%2C1x3)%20DISEASE%3Dnot%20specified%2CAlport%20syndrome%2CInborn%20genetic%20diseases%2Cnot%20provided%20GENE%3DCOL4A4]%3B;dbSNP=rs72969704;gnomAD=0.00048;gnomAD_sub=0.00031%2C0.00020%2C0.00000%2C0.00079%2C0.00021;gnomAD_hom_hemi=0%2C;gnomAD_het=73;gnomAD_wt=152309;phyloP=-1.8970;CADD=0.00;REVEL=0.172;AlphaMissense=0.05;MaxEntScan=/0.0>0.0/0.0>0.0;SpliceAI=COL4A4|0.00|0.00|0.00|0.00|-1|15|-41|-21;NGSD_hom=0;NGSD_het=32;NGSD_mosaic=0;NGSD_group=0%20/%202;gene_info=COL4A4%20(inh%3DAR+AD%20oe_syn%3D1.08%20oe_mis%3D0.91%20oe_lof%3D0.47)	GT	1/0
chr2	239139704	.	C	T	2336	.	quality=DP%3D229%3BQD%3D10.20%3BAF%3D0.42%3BMQM%3D60%3BSAP%3D13%3BABP%3D15%3BSAR%3D38%3BSAF%3D59;gene=HDAC4;variant_type=missense;coding_and_splicing=HDAC4:ENST00000345617.7:missense_variant:MODERATE:exon9/27:c.958G>A:p.Val320Ile:%2CHDAC4:ENST00000543185.6:missense_variant:MODERATE:exon9/27:c.958G>A:p.Val320Ile:;OMIM=605314_[GENE%3DHDAC4_PHENOS%3DNeurodevelopmental%20disorder%20with%20central%20hypotonia%20and%20dysmorphic%20facies%2C%20619797%20(3)%2C%20Autosomal%20dominant];ClinVar=284720%20[benign/likely%20benign%20DISEASE%3Dnot%20specified%2Cnot%20provided%20GENE%3DHDAC4]%3B;HGMD=CM1517528%20[CLASS%3DDP%20MUT%3DALT%20PHEN%3D"Prostate%20cancer%20association%20with"%20GENE%3DHDAC4]%3B;dbSNP=rs73000144;gnomAD=0.00319;gnomAD_sub=0.00099%2C0.00333%2C0.00000%2C0.00522%2C0.00062;gnomAD_hom_hemi=3%2C;gnomAD_het=480;gnomAD_wt=151868;phyloP=1.5590;CADD=12.17;REVEL=0.028;AlphaMissense=0.08;MaxEntScan=/6.7>5.3/0.0>0.0;COSMIC=COSV61862015;SpliceAI=HDAC4|0.00|0.00|0.00|0.00|-20|25|15|-42;PubMed=25335771;NGSD_hom=2;NGSD_het=368;NGSD_mosaic=0;NGSD_group=0%20/%2049;classification=2;classification_comment="[3]%20Stephan%20Waldmï¿½ller%2014.09.2015%20[2]%20swoedl%2023.12.2015%20Frequenz";gene_info=HDAC4%20(inh%3DAD%20oe_syn%3D1.19%20oe_mis%3D0.69%20oe_lof%3D0.00)	GT	1/0
chr3	7146493	.	T	C	1777	.	quality=DP%3D155%3BQD%3D11.46%3BAF%3D0.46%3BMQM%3D60%3BSAP%3D9%3BABP%3D5%3BSAR%3D29%3BSAF%3D43;gene=GRM7;variant_type=synonymous;coding_and_splicing=GRM7:ENST00000357716.9:synonymous_variant:LOW:exon2/10:c.561T>C:p.Ser187%3D:PF01094%20[Receptor%20family%20ligand%20binding%20region]%2CGRM7:ENST00000486284.5:synonymous_variant:LOW:exon2/11:c.561T>C:p.Ser187%3D:PF01094%20[Receptor%20family%20ligand%20binding%20region]%2CGRM7:ENST00000389336.8:synonymous_variant:LOW:exon2/10:c.561T>C:p.Ser187%3D:PF01094%20[Receptor%20family%20ligand%20binding%20region];OMIM=604101_[GENE%3DGRM7_PHENOS%3DNeurodevelopmental%20disorder%20with%20seizures%2C%20hypotonia%2C%20and%20brain%20abnormalities%2C%20618922%20(3)%2C%20Autosomal%20recessive];ClinVar=709766%20[benign%20DISEASE%3Dnot%20provided%20GENE%3DGRM7]%3B;dbSNP=rs35106713;gnomAD=0.00840;gnomAD_sub=0.00161%2C0.00792%2C0.00000%2C0.01269%2C0.00000;gnomAD_hom_hemi=14%2C;gnomAD_het=1251;gnomAD_wt=150951;phyloP=0.8030;CADD=7.16;MaxEntScan=/0.0>0.0/2.8>1.6;COSMIC=COSV63143571;SpliceAI=GRM7|0.00|0.00|0.00|0.00|-41|-32|11|-2;PubMed=19047183%2C24804643;NGSD_hom=11;NGSD_het=1147;NGSD_mosaic=0;NGSD_group=1%20/%20125;gene_info=GRM7%20(inh%3DAR%20oe_syn%3D1.12%20oe_mis%3D0.75%20oe_lof%3D0.11)	GT	1/0
chr3	16604489	.	G	A	1321	.	quality=DP%3D91%3BQD%3D14.52%3BAF%3D0.59%3BMQM%3D60%3BSAP%3D9%3BABP%3D10%3BSAR%3D33%3BSAF%3D21;gene=DAZL;variant_type=missense%2Cintron;coding_and_splicing=DAZL:ENST00000250863.12:missense_variant:MODERATE:exon1/11:c.14C>T:p.Ser5Leu:%2CDAZL:ENST00000399444.7:intron_variant:MODIFIER:intron1/10:c.3+714C>T::;OMIM=601486_[GENE%3DDAZL_PHENOS%3D{Spermatogenic%20failure%2C%20susceptibility%20to}%20(3)];dbSNP=rs55900737;gnomAD=0.00120;gnomAD_sub=0.00041%2C0.00131%2C0.00000%2C0.00187%2C0.00062;gnomAD_hom_hemi=1%2C;gnomAD_het=181;gnomAD_wt=152073;phyloP=0.0590;CADD=9.53;REVEL=0.038;MaxEntScan=/2.3>2.8/0.0>0.0;COSMIC=COSV105860266;SpliceAI=DAZL|0.02|0.00|0.00|0.00|-16|30|0|-49;NGSD_hom=1;NGSD_het=115;NGSD_mosaic=0;NGSD_group=0%20/%2013;gene_info=DAZL%20(inh%3Dn/a%20oe_syn%3D1.11%20oe_mis%3D0.90%20oe_lof%3D0.05)	GT	1/0
chr3	24165115	.	G	C	1687	.	quality=DP%3D144%3BQD%3D11.72%3BAF%3D0.47%3BMQM%3D60%3BSAP%3D4%3BABP%3D5%3BSAR%3D31%3BSAF%3D36;gene=THRB;variant_type=intron%2Csynonymous;coding_and_splicing=THRB:ENST00000396671.7:intron_variant:MODIFIER:intron4/9:c.284-12625C>G::%2CTHRB:ENST00000646209.2:intron_variant:MODIFIER:intron5/10:c.284-12625C>G::%2CTHRB:ENST00000356447.9:intron_variant:MODIFIER:intron5/10:c.284-12625C>G::%2CTHRB:ENST00000646432.1:intron_variant:MODIFIER:intron5/10:c.284-12625C>G::%2CTHRB:ENST00000643772.1:intron_variant:MODIFIER:intron5/10:c.284-12625C>G::%2CTHRB:ENST00000645139.1:intron_variant:MODIFIER:intron4/9:c.284-12625C>G::%2CTHRB:ENST00000642307.1:intron_variant:MODIFIER:intron4/9:c.284-12625C>G::%2CTHRB:ENST00000644321.1:intron_variant:MODIFIER:intron5/10:c.284-12625C>G::%2CTHRB:ENST00000416420.5:intron_variant:MODIFIER:intron6/11:c.284-12625C>G::%2CTHRB:ENST00000280696.9:synonymous_variant:LOW:exon1/7:c.240C>G:p.Ala80%3D:;OMIM=190160_[GENE%3DTHRB_PHENOS%3DThyroid%20hormone%20resistance%2C%20autosomal%20recessive%2C%20274300%20(3)%2C%20Autosomal%20recessive%3B%20Thyroid%20hormone%20resistance%2C%20188570%20(3)%2C%20Autosomal%20dominant%3B%20Thyroid%20hormone%20resistance%2C%20selective%20pituitary%2C%20145650%20(3)%2C%20Autosomal%20dominant];ClinVar=2653628%20[likely%20benign%20DISEASE%3Dnot%20provided%20GENE%3DTHRB]%3B;dbSNP=rs73035997;gnomAD=0.00504;gnomAD_sub=0.00060%2C0.00111%2C0.00000%2C0.00628%2C0.00062;gnomAD_hom_hemi=8%2C;gnomAD_het=750;gnomAD_wt=151362;phyloP=5.8850;CADD=23.10;MaxEntScan=/2.6>1.5/0.0>0.0;SpliceAI=THRB|0.01|0.00|0.00|0.00|48|-15|48|-15;NGSD_hom=0;NGSD_het=274;NGSD_mosaic=0;NGSD_group=0%20/%2034;gene_info=THRB%20(inh%3DAR+AD%20oe_syn%3D1.18%20oe_mis%3D0.55%20oe_lof%3D0.05)	GT	1/0
chr3	38004360	.	G	A	1162	.	quality=DP%3D144%3BQD%3D8.07%3BAF%3D0.37%3BMQM%3D60%3BSAP%3D3%3BABP%3D25%3BSAR%3D27%3BSAF%3D26;gene=VILL%2CPLCD1;variant_type=synonymous%2Cdownstream_gene;coding_and_splicing=VILL:ENST00000283713.10:synonymous_variant:LOW:exon16/20:c.1911G>A:p.Leu637%3D:PF00626%20[Gelsolin%20repeat]%2CVILL:ENST00000383759.7:synonymous_variant:LOW:exon16/20:c.1911G>A:p.Leu637%3D:PF00626%20[Gelsolin%20repeat]%2CVILL:ENST00000465644.5:synonymous_variant:LOW:exon8/12:c.1065G>A:p.Leu355%3D:PF00626%20[Gelsolin%20repeat]%2CPLCD1:ENST00000334661.5:downstream_gene_variant:MODIFIER::::%2CPLCD1:ENST00000463876.5:downstream_gene_variant:MODIFIER::::;regulatory=regulatory_region_variant:CTCF_binding_site%2Cregulatory_region_variant:open_chromatin_region;OMIM=602142_[GENE%3DPLCD1_PHENOS%3DNail%20disorder%2C%20nonsyndromic%20congenital%2C%203%2C%20(leukonychia)%2C%20151600%20(3)%2C%20Autosomal%20dominant%2C%20Autosomal%20recessive];dbSNP=rs75449732;phyloP=2.7020;CADD=4.53;MaxEntScan=/0.0>0.0/0.0>0.0;SpliceAI=VILL|0.00|0.00|0.03|0.00|5|-28|5|39;NGSD_hom=0;NGSD_het=5;NGSD_mosaic=1;NGSD_group=0%20/%201;gene_info=VILL%20(inh%3Dn/a%20oe_syn%3D0.94%20oe_mis%3D0.96%20oe_lof%3D0.84)%2C%20PLCD1%20(inh%3DAR+AD%20oe_syn%3D0.99%20oe_mis%3D0.97%20oe_lof%3D0.83)	GT	1/0
chr3	42210006	.	G	C	2316	.	quality=DP%3D185%3BQD%3D12.52%3BAF%3D0.51%3BMQM%3D60%3BSAP%3D48%3BABP%3D3%3BSAR%3D69%3BSAF%3D25;gene=TRAK1;variant_type=intron%2Cmissense;coding_and_splicing=TRAK1:ENST00000673621.2:intron_variant:MODIFIER:intron15/16:c.2047+21G>C::%2CTRAK1:ENST00000672026.1:intron_variant:MODIFIER:intron15/17:c.1651+21G>C::%2CTRAK1:ENST00000487159.5:intron_variant:MODIFIER:intron15/16:c.1651+21G>C::%2CTRAK1:ENST00000327628.10:intron_variant:MODIFIER:intron14/15:c.1963+21G>C::%2CTRAK1:ENST00000613405.4:missense_variant:MODERATE:exon13/13:c.1762G>C:p.Val588Leu:%2CTRAK1:ENST00000341421.7:missense_variant:MODERATE:exon13/13:c.1810G>C:p.Val604Leu:%2CTRAK1:ENST00000396175.5:intron_variant:MODIFIER:intron13/14:c.1789+21G>C::;OMIM=608112_[GENE%3DTRAK1_PHENOS%3DDevelopmental%20and%20epileptic%20encephalopathy%2068%2C%20618201%20(3)%2C%20Autosomal%20recessive];dbSNP=rs73056517;gnomAD=0.00135;gnomAD_sub=0.00022%2C0.00098%2C0.00000%2C0.00225%2C0.00041;gnomAD_hom_hemi=0%2C;gnomAD_het=206;gnomAD_wt=152120;phyloP=4.4080;CADD=17.21;REVEL=0.046;MaxEntScan=/4.5>4.8/0.0>0.0;SpliceAI=TRAK1|0.00|0.00|0.00|0.00|13|42|-14|-21;NGSD_hom=0;NGSD_het=169;NGSD_mosaic=0;NGSD_group=0%20/%2016;gene_info=TRAK1%20(inh%3DAR%20oe_syn%3D1.09%20oe_mis%3D0.87%20oe_lof%3D0.33)	GT	1/0
chr3	46898098	.	G	A	5777	.	quality=DP%3D479%3BQD%3D12.06%3BAF%3D0.48%3BMQM%3D60%3BSAP%3D7%3BABP%3D4%3BSAR%3D106%3BSAF%3D126;gene=PTH1R;variant_type=missense;coding_and_splicing=PTH1R:ENST00000449590.6:missense_variant:MODERATE:exon7/16:c.449G>A:p.Arg150His:PF02793%20[Hormone%20receptor%20domain]%2CPTH1R:ENST00000418619.5:missense_variant:MODERATE:exon7/16:c.449G>A:p.Arg150His:PF02793%20[Hormone%20receptor%20domain]%2CPTH1R:ENST00000430002.6:missense_variant:MODERATE:exon6/15:c.449G>A:p.Arg150His:PF02793%20[Hormone%20receptor%20domain]%2CPTH1R:ENST00000313049.9:missense_variant:MODERATE:exon5/14:c.449G>A:p.Arg150His:PF02793%20[Hormone%20receptor%20domain];regulatory=regulatory_region_variant:CTCF_binding_site;OMIM=168468_[GENE%3DPTH1R_PHENOS%3DMetaphyseal%20chondrodysplasia%2C%20Murk%20Jansen%20type%2C%20156400%20(3)%2C%20Autosomal%20dominant%3B%20Eiken%20syndrome%2C%20600002%20(3)%2C%20Autosomal%20recessive%3B%20Failure%20of%20tooth%20eruption%2C%20primary%2C%20125350%20(3)%2C%20Autosomal%20dominant%3B%20Chondrodysplasia%2C%20Blomstrand%20type%2C%20215045%20(3)%2C%20Autosomal%20recessive];ClinVar=899444%20[uncertain%20significance(replaced%20by%20megSAP%20based%20on%20classifications:1x2%2C1x3)%20DISEASE%3DMetaphyseal%20chondrodysplasia%2C%20Jansen%20type%2CChondrodysplasia%20Blomstrand%20type%20GENE%3DPTH1R]%3B;dbSNP=rs73067029;gnomAD=0.00003;gnomAD_sub=0.00005%2C0.00000%2C0.00000%2C0.00003%2C0.00000;gnomAD_hom_hemi=0%2C;gnomAD_het=4;gnomAD_wt=152322;phyloP=-0.0530;CADD=19.36;REVEL=0.151;AlphaMissense=0.08;MaxEntScan=/2.5>3.1/0.0>0.0;COSMIC=COSV100481169;SpliceAI=PTH1R|0.00|0.01|0.00|0.00|10|-24|-7|39;NGSD_hom=0;NGSD_het=13;NGSD_mosaic=1;NGSD_group=0%20/%201;gene_info=PTH1R%20(inh%3DAR+AD%20oe_syn%3D0.99%20oe_mis%3D0.76%20oe_lof%3D0.21)	GT	1/0
chr3	47410821	.	G	T	3183	.	quality=DP%3D260%3BQD%3D12.24%3BAF%3D0.52%3BMQM%3D60%3BSAP%3D3%3BABP%3D4%3BSAR%3D67%3BSAF%3D68;gene=PTPN23%2CSCAP;variant_type=missense%2Cdownstream_gene;coding_and_splicing=PTPN23:ENST00000265562.5:missense_variant:MODERATE:exon20/25:c.3023G>T:p.Gly1008Val:%2CSCAP:ENST00000265565.10:downstream_gene_variant:MODIFIER::::%2CSCAP:ENST00000648151.1:downstream_gene_variant:MODIFIER::::;OMIM=606584_[GENE%3DPTPN23_PHENOS%3DNeurodevelopmental%20disorder%20and%20structural%20brain%20anomalies%20with%20or%20without%20seizures%20and%20spasticity%2C%20618890%20(3)%2C%20Autosomal%20recessive];ClinVar=1375606%20[uncertain%20significance%20DISEASE%3Dnot%20provided%20GENE%3DPTPN23]%3B;dbSNP=rs56349424;gnomAD=0.00091;gnomAD_sub=0.00022%2C0.00211%2C0.00000%2C0.00123%2C0.00000;gnomAD_hom_hemi=0%2C;gnomAD_het=137;gnomAD_wt=150343;phyloP=1.0590;CADD=18.31;REVEL=0.024;AlphaMissense=0.10;MaxEntScan=/1.1>3.2/0.0>0.0;SpliceAI=PTPN23|0.00|0.00|0.00|0.00|-13|39|38|-34;NGSD_hom=0;NGSD_het=60;NGSD_mosaic=0;NGSD_group=0%20/%2010;gene_info=PTPN23%20(inh%3DAR%20oe_syn%3D1.11%20oe_mis%3D0.88%20oe_lof%3D0.25)%2C%20SCAP%20(inh%3Dn/a%20oe_syn%3D0.98%20oe_mis%3D0.74%20oe_lof%3D0.36)	GT	1/0
chr3	53811209	.	G	A	2973	.	quality=DP%3D233%3BQD%3D12.76%3BAF%3D0.51%3BMQM%3D60%3BSAP%3D25%3BABP%3D3%3BSAR%3D42%3BSAF%3D77;gene=CACNA1D%2CCHDH;variant_type=missense%2Cdownstream_gene;coding_and_splicing=CACNA1D:ENST00000637424.1:missense_variant:MODERATE:exon47/47:c.6316G>A:p.Asp2106Asn:PF16885%20[Voltage-gated%20calcium%20channel%20subunit%20alpha%20C-term]%2CCACNA1D:ENST00000481478.2:missense_variant:MODERATE:exon49/49:c.6349G>A:p.Asp2117Asn:PF16885%20[Voltage-gated%20calcium%20channel%20subunit%20alpha%20C-term]%2CCACNA1D:ENST00000288139.11:missense_variant:MODERATE:exon49/49:c.6349G>A:p.Asp2117Asn:PF16885%20[Voltage-gated%20calcium%20channel%20subunit%20alpha%20C-term]%2CCACNA1D:ENST00000350061.11:missense_variant:MODERATE:exon48/48:c.6289G>A:p.Asp2097Asn:PF16885%20[Voltage-gated%20calcium%20channel%20subunit%20alpha%20C-term]%2CCACNA1D:ENST00000636570.1:missense_variant:MODERATE:exon47/47:c.6244G>A:p.Asp2082Asn:PF16885%20[Voltage-gated%20calcium%20channel%20subunit%20alpha%20C-term]%2CCACNA1D:ENST00000422281.7:missense_variant:MODERATE:exon46/46:c.6217G>A:p.Asp2073Asn:PF16885%20[Voltage-gated%20calcium%20channel%20subunit%20alpha%20C-term]%2CCHDH:ENST00000315251.11:downstream_gene_variant:MODIFIER::::;OMIM=114206_[GENE%3DCACNA1D_PHENOS%3DPrimary%20aldosteronism%2C%20seizures%2C%20and%20neurologic%20abnormalities%2C%20615474%20(3)%2C%20Autosomal%20dominant%3B%20Sinoatrial%20node%20dysfunction%20and%20deafness%2C%20614896%20(3)%2C%20Autosomal%20recessive];ClinVar=504751%20[uncertain%20significance%20DISEASE%3Dnot%20specified%20GENE%3DCACNA1D]%3B;dbSNP=rs41276455;gnomAD=0.00001;gnomAD_sub=0.00000%2C0.00000%2C0.00000%2C0.00003%2C0.00000;gnomAD_hom_hemi=0%2C;gnomAD_het=2;gnomAD_wt=152246;phyloP=9.9230;CADD=28.80;REVEL=0.337;AlphaMissense=0.71;MaxEntScan=/0.0>0.0/0.0>0.0;SpliceAI=CACNA1D|0.00|0.00|0.00|0.00|6|-41|8|41;PubMed=26379493;NGSD_hom=0;NGSD_het=13;NGSD_mosaic=0;NGSD_group=0%20/%201;gene_info=CACNA1D%20(inh%3DAR+AD%20oe_syn%3D1.02%20oe_mis%3D0.64%20oe_lof%3D0.14)%2C%20CHDH%20(inh%3Dn/a%20oe_syn%3D0.97%20oe_mis%3D0.85%20oe_lof%3D0.56)	GT	1/0
chr3	57227919	.	G	C	1011	.	quality=DP%3D111%3BQD%3D9.11%3BAF%3D0.41%3BMQM%3D60%3BSAP%3D11%3BABP%3D12%3BSAR%3D29%3BSAF%3D16;gene=APPL1%2CHESX1;variant_type=synonymous%2Cupstream_gene;coding_and_splicing=APPL1:ENST00000288266.8:synonymous_variant:LOW:exon1/22:c.36G>C:p.Thr12%3D:PF16746%20[BAR%20domain%20of%20APPL%20family]%2CHESX1:ENST00000647958.1:upstream_gene_variant:MODIFIER::::;regulatory=regulatory_region_variant:open_chromatin_region;OMIM=601802_[GENE%3DHESX1_PHENOS%3DPituitary%20hormone%20deficiency%2C%20combined%2C%205%2C%20182230%20(3)%2C%20Autosomal%20dominant%2C%20Autosomal%20recessive%3B%20Septooptic%20dysplasia%2C%20182230%20(3)%2C%20Autosomal%20dominant%2C%20Autosomal%20recessive%3B%20Growth%20hormone%20deficiency%20with%20pituitary%20anomalies%2C%20182230%20(3)%2C%20Autosomal%20dominant%2C%20Autosomal%20recessive]&604299_[GENE%3DAPPL1_PHENOS%3D{Maturity-onset%20diabetes%20of%20the%20young%2C%20type%2014}%2C%20616511%20(3)%2C%20Autosomal%20dominant];ClinVar=1183160%20[benign/likely%20benign%20DISEASE%3Dnot%20provided%2Cnot%20specified%20GENE%3DAPPL1]%3B;dbSNP=rs79282761;gnomAD=0.00879;gnomAD_sub=0.00026%2C0.00020%2C0.00000%2C0.00890%2C0.00104;gnomAD_hom_hemi=38%2C;gnomAD_het=1261;gnomAD_wt=150755;phyloP=0.2650;CADD=9.88;MaxEntScan=/0.0>0.0/0.0>0.0;SpliceAI=APPL1|0.00|0.00|0.00|0.00|7|-17|14|18;PubMed=32854233%2C34575672;NGSD_hom=4;NGSD_het=708;NGSD_mosaic=0;NGSD_group=1%20/%2098;gene_info=HESX1%20(inh%3DAR+AD%20oe_syn%3D0.86%20oe_mis%3D1.05%20oe_lof%3D0.63)%2C%20APPL1%20(inh%3DAD%20oe_syn%3D0.90%20oe_mis%3D0.89%20oe_lof%3D0.20)	GT	1/0
chr3	58205547	.	C	G	812	.	quality=DP%3D61%3BQD%3D13.31%3BAF%3D0.54%3BMQM%3D60%3BSAP%3D27%3BABP%3D4%3BSAR%3D26%3BSAF%3D7;gene=DNASE1L3;variant_type=intron%2Cmissense;coding_and_splicing=DNASE1L3:ENST00000486455.5:intron_variant:MODIFIER:intron2/6:c.231-666G>C::%2CDNASE1L3:ENST00000394549.7:missense_variant:MODERATE:exon3/8:c.244G>C:p.Gly82Arg:PF03372%20[Endonuclease/Exonuclease/phosphatase%20family]%2CDNASE1L3:ENST00000483681.5:missense_variant:MODERATE:exon5/9:c.244G>C:p.Gly82Arg:PF03372%20[Endonuclease/Exonuclease/phosphatase%20family];OMIM=602244_[GENE%3DDNASE1L3_PHENOS%3DSystemic%20lupus%20erythematosus%2016%2C%20614420%20(3)%2C%20Autosomal%20recessive];ClinVar=196401%20[benign%20DISEASE%3Dnot%20specified%2Cnot%20provided%20GENE%3DDNASE1L3]%3B;HGMD=CM119735%20[CLASS%3DFP%20MUT%3DALT%20PHEN%3D"Reduced%20enzyme%20activity"%20GENE%3DDNASE1L3]%3B;dbSNP=rs74350392;gnomAD=0.00928;gnomAD_sub=0.00330%2C0.00614%2C0.00019%2C0.01604%2C0.00166;gnomAD_hom_hemi=12%2C;gnomAD_het=1389;gnomAD_wt=150905;phyloP=-0.6500;CADD=4.98;REVEL=0.045;AlphaMissense=0.20;MaxEntScan=/0.0>0.0/1.0>0.0;COSMIC=COSV59157634;SpliceAI=DNASE1L3|0.00|0.00|0.00|0.00|13|-26|-2|34;PubMed=37239388;NGSD_hom=16;NGSD_het=928;NGSD_mosaic=0;NGSD_group=1%20/%2095;gene_info=DNASE1L3%20(inh%3DAR%20oe_syn%3D0.98%20oe_mis%3D1.01%20oe_lof%3D0.64)	GT	1/0
chr3	113400570	.	A	G	1068	.	quality=DP%3D89%3BQD%3D12.00%3BAF%3D0.48%3BMQM%3D60%3BSAP%3D9%3BABP%3D3%3BSAR%3D16%3BSAF%3D27;gene=CFAP44%2CCFAP44-AS1;variant_type=synonymous%2Cupstream_gene;coding_and_splicing=CFAP44:ENST00000393845.9:synonymous_variant:LOW:exon12/35:c.1449T>C:p.Tyr483%3D:PF00400%20[WD%20domain%20G-beta%20repeat]%2CCFAP44:ENST00000295868.6:synonymous_variant:LOW:exon12/21:c.1449T>C:p.Tyr483%3D:PF00400%20[WD%20domain%20G-beta%20repeat]%2CCFAP44-AS1:ENST00000669165.1:upstream_gene_variant:MODIFIER::::;OMIM=617559_[GENE%3DCFAP44_PHENOS%3DSpermatogenic%20failure%2020%2C%20617593%20(3)%2C%20Autosomal%20recessive];ClinVar=731900%20[likely%20benign%20DISEASE%3Dnot%20provided%20GENE%3DCFAP44]%3B;dbSNP=rs73237120;gnomAD=0.00042;gnomAD_sub=0.00019%2C0.00013%2C0.00000%2C0.00075%2C0.00000;gnomAD_hom_hemi=0%2C;gnomAD_het=63;gnomAD_wt=151727;phyloP=-0.0450;CADD=0.52;MaxEntScan=/0.9>1.1/0.0>0.0;SpliceAI=CFAP44|0.00|0.00|0.00|0.00|34|-15|-25|-20;NGSD_hom=0;NGSD_het=34;NGSD_mosaic=0;NGSD_group=0%20/%205;gene_info=CFAP44%20(inh%3DAR%20oe_syn%3D0.90%20oe_mis%3D0.87%20oe_lof%3D0.43)%2C%20CFAP44-AS1%20(inh%3DAR%20oe_syn%3Dn/a%20oe_mis%3Dn/a%20oe_lof%3Dn/a)	GT	1/0
chr3	127012030	.	G	A	2646	.	quality=DP%3D172%3BQD%3D15.38%3BAF%3D0.58%3BMQM%3D60%3BSAP%3D4%3BABP%3D12%3BSAR%3D53%3BSAF%3D46;gene=PLXNA1;variant_type=missense;coding_and_splicing=PLXNA1:ENST00000393409.3:missense_variant:MODERATE:exon10/32:c.2185G>A:p.Ala729Thr:PF18020%20[TIG%20domain%20found%20in%20plexin];regulatory=regulatory_region_variant:enhancer;OMIM=601055_[GENE%3DPLXNA1_PHENOS%3DDworschak-Punetha%20neurodevelopmental%20syndrome%2C%20619955%20(3)%2C%20Autosomal%20recessive];HGMD=CM1725244%20[CLASS%3DDM?%20MUT%3DALT%20PHEN%3D"Autism%20spectrum%20disorder%20increased%20risk%20of"%20GENE%3DPLXNA1]%3B;dbSNP=rs78052417;gnomAD=0.00001;gnomAD_sub=0.00000%2C0.00000%2C0.00000%2C0.00001%2C0.00000;gnomAD_hom_hemi=0%2C;gnomAD_het=1;gnomAD_wt=152341;phyloP=9.9930;CADD=26.80;REVEL=0.348;AlphaMissense=0.80;MaxEntScan=/0.8>1.1/0.0>0.0;SpliceAI=PLXNA1|0.00|0.00|0.00|0.00|18|-42|18|-22;NGSD_hom=0;NGSD_het=11;NGSD_mosaic=0;NGSD_group=0%20/%201;gene_info=PLXNA1%20(inh%3DAR%20oe_syn%3D1.07%20oe_mis%3D0.73%20oe_lof%3D0.17)	GT	1/0
chr3	127022265	.	G	A	2464	.	quality=DP%3D163%3BQD%3D15.12%3BAF%3D0.60%3BMQM%3D60%3BSAP%3D9%3BABP%3D16%3BSAR%3D57%3BSAF%3D40;gene=PLXNA1;variant_type=missense;coding_and_splicing=PLXNA1:ENST00000393409.3:missense_variant:MODERATE:exon22/32:c.4219G>A:p.Val1407Met:PF08337%20[Plexin%20cytoplasmic%20RasGAP%20domain];OMIM=601055_[GENE%3DPLXNA1_PHENOS%3DDworschak-Punetha%20neurodevelopmental%20syndrome%2C%20619955%20(3)%2C%20Autosomal%20recessive];dbSNP=rs73196567;gnomAD=0.00001;gnomAD_sub=0.00000%2C0.00000%2C0.00000%2C0.00001%2C0.00000;gnomAD_hom_hemi=0%2C;gnomAD_het=1;gnomAD_wt=152363;phyloP=6.8300;CADD=25.40;REVEL=0.301;AlphaMissense=0.56;MaxEntScan=/0.0>0.0/0.0>1.6;SpliceAI=PLXNA1|0.00|0.00|0.00|0.00|-2|-24|-3|-24;NGSD_hom=0;NGSD_het=11;NGSD_mosaic=0;NGSD_group=0%20/%201;gene_info=PLXNA1%20(inh%3DAR%20oe_syn%3D1.07%20oe_mis%3D0.73%20oe_lof%3D0.17)	GT	1/0
chr3	127028347	.	G	A	647	.	quality=DP%3D59%3BQD%3D10.97%3BAF%3D0.53%3BMQM%3D60%3BSAP%3D40%3BABP%3D3%3BSAR%3D27%3BSAF%3D4;gene=PLXNA1;variant_type=splice_region&intron;coding_and_splicing=PLXNA1:ENST00000393409.3:splice_region_variant&intron_variant:LOW:intron25/31:c.4669+7G>A::;OMIM=601055_[GENE%3DPLXNA1_PHENOS%3DDworschak-Punetha%20neurodevelopmental%20syndrome%2C%20619955%20(3)%2C%20Autosomal%20recessive];ClinVar=1653317%20[benign%20DISEASE%3Dnot%20provided%20GENE%3DPLXNA1]%3B;dbSNP=rs73196573;gnomAD=0.00704;gnomAD_sub=0.00224%2C0.00523%2C0.00000%2C0.01154%2C0.00041;gnomAD_hom_hemi=8%2C;gnomAD_het=1057;gnomAD_wt=151277;phyloP=-0.4390;CADD=1.25;MaxEntScan=/0.0>0.0/0.0>0.0;SpliceAI=PLXNA1|0.00|0.00|0.00|0.00|-34|-25|-7|22;NGSD_hom=8;NGSD_het=754;NGSD_mosaic=0;NGSD_group=0%20/%2093;gene_info=PLXNA1%20(inh%3DAR%20oe_syn%3D1.07%20oe_mis%3D0.73%20oe_lof%3D0.17)	GT	1/0
chr3	142469495	.	A	C	1432	.	quality=DP%3D138%3BQD%3D10.38%3BAF%3D0.43%3BMQM%3D60%3BSAP%3D10%3BABP%3D8%3BSAR%3D37%3BSAF%3D23;gene=ATR;variant_type=missense;coding_and_splicing=ATR:ENST00000350721.9:missense_variant:MODERATE:exon38/47:c.6394T>G:p.Tyr2132Asp:%2CATR:ENST00000661310.1:missense_variant:MODERATE:exon37/46:c.6202T>G:p.Tyr2068Asp:;OMIM=601215_[GENE%3DATR_PHENOS%3DSeckel%20syndrome%201%2C%20210600%20(3)%2C%20Autosomal%20recessive%3B%20?Cutaneous%20telangiectasia%20and%20cancer%20syndrome%2C%20familial%2C%20614564%20(3)%2C%20Autosomal%20dominant];ClinVar=158000%20[benign/likely%20benign%20DISEASE%3Dnot%20specified%2CFamilial%20cutaneous%20telangiectasia%20and%20oropharyngeal%20predisposition%20cancer%20syndrome%2CATR-related%20disorder%2CSeckel%20syndrome%201%2Cnot%20provided%20GENE%3DATR]%3B;HGMD=CM1725174%20[CLASS%3DDP%20MUT%3DALT%20PHEN%3D"Haematological%20traits%20association%20with"%20GENE%3DATR]%3B;dbSNP=rs28910273;gnomAD=0.00340;gnomAD_sub=0.00149%2C0.00144%2C0.00000%2C0.00603%2C0.00207;gnomAD_hom_hemi=0%2C;gnomAD_het=518;gnomAD_wt=151814;phyloP=2.4040;CADD=20.10;REVEL=0.048;AlphaMissense=0.07;MaxEntScan=/0.4>0.0/0.0>0.0;COSMIC=COSV63384218;SpliceAI=ATR|0.00|0.00|0.00|0.00|21|-7|-10|36;PubMed=25741868%2C18414213%2C17010193%2C28787443%2C32888494%2C30595370;NGSD_hom=0;NGSD_het=424;NGSD_mosaic=0;NGSD_group=0%20/%2066;classification=2;classification_comment="[2]%20Ilnaz%20Sepahi%2029-03-2016%20batch%20import";gene_info=ATR%20(inh%3DAR+AD%20oe_syn%3D0.95%20oe_mis%3D0.67%20oe_lof%3D0.31)	GT	1/0
chr3	155828335	.	C	T	655	.	quality=DP%3D60%3BQD%3D10.92%3BAF%3D0.52%3BMQM%3D45%3BSAP%3D11%3BABP%3D3%3BSAR%3D21%3BSAF%3D10;gene=SLC33A1;variant_type=missense;coding_and_splicing=SLC33A1:ENST00000643144.2:missense_variant:MODERATE:exon6/6:c.1525G>A:p.Gly509Ser:PF13000%20[Acetyl-coenzyme%20A%20transporter%201]%2CSLC33A1:ENST00000359479.7:missense_variant:MODERATE:exon6/7:c.1525G>A:p.Gly509Ser:PF13000%20[Acetyl-coenzyme%20A%20transporter%201]%2CSLC33A1:ENST00000646424.1:missense_variant:MODERATE:exon4/4:c.1219G>A:p.Gly407Ser:PF13000%20[Acetyl-coenzyme%20A%20transporter%201];regulatory=regulatory_region_variant:enhancer;OMIM=603690_[GENE%3DSLC33A1_PHENOS%3DSpastic%20paraplegia%2042%2C%20autosomal%20dominant%2C%20612539%20(3)%2C%20Autosomal%20dominant%3B%20Congenital%20cataracts%2C%20hearing%20loss%2C%20and%20neurodegeneration%2C%20614482%20(3)%2C%20Autosomal%20recessive];ClinVar=343874%20[likely%20benign(replaced%20by%20megSAP%20based%20on%20classifications:4x1%2C2x2%2C1x3)%20DISEASE%3DHereditary%20spastic%20paraplegia%2CSpastic%20paraplegia%2Cnot%20specified%2Cnot%20provided%2CHereditary%20spastic%20paraplegia%2042%20GENE%3DSLC33A1]%3B;dbSNP=rs76440173;gnomAD=0.00252;gnomAD_sub=0.00128%2C0.00007%2C0.00000%2C0.00471%2C0.00021;gnomAD_hom_hemi=0%2C;gnomAD_het=383;gnomAD_wt=151849;phyloP=6.0230;CADD=27.90;REVEL=0.862;AlphaMissense=0.91;MaxEntScan=/0.0>0.0/0.3>0.0;COSMIC=COSV100848375;SpliceAI=SLC33A1|0.00|0.05|0.00|0.00|-2|42|-8|-42;PubMed=25741868%2C24583203%2C34887591%2C34594039;NGSD_hom=2;NGSD_het=324;NGSD_mosaic=0;NGSD_group=0%20/%2045;classification=3;classification_comment="VUS3%2C%20best.%2C%20MR%2C%2016.03.2017%20VUS3%2C%20MR%2C%2002.05.2016%2C%20[3]%20Peter%20Bauer%2029.01.2015";gene_info=SLC33A1%20(inh%3DAR+AD%20oe_syn%3D1.04%20oe_mis%3D0.67%20oe_lof%3D0.48)	GT	1/0
chr3	169122674	.	T	C	1247	.	quality=DP%3D128%3BQD%3D9.74%3BAF%3D0.44%3BMQM%3D60%3BSAP%3D4%3BABP%3D7%3BSAR%3D31%3BSAF%3D25;gene=MECOM;variant_type=missense;coding_and_splicing=MECOM:ENST00000264674.7:missense_variant:MODERATE:exon6/17:c.512A>G:p.Gln171Arg:PF00096%20[Zinc%20finger%20C2H2%20type]%2CMECOM:ENST00000628990.2:missense_variant:MODERATE:exon5/16:c.320A>G:p.Gln107Arg:PF00096%20[Zinc%20finger%20C2H2%20type]%2CMECOM:ENST00000464456.5:missense_variant:MODERATE:exon5/15:c.320A>G:p.Gln107Arg:PF00096%20[Zinc%20finger%20C2H2%20type]%2CMECOM:ENST00000651503.2:missense_variant:MODERATE:exon6/17:c.884A>G:p.Gln295Arg:PF00096%20[Zinc%20finger%20C2H2%20type]%2CMECOM:ENST00000472280.5:missense_variant:MODERATE:exon5/16:c.320A>G:p.Gln107Arg:PF00096%20[Zinc%20finger%20C2H2%20type]%2CMECOM:ENST00000494292.6:missense_variant:MODERATE:exon6/16:c.884A>G:p.Gln295Arg:PF00096%20[Zinc%20finger%20C2H2%20type]%2CMECOM:ENST00000468789.5:missense_variant:MODERATE:exon5/16:c.320A>G:p.Gln107Arg:PF00096%20[Zinc%20finger%20C2H2%20type]%2CMECOM:ENST00000460814.5:missense_variant:MODERATE:exon4/15:c.320A>G:p.Gln107Arg:PF00096%20[Zinc%20finger%20C2H2%20type]%2CMECOM:ENST00000433243.6:missense_variant:MODERATE:exon6/17:c.320A>G:p.Gln107Arg:PF00096%20[Zinc%20finger%20C2H2%20type];regulatory=regulatory_region_variant:CTCF_binding_site%2Cregulatory_region_variant:promoter;OMIM=165215_[GENE%3DMECOM_PHENOS%3DRadioulnar%20synostosis%20with%20amegakaryocytic%20thrombocytopenia%202%2C%20616738%20(3)%2C%20Autosomal%20dominant];ClinVar=2041744%20[benign%20DISEASE%3Dnot%20specified%2Cnot%20provided%20GENE%3DMECOM]%3B;HGMD=CM237164%20[CLASS%3DDM?%20MUT%3DALT%20PHEN%3D"Cholesteatoma"%20GENE%3DMECOM]%3B;dbSNP=rs34896995;gnomAD=0.00240;gnomAD_sub=0.00125%2C0.00092%2C0.00000%2C0.00407%2C0.00000;gnomAD_hom_hemi=1%2C;gnomAD_het=363;gnomAD_wt=151963;phyloP=7.6740;CADD=25.50;REVEL=0.240;AlphaMissense=0.65;MaxEntScan=/0.0>3.9/0.0>0.0;COSMIC=COSV99245826;SpliceAI=MECOM|0.00|0.00|0.00|0.00|-11|-47|31|-10;PubMed=29540340;NGSD_hom=1;NGSD_het=258;NGSD_mosaic=0;NGSD_group=0%20/%2039;gene_info=MECOM%20(inh%3DAD%20oe_syn%3D1.11%20oe_mis%3D0.82%20oe_lof%3D0.04)	GT	1/0
chr3	180951420	.	C	T	936	.	quality=DP%3D81%3BQD%3D11.56%3BAF%3D0.47%3BMQM%3D60%3BSAP%3D22%3BABP%3D4%3BSAR%3D28%3BSAF%3D10;gene=FXR1;variant_type=synonymous;coding_and_splicing=FXR1:ENST00000305586.11:synonymous_variant:LOW:exon9/18:c.498C>T:p.Thr166%3D:PF00013%20[KH%20domain]%2CFXR1:ENST00000698793.1:synonymous_variant:LOW:exon8/15:c.753C>T:p.Thr251%3D:PF00013%20[KH%20domain]%2CFXR1:ENST00000698794.1:synonymous_variant:LOW:exon8/16:c.753C>T:p.Thr251%3D:PF00013%20[KH%20domain]%2CFXR1:ENST00000357559.9:synonymous_variant:LOW:exon8/17:c.753C>T:p.Thr251%3D:PF00013%20[KH%20domain]%2CFXR1:ENST00000491062.5:synonymous_variant:LOW:exon6/14:c.606C>T:p.Thr202%3D:PF00013%20[KH%20domain]%2CFXR1:ENST00000468861.5:synonymous_variant:LOW:exon7/15:c.498C>T:p.Thr166%3D:PF00013%20[KH%20domain]%2CFXR1:ENST00000445140.6:synonymous_variant:LOW:exon8/16:c.753C>T:p.Thr251%3D:PF00013%20[KH%20domain]%2CFXR1:ENST00000480918.5:synonymous_variant:LOW:exon8/17:c.714C>T:p.Thr238%3D:PF00013%20[KH%20domain];OMIM=600819_[GENE%3DFXR1_PHENOS%3DCongenital%20myopathy%209B%2C%20proximal%2C%20with%20minicore%20lesions%2C%20618823%20(3)%2C%20Autosomal%20recessive%3B%20?Congenital%20myopathy%209A%20with%20respiratory%20insufficiency%20and%20bone%20fractures%2C%20618822%20(3)%2C%20Autosomal%20recessive];ClinVar=777377%20[benign/likely%20benign%20DISEASE%3Dnot%20provided%20GENE%3DFXR1]%3B;dbSNP=rs73176330;gnomAD=0.00849;gnomAD_sub=0.00123%2C0.00412%2C0.00000%2C0.00910%2C0.00249;gnomAD_hom_hemi=16%2C;gnomAD_het=1260;gnomAD_wt=150862;phyloP=-1.7600;CADD=6.90;MaxEntScan=/0.0>0.0/0.0>0.0;COSMIC=COSV99976765;SpliceAI=FXR1|0.00|0.00|0.00|0.00|14|-18|-41|48;NGSD_hom=10;NGSD_het=748;NGSD_mosaic=1;NGSD_group=0%20/%2083;gene_info=FXR1%20(inh%3DAR%20oe_syn%3D0.89%20oe_mis%3D0.52%20oe_lof%3D0.03)	GT	1/0
chr3	183762226	.	G	A	1341	.	quality=DP%3D100%3BQD%3D13.41%3BAF%3D0.53%3BMQM%3D60%3BSAP%3D3%3BABP%3D4%3BSAR%3D28%3BSAF%3D25;gene=YEATS2;variant_type=missense;coding_and_splicing=YEATS2:ENST00000305135.10:missense_variant:MODERATE:exon15/31:c.1894G>A:p.Val632Ile:;OMIM=613373_[GENE%3DYEATS2_PHENOS%3D?Epilepsy%2C%20myoclonic%2C%20familial%20adult%2C%204%2C%20615127%20(3)%2C%20Autosomal%20dominant];dbSNP=rs73175329;gnomAD=0.00009;gnomAD_sub=0.00000%2C0.00007%2C0.00000%2C0.00019%2C0.00000;gnomAD_hom_hemi=0%2C;gnomAD_het=14;gnomAD_wt=152290;phyloP=1.5450;CADD=19.33;REVEL=0.027;AlphaMissense=0.08;MaxEntScan=/8.4>7.5/3.0>0.0;SpliceAI=YEATS2|0.00|0.00|0.01|0.00|38|0|38|-1;NGSD_hom=0;NGSD_het=43;NGSD_mosaic=0;NGSD_group=0%20/%207;gene_info=YEATS2%20(inh%3DAD%20oe_syn%3D0.92%20oe_mis%3D0.90%20oe_lof%3D0.18)	GT	1/0
chr3	184165174	.	C	G	760	.	quality=DP%3D138%3BQD%3D5.51%3BAF%3D0.29%3BMQM%3D60%3BSAP%3D3%3BABP%3D56%3BSAR%3D21%3BSAF%3D19;gene=DVL3;variant_type=missense;coding_and_splicing=DVL3:ENST00000313143.9:missense_variant:MODERATE:exon6/15:c.661C>G:p.Arg221Gly:PF02377%20[Dishevelled%20specific%20domain]%2CDVL3:ENST00000431765.6:missense_variant:MODERATE:exon6/15:c.661C>G:p.Arg221Gly:PF02377%20[Dishevelled%20specific%20domain];OMIM=601368_[GENE%3DDVL3_PHENOS%3DRobinow%20syndrome%2C%20autosomal%20dominant%203%2C%20616894%20(3)%2C%20Autosomal%20dominant];dbSNP=rs76594728;phyloP=2.5070;CADD=29.20;REVEL=0.296;AlphaMissense=0.83;MaxEntScan=/0.0>0.0/0.0>0.0;COSMIC=COSV57458079;SpliceAI=DVL3|0.00|0.00|0.00|0.00|14|-44|-1|14;NGSD_hom=0;NGSD_het=4;NGSD_mosaic=1;NGSD_group=0%20/%201;gene_info=DVL3%20(inh%3DAD%20oe_syn%3D0.95%20oe_mis%3D0.70%20oe_lof%3D0.22)	GT	1/0
chr3	184355450	.	G	A	2487	.	quality=DP%3D213%3BQD%3D11.68%3BAF%3D0.46%3BMQM%3D60%3BSAP%3D4%3BABP%3D6%3BSAR%3D45%3BSAF%3D53;gene=CLCN2;variant_type=missense;coding_and_splicing=CLCN2:ENST00000265593.9:missense_variant:MODERATE:exon12/24:c.1250C>T:p.Pro417Leu:PF00654%20[Voltage%20gated%20chloride%20channel]%2CCLCN2:ENST00000344937.11:missense_variant:MODERATE:exon12/24:c.1250C>T:p.Pro417Leu:PF00654%20[Voltage%20gated%20chloride%20channel]%2CCLCN2:ENST00000434054.6:missense_variant:MODERATE:exon11/23:c.1118C>T:p.Pro373Leu:PF00654%20[Voltage%20gated%20chloride%20channel]%2CCLCN2:ENST00000457512.1:missense_variant:MODERATE:exon12/23:c.1250C>T:p.Pro417Leu:PF00654%20[Voltage%20gated%20chloride%20channel];regulatory=regulatory_region_variant:CTCF_binding_site;OMIM=600570_[GENE%3DCLCN2_PHENOS%3DLeukoencephalopathy%20with%20ataxia%2C%20615651%20(3)%2C%20Autosomal%20recessive%3B%20Hyperaldosteronism%2C%20familial%2C%20type%20II%2C%20605635%20(3)%2C%20Autosomal%20dominant%3B%20{Epilepsy%2C%20juvenile%20myoclonic%2C%20susceptibility%20to%2C%208}%2C%20607628%20(3)%2C%20Autosomal%20dominant%3B%20{Epilepsy%2C%20juvenile%20absence%2C%20susceptibility%20to%2C%202}%2C%20607628%20(3)%2C%20Autosomal%20dominant%3B%20{Epilepsy%2C%20idiopathic%20generalized%2C%20susceptibility%20to%2C%2011}%2C%20607628%20(3)%2C%20Autosomal%20dominant];dbSNP=rs73189627;gnomAD=0.00001;gnomAD_sub=0.00000%2C0.00000%2C0.00000%2C0.00001%2C0.00000;gnomAD_hom_hemi=0%2C;gnomAD_het=1;gnomAD_wt=152265;phyloP=1.6150;CADD=18.19;REVEL=0.157;AlphaMissense=0.06;MaxEntScan=/0.0>0.0/0.0>0.0;SpliceAI=CLCN2|0.00|0.00|0.00|0.00|-17|22|22|-32;NGSD_hom=0;NGSD_het=11;NGSD_mosaic=0;NGSD_group=0%20/%201;gene_info=CLCN2%20(inh%3DAR+AD%20oe_syn%3D1.08%20oe_mis%3D0.92%20oe_lof%3D0.55)	GT	1/0
chr3	188609319	.	C	T	2505	.	quality=DP%3D197%3BQD%3D12.72%3BAF%3D0.50%3BMQM%3D60%3BSAP%3D3%3BABP%3D3%3BSAR%3D51%3BSAF%3D47;gene=LPP;variant_type=synonymous;coding_and_splicing=LPP:ENST00000448637.5:synonymous_variant:LOW:exon6/7:c.588C>T:p.Ile196%3D:%2CLPP:ENST00000414139.6:synonymous_variant:LOW:exon6/11:c.588C>T:p.Ile196%3D:%2CLPP:ENST00000617246.5:synonymous_variant:LOW:exon7/12:c.588C>T:p.Ile196%3D:%2CLPP:ENST00000420410.6:synonymous_variant:LOW:exon5/10:c.588C>T:p.Ile196%3D:%2CLPP:ENST00000618621.5:synonymous_variant:LOW:exon6/11:c.588C>T:p.Ile196%3D:;OMIM=600700_[GENE%3DLPP_PHENOS%3DLipoma%20(3)%3B%20Leukemia%2C%20acute%20myeloid%2C%20601626%20(3)%2C%20Somatic%20mutation%2C%20Autosomal%20dominant];ClinVar=775935%20[benign%20DISEASE%3Dnot%20provided%20GENE%3DLPP]%3B;dbSNP=rs55674610;gnomAD=0.00134;gnomAD_sub=0.00063%2C0.00268%2C0.00697%2C0.00128%2C0.00145;gnomAD_hom_hemi=0%2C;gnomAD_het=204;gnomAD_wt=152022;phyloP=-0.9230;CADD=3.13;MaxEntScan=/0.1>0.0/0.0>0.0;COSMIC=COSV100448338;NGSD_hom=0;NGSD_het=145;NGSD_mosaic=0;NGSD_group=0%20/%2023;gene_info=LPP%20(inh%3DAD%20oe_syn%3D1.21%20oe_mis%3D1.22%20oe_lof%3D0.32)	GT	1/0
chr4	989824	.	C	T	1205	.	quality=DP%3D107%3BQD%3D11.26%3BAF%3D0.45%3BMQM%3D60%3BSAP%3D5%3BABP%3D5%3BSAR%3D21%3BSAF%3D27;gene=SLC26A1%2CIDUA;variant_type=intron%2Cmissense;coding_and_splicing=SLC26A1:ENST00000398520.6:intron_variant:MODIFIER:intron2/2:c.576+1304G>A::%2CSLC26A1:ENST00000622731.4:intron_variant:MODIFIER:intron3/3:c.576+1304G>A::%2CIDUA:ENST00000247933.9:intron_variant:MODIFIER:intron2/13:c.299+1875C>T::%2CIDUA:ENST00000514224.2:intron_variant:MODIFIER:intron2/13:c.299+1875C>T::%2CSLC26A1:ENST00000398516.3:missense_variant:MODERATE:exon3/3:c.1115G>A:p.Arg372His:PF00916%20[Sulfate%20permease%20family]%2CSLC26A1:ENST00000361661.6:missense_variant:MODERATE:exon4/4:c.1115G>A:p.Arg372His:PF00916%20[Sulfate%20permease%20family];OMIM=610130_[GENE%3DSLC26A1_PHENOS%3D?Hypersulfaturia%2C%20620372%20(3)%2C%20Autosomal%20recessive%3B%20?Nephrolithiasis%2C%20calcium%20oxalate%2C%201%2C%20167030%20(3)%2C%20Autosomal%20recessive]&252800_[GENE%3DIDUA_PHENOS%3DMucopolysaccharidosis%20Is%2C%20607016%20(3)%2C%20Autosomal%20recessive%3B%20Mucopolysaccharidosis%20Ih/s%2C%20607015%20(3)%2C%20Autosomal%20recessive%3B%20Mucopolysaccharidosis%20Ih%2C%20607014%20(3)%2C%20Autosomal%20recessive];ClinVar=376863%20[benign/likely%20benign%20DISEASE%3DNephrolithiasis%2C%20calcium%20oxalate%2Cnot%20provided%20GENE%3DIDUA]%3B;dbSNP=rs73219719;gnomAD=0.00971;gnomAD_sub=0.00171%2C0.02783%2C0.00058%2C0.01041%2C0.00290;gnomAD_hom_hemi=21%2C;gnomAD_het=1438;gnomAD_wt=150888;phyloP=0.0440;CADD=20.80;REVEL=0.214;AlphaMissense=0.09;MaxEntScan=/6.7>5.6/2.8>0.0%2C/1.5>2.6/0.0>0.0;COSMIC=COSV56101715%2CCOSV56102473;SpliceAI=IDUA|0.00|0.00|0.00|0.00|7|-30|-49|-4%2CSLC26A1|0.00|0.00|0.00|0.00|-11|17|30|5;PubMed=25741868%2C24250268;NGSD_hom=6;NGSD_het=786;NGSD_mosaic=1;NGSD_group=2%20/%20100;gene_info=SLC26A1%20(inh%3DAR%20oe_syn%3D1.02%20oe_mis%3D0.95%20oe_lof%3D0.99)%2C%20IDUA%20(inh%3DAR%20oe_syn%3D1.27%20oe_mis%3D1.09%20oe_lof%3D0.82)	GT	1/0
chr4	1093539	.	G	GCTGCCCAGGCTGGAGCC	4297	.	quality=DP%3D141%3BQD%3D30.48%3BAF%3D0.96%3BMQM%3D60%3BSAP%3D4%3BABP%3D0%3BSAR%3D71%3BSAF%3D64;gene=RNF212;variant_type=intron%2Cframeshift;coding_and_splicing=RNF212:ENST00000698262.1:intron_variant:MODIFIER:intron3/11:c.247-2702_247-2701insGGCTCCAGCCTGGGCAG::%2CRNF212:ENST00000382968.9:intron_variant:MODIFIER:intron3/9:c.247-2702_247-2701insGGCTCCAGCCTGGGCAG::%2CRNF212:ENST00000433731.7:intron_variant:MODIFIER:intron3/9:c.247-2702_247-2701insGGCTCCAGCCTGGGCAG::%2CRNF212:ENST00000333673.5:frameshift_variant:HIGH:exon4/4:c.721_722insGGCTCCAGCCTGGGCAG:p.Ser241TrpfsTer26:;OMIM=612041_[GENE%3DRNF212_PHENOS%3D?Spermatogenic%20failure%2062%2C%20619673%20(3)%2C%20Autosomal%20recessive%3B%20Recombination%20rate%20QTL%201%2C%20612042%20(3)];dbSNP=rs138488801;MaxEntScan=/0.0>0.0/0.0>1.4;COSMIC=COSV61363892;SpliceAI=RNF212|0.00|0.00|0.00|0.00|24|-47|24|-37;NGSD_hom=20049;NGSD_het=10756;NGSD_mosaic=2601;NGSD_group=1791%20/%20942;gene_info=RNF212%20(inh%3DAR%20oe_syn%3D0.97%20oe_mis%3D0.98%20oe_lof%3D0.46)	GT	1/1
chr4	1093540	.	A	AGC	4297	.	quality=DP%3D141%3BQD%3D30.48%3BAF%3D0.96%3BMQM%3D60%3BSAP%3D4%3BABP%3D0%3BSAR%3D71%3BSAF%3D64;gene=RNF212;variant_type=intron%2Cframeshift;coding_and_splicing=RNF212:ENST00000698262.1:intron_variant:MODIFIER:intron3/11:c.247-2703_247-2702insGC::%2CRNF212:ENST00000382968.9:intron_variant:MODIFIER:intron3/9:c.247-2703_247-2702insGC::%2CRNF212:ENST00000433731.7:intron_variant:MODIFIER:intron3/9:c.247-2703_247-2702insGC::%2CRNF212:ENST00000333673.5:frameshift_variant:HIGH:exon4/4:c.720_721insGC:p.Ser241AlafsTer21:;OMIM=612041_[GENE%3DRNF212_PHENOS%3D?Spermatogenic%20failure%2062%2C%20619673%20(3)%2C%20Autosomal%20recessive%3B%20Recombination%20rate%20QTL%201%2C%20612042%20(3)];dbSNP=rs539986150;MaxEntScan=/0.0>0.0/0.0>0.0;COSMIC=COSV61365919;SpliceAI=RNF212|0.00|0.00|0.00|0.00|-44|23|12|-38;NGSD_hom=15422;NGSD_het=8242;NGSD_mosaic=2600;NGSD_group=1316%20/%20688;gene_info=RNF212%20(inh%3DAR%20oe_syn%3D0.97%20oe_mis%3D0.98%20oe_lof%3D0.46)	GT	1/1
chr4	1093541	.	C	CAT	4297	.	quality=DP%3D141%3BQD%3D30.48%3BAF%3D0.96%3BMQM%3D60%3BSAP%3D4%3BABP%3D0%3BSAR%3D71%3BSAF%3D64;gene=RNF212;variant_type=intron%2Cframeshift;coding_and_splicing=RNF212:ENST00000698262.1:intron_variant:MODIFIER:intron3/11:c.247-2704_247-2703insAT::%2CRNF212:ENST00000382968.9:intron_variant:MODIFIER:intron3/9:c.247-2704_247-2703insAT::%2CRNF212:ENST00000433731.7:intron_variant:MODIFIER:intron3/9:c.247-2704_247-2703insAT::%2CRNF212:ENST00000333673.5:frameshift_variant:HIGH:exon4/4:c.719_720insAT:p.Ser241CysfsTer21:;OMIM=612041_[GENE%3DRNF212_PHENOS%3D?Spermatogenic%20failure%2062%2C%20619673%20(3)%2C%20Autosomal%20recessive%3B%20Recombination%20rate%20QTL%201%2C%20612042%20(3)];dbSNP=rs555719638;MaxEntScan=/0.0>0.0/0.0>0.0;COSMIC=COSV61363816;SpliceAI=RNF212|0.01|0.00|0.00|0.00|22|-49|22|1;NGSD_hom=15422;NGSD_het=8242;NGSD_mosaic=2600;NGSD_group=1316%20/%20688;gene_info=RNF212%20(inh%3DAR%20oe_syn%3D0.97%20oe_mis%3D0.98%20oe_lof%3D0.46)	GT	1/1
chr4	5745187	.	TTC	T	4730	.	quality=DP%3D177%3BQD%3D26.72%3BAF%3D0.45%3BMQM%3D60%3BSAP%3D82%3BABP%3D7%3BSAR%3D13%3BSAF%3D67;gene=EVC;variant_type=splice_region&intron;coding_and_splicing=EVC:ENST00000264956.11:splice_region_variant&intron_variant:LOW:intron6/20:c.802-15_802-14del::%2CEVC:ENST00000509451.1:splice_region_variant&intron_variant:LOW:intron6/11:c.802-15_802-14del::;OMIM=604831_[GENE%3DEVC_PHENOS%3DEllis-van%20Creveld%20syndrome%2C%20225500%20(3)%2C%20Autosomal%20recessive%3B%20?Weyers%20acrofacial%20dysostosis%2C%20193530%20(3)%2C%20Autosomal%20dominant];RepeatMasker=(TTTC)n%20(Simple_repeat);dbSNP=rs554199549;phyloP=-0.5260;MaxEntScan=/12.9>12.7/0.0>0.0;SpliceAI=EVC|0.00|0.00|0.00|0.00|26|17|46|39;NGSD_hom=179;NGSD_het=4007;NGSD_mosaic=665;NGSD_group=19%20/%20340;gene_info=EVC%20(inh%3DAR+AD%20oe_syn%3D1.20%20oe_mis%3D1.16%20oe_lof%3D0.83)	GT	1/0
chr4	5745191	.	TC	T	4730	.	quality=DP%3D177%3BQD%3D26.72%3BAF%3D0.45%3BMQM%3D60%3BSAP%3D82%3BABP%3D7%3BSAR%3D13%3BSAF%3D67;gene=EVC;variant_type=splice_region&intron;coding_and_splicing=EVC:ENST00000264956.11:splice_region_variant&intron_variant:LOW:intron6/20:c.802-12del::%2CEVC:ENST00000509451.1:splice_region_variant&intron_variant:LOW:intron6/11:c.802-12del::;OMIM=604831_[GENE%3DEVC_PHENOS%3DEllis-van%20Creveld%20syndrome%2C%20225500%20(3)%2C%20Autosomal%20recessive%3B%20?Weyers%20acrofacial%20dysostosis%2C%20193530%20(3)%2C%20Autosomal%20dominant];RepeatMasker=(TTTC)n%20(Simple_repeat);dbSNP=rs1378179545;phyloP=-0.7450;MaxEntScan=/12.9>13.0/0.0>0.0;SpliceAI=EVC|0.00|0.00|0.00|0.00|13|14|24|13;NGSD_hom=182;NGSD_het=4059;NGSD_mosaic=653;NGSD_group=19%20/%20340;gene_info=EVC%20(inh%3DAR+AD%20oe_syn%3D1.20%20oe_mis%3D1.16%20oe_lof%3D0.83)	GT	1/0
chr4	94278750	.	A	G	363	.	quality=DP%3D41%3BQD%3D8.85%3BAF%3D0.41%3BMQM%3D60%3BSAP%3D25%3BABP%3D6%3BSAR%3D15%3BSAF%3D2;gene=SMARCAD1;variant_type=splice_region&intron;coding_and_splicing=SMARCAD1:ENST00000457823.6:splice_region_variant&intron_variant:LOW:intron18/23:c.2296+17A>G::%2CSMARCAD1:ENST00000354268.9:splice_region_variant&intron_variant:LOW:intron18/23:c.2296+17A>G::%2CSMARCAD1:ENST00000509418.1:splice_region_variant&intron_variant:LOW:intron10/15:c.1006+17A>G::;OMIM=612761_[GENE%3DSMARCAD1_PHENOS%3DBasan%20syndrome%2C%20129200%20(3)%2C%20Autosomal%20dominant%3B%20Huriez%20syndrome%2C%20181600%20(3)%2C%20Autosomal%20dominant%3B%20Adermatoglyphia%2C%20136000%20(3)%2C%20Autosomal%20dominant];dbSNP=rs72665680;gnomAD=0.00398;gnomAD_sub=0.00108%2C0.00072%2C0.00000%2C0.00718%2C0.00042;gnomAD_hom_hemi=1%2C;gnomAD_het=603;gnomAD_wt=151583;phyloP=-0.2600;CADD=4.73;MaxEntScan=/2.4>3.1/0.0>0.0;SpliceAI=SMARCAD1|0.00|0.00|0.00|0.01|49|-42|-18|-17;NGSD_hom=3;NGSD_het=434;NGSD_mosaic=0;NGSD_group=0%20/%2048;gene_info=SMARCAD1%20(inh%3DAD%20oe_syn%3D1.06%20oe_mis%3D0.57%20oe_lof%3D0.02)	GT	1/0
chr4	99582002	.	C	A	1827	.	quality=DP%3D191%3BQD%3D9.57%3BAF%3D0.41%3BMQM%3D60%3BSAP%3D7%3BABP%3D17%3BSAR%3D45%3BSAF%3D33;gene=MTTP;variant_type=missense%2C5'UTR;coding_and_splicing=MTTP:ENST00000457717.6:missense_variant:MODERATE:exon3/19:c.159C>A:p.Asp53Glu:PF01347%20[Lipoprotein%20amino%20terminal%20region]%2CMTTP:ENST00000511045.6:5_prime_UTR_variant:MODIFIER:exon2/18:c.-91C>A::%2CMTTP:ENST00000422897.6:missense_variant:MODERATE:exon2/3:c.159C>A:p.Asp53Glu:PF01347%20[Lipoprotein%20amino%20terminal%20region]%2CMTTP:ENST00000265517.10:missense_variant:MODERATE:exon2/18:c.159C>A:p.Asp53Glu:PF01347%20[Lipoprotein%20amino%20terminal%20region];OMIM=157147_[GENE%3DMTTP_PHENOS%3DAbetalipoproteinemia%2C%20200100%20(3)%2C%20Autosomal%20recessive];ClinVar=901698%20[uncertain%20significance%20DISEASE%3Dnot%20provided%2CAbetalipoproteinaemia%20GENE%3DMTTP]%3B;dbSNP=rs72681995;gnomAD=0.00001;gnomAD_sub=0.00000%2C0.00000%2C0.00000%2C0.00001%2C0.00000;gnomAD_hom_hemi=0%2C;gnomAD_het=1;gnomAD_wt=152349;phyloP=-0.0350;CADD=10.00;REVEL=0.082;AlphaMissense=0.13;MaxEntScan=/0.0>0.0/0.0>0.0;SpliceAI=MTTP|0.00|0.00|0.00|0.00|-34|-13|-49|3;NGSD_hom=0;NGSD_het=11;NGSD_mosaic=0;NGSD_group=0%20/%201;gene_info=MTTP%20(inh%3DAR+AD%20oe_syn%3D0.95%20oe_mis%3D0.87%20oe_lof%3D0.39)	GT	1/0
chr4	108165124	.	C	T	1682	.	quality=DP%3D169%3BQD%3D9.95%3BAF%3D0.43%3BMQM%3D60%3BSAP%3D4%3BABP%3D10%3BSAR%3D40%3BSAF%3D33;gene=LEF1%2CLEF1-AS1;variant_type=missense%2Cupstream_gene;coding_and_splicing=LEF1:ENST00000379951.6:missense_variant:MODERATE:exon2/10:c.253G>A:p.Asp85Asn:PF08347%20[N-terminal%20CTNNB1%20binding]%2CLEF1:ENST00000265165.6:missense_variant:MODERATE:exon2/12:c.253G>A:p.Asp85Asn:PF08347%20[N-terminal%20CTNNB1%20binding]%2CLEF1:ENST00000438313.6:missense_variant:MODERATE:exon2/11:c.253G>A:p.Asp85Asn:PF08347%20[N-terminal%20CTNNB1%20binding]%2CLEF1:ENST00000510624.5:missense_variant:MODERATE:exon2/11:c.49G>A:p.Asp17Asn:PF08347%20[N-terminal%20CTNNB1%20binding]%2CLEF1:ENST00000512172.1:missense_variant:MODERATE:exon2/5:c.49G>A:p.Asp17Asn:PF08347%20[N-terminal%20CTNNB1%20binding]%2CLEF1-AS1:ENST00000436413.5:upstream_gene_variant:MODIFIER::::;regulatory=regulatory_region_variant:open_chromatin_region;OMIM=153245_[GENE%3DLEF1_PHENOS%3DSebaceous%20tumors%2C%20somatic%20(3)];ClinVar=773869%20[benign%20DISEASE%3Dnot%20provided%20GENE%3DLEF1]%3B;dbSNP=rs61752607;gnomAD=0.00624;gnomAD_sub=0.00183%2C0.00876%2C0.00270%2C0.00791%2C0.01226;gnomAD_hom_hemi=3%2C;gnomAD_het=944;gnomAD_wt=151286;phyloP=5.3990;CADD=25.40;REVEL=0.486;AlphaMissense=0.10;MaxEntScan=/0.0>0.0/0.0>0.0;COSMIC=COSV54469014;SpliceAI=LEF1|0.00|0.00|0.00|0.02|-27|39|39|-27;NGSD_hom=8;NGSD_het=689;NGSD_mosaic=0;NGSD_group=0%20/%2066;gene_info=LEF1%20(inh%3DAD%20oe_syn%3D0.96%20oe_mis%3D0.71%20oe_lof%3D0.04)%2C%20LEF1-AS1%20(inh%3DAD%20oe_syn%3Dn/a%20oe_mis%3Dn/a%20oe_lof%3Dn/a)	GT	1/0
chr4	118338293	.	C	T	725	.	quality=DP%3D122%3BQD%3D5.94%3BAF%3D0.30%3BMQM%3D60%3BSAP%3D20%3BABP%3D44%3BSAR%3D27%3BSAF%3D10;gene=PRSS12;variant_type=missense;coding_and_splicing=PRSS12:ENST00000296498.3:missense_variant:MODERATE:exon2/13:c.524G>A:p.Gly175Asp:PF00530%20[Scavenger%20receptor%20cysteine-rich%20domain];regulatory=regulatory_region_variant:enhancer%2CTF_binding_site_variant;OMIM=606709_[GENE%3DPRSS12_PHENOS%3DIntellectual%20developmental%20disorder%2C%20autosomal%20recessive%201%2C%20249500%20(3)%2C%20Autosomal%20recessive];ClinVar=903346%20[uncertain%20significance%20DISEASE%3DIntellectual%20disability%2C%20autosomal%20recessive%201%20GENE%3DPRSS12]%3B;dbSNP=rs72677056;phyloP=3.4680;CADD=19.57;REVEL=0.303;AlphaMissense=0.14;MaxEntScan=/0.0>0.0/0.0>0.0;COSMIC=COSV56604268;SpliceAI=PRSS12|0.00|0.00|0.00|0.00|21|39|-9|21;NGSD_hom=0;NGSD_het=4;NGSD_mosaic=2;NGSD_group=0%20/%201;gene_info=PRSS12%20(inh%3DAR%20oe_syn%3D0.96%20oe_mis%3D0.95%20oe_lof%3D0.96)	GT	1/0
chr4	122271085	.	A	C	2350	.	quality=DP%3D183%3BQD%3D12.84%3BAF%3D0.54%3BMQM%3D60%3BSAP%3D5%3BABP%3D5%3BSAR%3D54%3BSAF%3D44;gene=BLTP1;variant_type=missense;coding_and_splicing=BLTP1:ENST00000679879.1:missense_variant:MODERATE:exon47/88:c.7561A>C:p.Ser2521Arg:%2CBLTP1:ENST00000264501.8:missense_variant:MODERATE:exon47/86:c.7561A>C:p.Ser2521Arg:%2CBLTP1:ENST00000388738.8:missense_variant:MODERATE:exon47/85:c.7561A>C:p.Ser2521Arg:;OMIM=611565_[GENE%3DBLTP1_PHENOS%3DAlkuraya-Kucinskas%20syndrome%2C%20617822%20(3)%2C%20Autosomal%20recessive];dbSNP=rs45608936;gnomAD=0.00937;gnomAD_sub=0.00308%2C0.00491%2C0.00000%2C0.01589%2C0.00746;gnomAD_hom_hemi=17%2C;gnomAD_het=1392;gnomAD_wt=150828;phyloP=7.2400;CADD=22.60;REVEL=0.216;AlphaMissense=0.68;MaxEntScan=/0.0>0.0/0.0>0.0;SpliceAI=KIAA1109|0.00|0.00|0.00|0.00|-4|2|19|0;PubMed=32888493%2C32888494;NGSD_hom=9;NGSD_het=1032;NGSD_mosaic=0;NGSD_group=2%20/%20134;gene_info=BLTP1%20(inh%3DAR%20oe_syn%3D0.94%20oe_mis%3D0.67%20oe_lof%3D0.34)	GT	1/0
chr4	143997521	.	T	G	731	.	quality=DP%3D67%3BQD%3D10.91%3BAF%3D0.49%3BMQM%3D60%3BSAP%3D32%3BABP%3D3%3BSAR%3D6%3BSAF%3D27;gene=GUSBP5%2CGYPB;variant_type=intron&non_coding_transcript%2Csplice_region&intron;coding_and_splicing=GUSBP5:ENST00000641741.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/12:n.309-84637T>G::%2CGUSBP5:ENST00000506982.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/4:n.184+28142T>G::%2CGYPB:ENST00000429670.3:splice_region_variant&intron_variant:LOW:intron4/4:c.*5+19A>C::%2CGYPB:ENST00000502664.6:splice_region_variant&intron_variant:LOW:intron4/4:c.270+19A>C::%2CGYPB:ENST00000513128.5:splice_region_variant&intron_variant:LOW:intron3/3:c.171+19A>C::%2CGYPB:ENST00000506516.6:splice_region_variant&intron_variant:LOW:intron5/5:c.192+19A>C::;OMIM=617923_[GENE%3DGYPB_PHENOS%3DBlood%20group%2C%20Ss%2C%20111740%20(3)%3B%20{Malaria%2C%20resistance%20to}%2C%20611162%20(3)];dbSNP=rs55682721;gnomAD=0.00332;gnomAD_sub=0.00113%2C0.00098%2C0.00000%2C0.00582%2C0.00519;gnomAD_hom_hemi=3%2C;gnomAD_het=497;gnomAD_wt=150943;phyloP=0.2450;CADD=5.57;MaxEntScan=/0.0>0.0/0.0>1.2%2C/3.6>5.0/0.0>0.0;SpliceAI=GYPB|0.03|0.00|0.00|0.00|37|39|19|13;NGSD_hom=2;NGSD_het=535;NGSD_mosaic=0;NGSD_group=0%20/%2063;gene_info=GUSBP5%20(inh%3Dn/a%20oe_syn%3Dn/a%20oe_mis%3Dn/a%20oe_lof%3Dn/a)%2C%20GYPB%20(inh%3Dn/a%20oe_syn%3D1.26%20oe_mis%3D1.43%20oe_lof%3D1.03)	GT	1/0
chr4	150817188	.	A	G	2470	.	quality=DP%3D206%3BQD%3D11.99%3BAF%3D0.49%3BMQM%3D60%3BSAP%3D12%3BABP%3D3%3BSAR%3D60%3BSAF%3D40;gene=LRBA;variant_type=synonymous;coding_and_splicing=LRBA:ENST00000651943.2:synonymous_variant:LOW:exon31/57:c.5241T>C:p.Asn1747%3D:%2CLRBA:ENST00000357115.9:synonymous_variant:LOW:exon31/58:c.5241T>C:p.Asn1747%3D:%2CLRBA:ENST00000510413.5:synonymous_variant:LOW:exon31/57:c.5241T>C:p.Asn1747%3D:%2CLRBA:ENST00000651695.2:synonymous_variant:LOW:exon31/57:c.5241T>C:p.Asn1747%3D:%2CLRBA:ENST00000507224.5:synonymous_variant:LOW:exon31/51:c.5241T>C:p.Asn1747%3D:;OMIM=606453_[GENE%3DLRBA_PHENOS%3DImmunodeficiency%2C%20common%20variable%2C%208%2C%20with%20autoimmunity%2C%20614700%20(3)%2C%20Autosomal%20recessive];ClinVar=425340%20[benign/likely%20benign%20DISEASE%3Dnot%20provided%2CCombined%20immunodeficiency%20due%20to%20LRBA%20deficiency%20GENE%3DLRBA]%3B;dbSNP=rs72719631;gnomAD=0.00096;gnomAD_sub=0.00026%2C0.00112%2C0.00000%2C0.00153%2C0.00000;gnomAD_hom_hemi=0%2C;gnomAD_het=146;gnomAD_wt=151984;phyloP=0.4790;CADD=3.41;REVEL=0.044;MaxEntScan=/1.9>1.6/0.0>0.0;SpliceAI=LRBA|0.00|0.00|0.00|0.00|12|-23|-1|46;NGSD_hom=1;NGSD_het=88;NGSD_mosaic=0;NGSD_group=0%20/%2012;gene_info=LRBA%20(inh%3DAR%20oe_syn%3D1.06%20oe_mis%3D0.95%20oe_lof%3D0.33)	GT	1/0
chr4	151014529	.	C	A	3276	.	quality=DP%3D250%3BQD%3D13.10%3BAF%3D0.50%3BMQM%3D60%3BSAP%3D4%3BABP%3D3%3BSAR%3D67%3BSAF%3D58;gene=LRBA;variant_type=synonymous;coding_and_splicing=LRBA:ENST00000651943.2:synonymous_variant:LOW:exon2/57:c.114G>T:p.Gly38%3D:%2CLRBA:ENST00000357115.9:synonymous_variant:LOW:exon2/58:c.114G>T:p.Gly38%3D:%2CLRBA:ENST00000510413.5:synonymous_variant:LOW:exon2/57:c.114G>T:p.Gly38%3D:%2CLRBA:ENST00000651695.2:synonymous_variant:LOW:exon2/57:c.114G>T:p.Gly38%3D:%2CLRBA:ENST00000507224.5:synonymous_variant:LOW:exon2/51:c.114G>T:p.Gly38%3D:;regulatory=regulatory_region_variant:open_chromatin_region;OMIM=606453_[GENE%3DLRBA_PHENOS%3DImmunodeficiency%2C%20common%20variable%2C%208%2C%20with%20autoimmunity%2C%20614700%20(3)%2C%20Autosomal%20recessive];ClinVar=425341%20[likely%20benign(replaced%20by%20megSAP%20based%20on%20classifications:1x1%2C1x2%2C1x3)%20DISEASE%3DCombined%20immunodeficiency%20due%20to%20LRBA%20deficiency%2Cnot%20provided%20GENE%3DLRBA]%3B;dbSNP=rs72721739;gnomAD=0.00111;gnomAD_sub=0.00029%2C0.00137%2C0.00000%2C0.00168%2C0.00145;gnomAD_hom_hemi=0%2C;gnomAD_het=169;gnomAD_wt=152185;phyloP=-0.0500;CADD=10.90;MaxEntScan=/5.7>6.4/0.0>0.8;SpliceAI=LRBA|0.25|0.00|0.00|0.00|-12|0|2|23;NGSD_hom=1;NGSD_het=96;NGSD_mosaic=0;NGSD_group=0%20/%2012;gene_info=LRBA%20(inh%3DAR%20oe_syn%3D1.06%20oe_mis%3D0.95%20oe_lof%3D0.33)	GT	1/0
chr4	169477323	.	A	C	947	.	quality=DP%3D67%3BQD%3D14.13%3BAF%3D0.58%3BMQM%3D60%3BSAP%3D16%3BABP%3D7%3BSAR%3D27%3BSAF%3D12;gene=NEK1;variant_type=missense;coding_and_splicing=NEK1:ENST00000507142.6:missense_variant:MODERATE:exon26/36:c.2235T>G:p.Asn745Lys:%2CNEK1:ENST00000687643.1:missense_variant:MODERATE:exon25/35:c.2178T>G:p.Asn726Lys:%2CNEK1:ENST00000685111.1:missense_variant:MODERATE:exon24/34:c.2067T>G:p.Asn689Lys:%2CNEK1:ENST00000686697.1:missense_variant:MODERATE:exon22/31:c.1929T>G:p.Asn643Lys:%2CNEK1:ENST00000688934.1:missense_variant:MODERATE:exon6/16:c.258T>G:p.Asn86Lys:%2CNEK1:ENST00000439128.6:missense_variant:MODERATE:exon24/34:c.2151T>G:p.Asn717Lys:%2CNEK1:ENST00000511633.5:missense_variant:MODERATE:exon25/35:c.2103T>G:p.Asn701Lys:%2CNEK1:ENST00000510533.5:missense_variant:MODERATE:exon23/33:c.2019T>G:p.Asn673Lys:%2CNEK1:ENST00000512193.5:missense_variant:MODERATE:exon23/33:c.1944T>G:p.Asn648Lys:;OMIM=604588_[GENE%3DNEK1_PHENOS%3DShort-rib%20thoracic%20dysplasia%206%20with%20or%20without%20polydactyly%2C%20263520%20(3)%2C%20Digenic%20recessive%2C%20Autosomal%20recessive%3B%20{Amyotrophic%20lateral%20sclerosis%2C%20susceptibility%20to%2C%2024}%2C%20617892%20(3)%2C%20Autosomal%20dominant];ClinVar=266051%20[likely%20benign(replaced%20by%20megSAP%20based%20on%20classifications:3x1%2C4x2%2C1x3)%20DISEASE%3Dnot%20provided%2CShort-rib%20thoracic%20dysplasia%206%20with%20or%20without%20polydactyly%2CMotor%20neuron%20disease%2Cnot%20specified%20GENE%3DNEK1]%3B;HGMD=CM171615%20[CLASS%3DDM?%20MUT%3DALT%20PHEN%3D"Motor%20neuron%20disease"%20GENE%3DNEK1]%3B;dbSNP=rs34324114;gnomAD=0.00406;gnomAD_sub=0.00060%2C0.00072%2C0.00000%2C0.00596%2C0.00166;gnomAD_hom_hemi=2%2C;gnomAD_het=614;gnomAD_wt=151484;phyloP=3.0620;CADD=22.60;REVEL=0.372;AlphaMissense=0.84;MaxEntScan=/1.6>0.0/0.0>0.7;SpliceAI=NEK1|0.04|0.00|0.00|0.00|6|-14|6|-14;PubMed=28089114%2C35495032;NGSD_hom=0;NGSD_het=529;NGSD_mosaic=0;NGSD_group=0%20/%2055;gene_info=NEK1%20(inh%3DAR+AD%20oe_syn%3D1.01%20oe_mis%3D0.88%20oe_lof%3D0.68)	GT	1/0
chr5	33461912	.	A	G	416	.	quality=DP%3D48%3BQD%3D8.67%3BAF%3D0.42%3BMQM%3D60%3BSAP%3D10%3BABP%3D6%3BSAR%3D6%3BSAF%3D14;gene=TARS1;variant_type=missense;coding_and_splicing=TARS1:ENST00000502553.5:missense_variant:MODERATE:exon16/20:c.1636A>G:p.Ile546Val:PF00587%20[tRNA%20synthetase%20class%20II%20core%20domain%20(G%20H%20P%20S%20and%20T)]%2CTARS1:ENST00000455217.6:missense_variant:MODERATE:exon16/20:c.1735A>G:p.Ile579Val:PF00587%20[tRNA%20synthetase%20class%20II%20core%20domain%20(G%20H%20P%20S%20and%20T)]%2CTARS1:ENST00000265112.8:missense_variant:MODERATE:exon15/19:c.1636A>G:p.Ile546Val:PF00587%20[tRNA%20synthetase%20class%20II%20core%20domain%20(G%20H%20P%20S%20and%20T)];OMIM=187790_[GENE%3DTARS1_PHENOS%3DTrichothiodystrophy%207%2C%20nonphotosensitive%2C%20618546%20(3)%2C%20Autosomal%20recessive];dbSNP=rs72737350;gnomAD=0.00004;gnomAD_sub=0.00000%2C0.00000%2C0.00000%2C0.00009%2C0.00000;gnomAD_hom_hemi=0%2C;gnomAD_het=6;gnomAD_wt=152318;phyloP=9.2940;CADD=23.50;REVEL=0.172;AlphaMissense=0.18;MaxEntScan=/1.4>0.4/0.0>0.0;SpliceAI=TARS|0.00|0.00|0.00|0.00|-20|6|-1|-49;NGSD_hom=0;NGSD_het=14;NGSD_mosaic=0;NGSD_group=0%20/%201;gene_info=TARS1%20(inh%3DAR%20oe_syn%3D1.03%20oe_mis%3D0.84%20oe_lof%3D0.58)	GT	1/0
chr5	37153769	.	G	T	3896	.	quality=DP%3D345%3BQD%3D11.29%3BAF%3D0.46%3BMQM%3D60%3BSAP%3D132%3BABP%3D8%3BSAR%3D31%3BSAF%3D128;gene=CPLANE1;variant_type=missense;coding_and_splicing=CPLANE1:ENST00000508244.5:missense_variant:MODERATE:exon40/51:c.8182C>A:p.Pro2728Thr:%2CCPLANE1:ENST00000651892.2:missense_variant:MODERATE:exon42/53:c.8344C>A:p.Pro2782Thr:;OMIM=614571_[GENE%3DCPLANE1_PHENOS%3DOrofaciodigital%20syndrome%20VI%2C%20277170%20(3)%2C%20Autosomal%20recessive%3B%20Joubert%20syndrome%2017%2C%20614615%20(3)%2C%20Autosomal%20recessive];ClinVar=158055%20[benign/likely%20benign%20DISEASE%3DJoubert%20syndrome%2017%2Cnot%20specified%2COrofaciodigital%20syndrome%20type%206%2Cnot%20provided%20GENE%3DCPLANE1]%3B;dbSNP=rs77014998;gnomAD=0.00690;gnomAD_sub=0.00244%2C0.00439%2C0.00019%2C0.01107%2C0.00105;gnomAD_hom_hemi=7%2C;gnomAD_het=1035;gnomAD_wt=150913;phyloP=0.3240;CADD=3.88;REVEL=0.037;AlphaMissense=0.08;MaxEntScan=/0.0>0.0/0.0>0.0;COSMIC=COSV99073217;SpliceAI=C5orf42|0.00|0.00|0.00|0.00|36|0|-29|-32;PubMed=25741868%2C18414213;NGSD_hom=4;NGSD_het=650;NGSD_mosaic=0;NGSD_group=1%20/%2083;classification=2;classification_comment="[2]%20Frequenz%20>0%2C5%0Ahschak1%2003.11.2016";gene_info=CPLANE1%20(inh%3DAR%20oe_syn%3D0.93%20oe_mis%3D0.86%20oe_lof%3D0.56)	GT	1/0
chr5	55226608	.	C	G	2352	.	quality=DP%3D183%3BQD%3D12.85%3BAF%3D0.51%3BMQM%3D60%3BSAP%3D4%3BABP%3D3%3BSAR%3D50%3BSAF%3D43;gene=MCIDAS%2CCCNO;variant_type=missense%2Cdownstream_gene;coding_and_splicing=MCIDAS:ENST00000513312.3:missense_variant:MODERATE:exon3/7:c.277G>C:p.Ala93Pro:%2CCCNO:ENST00000282572.5:downstream_gene_variant:MODIFIER::::;regulatory=regulatory_region_variant:CTCF_binding_site%2Cregulatory_region_variant:open_chromatin_region%2CTF_binding_site_variant;OMIM=614086_[GENE%3DMCIDAS_PHENOS%3DCiliary%20dyskinesia%2C%20primary%2C%2042%2C%20618695%20(3)%2C%20Autosomal%20recessive]&607752_[GENE%3DCCNO_PHENOS%3DCiliary%20dyskinesia%2C%20primary%2C%2029%2C%20615872%20(3)%2C%20Autosomal%20recessive];ClinVar=454528%20[uncertain%20significance%20DISEASE%3DPrimary%20ciliary%20dyskinesia%20GENE%3DMCIDAS]%3B;dbSNP=rs115971569;gnomAD=0.00001;gnomAD_sub=0.00000%2C0.00000%2C0.00000%2C0.00001%2C0.00000;gnomAD_hom_hemi=0%2C;gnomAD_het=1;gnomAD_wt=152335;phyloP=0.0890;CADD=18.29;REVEL=0.053;AlphaMissense=0.09;MaxEntScan=/0.0>0.0/0.0>0.0;SpliceAI=MCIDAS|0.00|0.00|0.00|0.03|-10|36|8|-32;NGSD_hom=0;NGSD_het=11;NGSD_mosaic=0;NGSD_group=0%20/%201;gene_info=MCIDAS%20(inh%3DAR%20oe_syn%3D0.80%20oe_mis%3D0.63%20oe_lof%3D0.41)%2C%20CCNO%20(inh%3DAR%20oe_syn%3D1.06%20oe_mis%3D1.03%20oe_lof%3D0.56)	GT	1/0
chr5	69420283	.	T	A	1970	.	quality=DP%3D169%3BQD%3D11.66%3BAF%3D0.47%3BMQM%3D60%3BSAP%3D11%3BABP%3D5%3BSAR%3D48%3BSAF%3D31;gene=MARVELD2;variant_type=missense%2Cintron;coding_and_splicing=MARVELD2:ENST00000647531.1:missense_variant:MODERATE:exon2/6:c.898T>A:p.Leu300Met:PF01284%20[Membrane-associating%20domain]%2CMARVELD2:ENST00000645446.1:missense_variant:MODERATE:exon2/7:c.898T>A:p.Leu300Met:PF01284%20[Membrane-associating%20domain]%2CMARVELD2:ENST00000325631.10:missense_variant:MODERATE:exon2/7:c.898T>A:p.Leu300Met:PF01284%20[Membrane-associating%20domain]%2CMARVELD2:ENST00000454295.6:missense_variant:MODERATE:exon2/6:c.898T>A:p.Leu300Met:PF01284%20[Membrane-associating%20domain]%2CMARVELD2:ENST00000436532.7:intron_variant:MODIFIER:intron1/6:c.725+173T>A::;OMIM=610572_[GENE%3DMARVELD2_PHENOS%3DDeafness%2C%20autosomal%20recessive%2049%2C%20610153%20(3)%2C%20Autosomal%20recessive];ClinVar=178409%20[likely%20benign(replaced%20by%20megSAP%20based%20on%20classifications:2x1%2C2x2%2C4x3)%20DISEASE%3DAutosomal%20recessive%20nonsyndromic%20hearing%20loss%2049%2Cnot%20provided%2Cnot%20specified%20GENE%3DMARVELD2]%3B;dbSNP=rs72773422;gnomAD=0.00161;gnomAD_sub=0.00034%2C0.00046%2C0.00000%2C0.00294%2C0.00000;gnomAD_hom_hemi=1%2C;gnomAD_het=243;gnomAD_wt=152069;phyloP=0.0900;CADD=16.99;REVEL=0.153;AlphaMissense=0.10;MaxEntScan=/0.7>0.6/0.0>0.0;COSMIC=COSV57782616;SpliceAI=MARVELD2|0.00|0.00|0.00|0.00|2|25|10|25;PubMed=24033266%2C25885414;NGSD_hom=1;NGSD_het=217;NGSD_mosaic=0;NGSD_group=0%20/%2021;gene_info=MARVELD2%20(inh%3DAR%20oe_syn%3D0.96%20oe_mis%3D0.97%20oe_lof%3D0.82)	GT	1/0
chr5	75379425	.	T	C	1596	.	quality=DP%3D111%3BQD%3D14.38%3BAF%3D0.56%3BMQM%3D60%3BSAP%3D14%3BABP%3D6%3BSAR%3D40%3BSAF%3D22;gene=CERT1;variant_type=intron%2Cmissense;coding_and_splicing=CERT1:ENST00000644912.1:intron_variant:MODIFIER:intron15/15:c.1669+1647A>G::%2CCERT1:ENST00000644445.1:missense_variant:MODERATE:exon16/17:c.1718A>G:p.Lys573Arg:PF01852%20[START%20domain]%2CCERT1:ENST00000644072.2:missense_variant:MODERATE:exon17/18:c.1796A>G:p.Lys599Arg:PF01852%20[START%20domain]%2CCERT1:ENST00000261415.12:missense_variant:MODERATE:exon17/18:c.1796A>G:p.Lys599Arg:PF01852%20[START%20domain]%2CCERT1:ENST00000642809.1:missense_variant:MODERATE:exon16/17:c.1712A>G:p.Lys571Arg:PF01852%20[START%20domain]%2CCERT1:ENST00000642556.1:intron_variant:MODIFIER:intron15/15:c.1669+1647A>G::%2CCERT1:ENST00000646713.1:missense_variant:MODERATE:exon16/17:c.1712A>G:p.Lys571Arg:PF01852%20[START%20domain]%2CCERT1:ENST00000645866.1:missense_variant:MODERATE:exon15/16:c.1625A>G:p.Lys542Arg:PF01852%20[START%20domain]%2CCERT1:ENST00000645483.1:missense_variant:MODERATE:exon16/17:c.1718A>G:p.Lys573Arg:PF01852%20[START%20domain]%2CCERT1:ENST00000405807.10:missense_variant:MODERATE:exon18/19:c.2180A>G:p.Lys727Arg:PF01852%20[START%20domain]%2CCERT1:ENST00000643780.2:missense_variant:MODERATE:exon17/17:c.1796A>G:p.Lys599Arg:PF01852%20[START%20domain]%2CCERT1:ENST00000643158.1:missense_variant:MODERATE:exon15/15:c.1622A>G:p.Lys541Arg:PF01852%20[START%20domain]%2CCERT1:ENST00000646511.1:missense_variant:MODERATE:exon16/16:c.1718A>G:p.Lys573Arg:PF01852%20[START%20domain];OMIM=604677_[GENE%3DCERT1_PHENOS%3DIntellectual%20developmental%20disorder%2C%20autosomal%20dominant%2034%2C%20616351%20(3)%2C%20Autosomal%20dominant];dbSNP=rs55882089;gnomAD=0.00002;gnomAD_sub=0.00000%2C0.00000%2C0.00000%2C0.00004%2C0.00000;gnomAD_hom_hemi=0%2C;gnomAD_het=3;gnomAD_wt=152327;phyloP=8.0170;CADD=27.20;REVEL=0.485;AlphaMissense=0.11;MaxEntScan=/0.0>0.0/0.0>0.9;SpliceAI=COL4A3BP|0.00|0.02|0.00|0.00|-1|48|0|-6;NGSD_hom=0;NGSD_het=11;NGSD_mosaic=0;NGSD_group=0%20/%201;gene_info=CERT1%20(inh%3DAD%20oe_syn%3D1.19%20oe_mis%3D0.67%20oe_lof%3D0.21)	GT	1/0
chr5	79044473	.	T	G	1238	.	quality=DP%3D111%3BQD%3D11.15%3BAF%3D0.48%3BMQM%3D60%3BSAP%3D18%3BABP%3D3%3BSAR%3D36%3BSAF%3D17;gene=DMGDH;variant_type=synonymous;coding_and_splicing=DMGDH:ENST00000255189.8:synonymous_variant:LOW:exon6/16:c.825A>C:p.Thr275%3D:PF01266%20[FAD%20dependent%20oxidoreductase];OMIM=605849_[GENE%3DDMGDH_PHENOS%3DDimethylglycine%20dehydrogenase%20deficiency%2C%20605850%20(3)%2C%20Autosomal%20recessive];dbSNP=rs72764936;gnomAD=0.00001;gnomAD_sub=0.00000%2C0.00000%2C0.00000%2C0.00001%2C0.00000;gnomAD_hom_hemi=0%2C;gnomAD_het=1;gnomAD_wt=152331;phyloP=-0.6060;CADD=1.00;MaxEntScan=/0.0>0.0/0.0>0.0;SpliceAI=DMGDH|0.01|0.00|0.00|0.00|-17|0|-17|5;NGSD_hom=0;NGSD_het=11;NGSD_mosaic=0;NGSD_group=0%20/%201;gene_info=DMGDH%20(inh%3DAR%20oe_syn%3D1.08%20oe_mis%3D0.92%20oe_lof%3D0.90)	GT	1/0
chr5	90674063	.	A	G	555	.	quality=DP%3D56%3BQD%3D9.91%3BAF%3D0.46%3BMQM%3D60%3BSAP%3D36%3BABP%3D4%3BSAR%3D3%3BSAF%3D23;gene=ADGRV1;variant_type=missense;coding_and_splicing=ADGRV1:ENST00000405460.9:missense_variant:MODERATE:exon23/90:c.4939A>G:p.Ile1647Val:PF03160%20[Calx-beta%20domain];OMIM=602851_[GENE%3DADGRV1_PHENOS%3DUsher%20syndrome%2C%20type%202C%2C%20605472%20(3)%2C%20Digenic%20dominant%2C%20Autosomal%20recessive%3B%20Usher%20syndrome%2C%20type%202C%2C%20GPR98/PDZD7%20digenic%2C%20605472%20(3)%2C%20Digenic%20dominant%2C%20Autosomal%20recessive%3B%20?Febrile%20seizures%2C%20familial%2C%204%2C%20604352%20(3)%2C%20Autosomal%20dominant];ClinVar=46331%20[likely%20benign(replaced%20by%20megSAP%20based%20on%20classifications:4x1%2C3x2%2C1x3)%20DISEASE%3DUsher%20syndrome%20type%202C%2Cnot%20provided%2Cnot%20specified%20GENE%3DADGRV1]%3B;HGMD=CM2014150%20[CLASS%3DDM?%20MUT%3DALT%20PHEN%3D"Uveitis"%20GENE%3DADGRV1]%3B;dbSNP=rs72782753;gnomAD=0.00496;gnomAD_sub=0.00135%2C0.00680%2C0.00000%2C0.00779%2C0.00269;gnomAD_hom_hemi=0%2C;gnomAD_het=755;gnomAD_wt=151505;phyloP=0.2220;CADD=4.93;REVEL=0.074;AlphaMissense=0.08;MaxEntScan=/0.0>0.0/0.0>0.0;SpliceAI=ADGRV1|0.00|0.00|0.00|0.00|-34|2|-1|37;PubMed=25741868%2C24033266;NGSD_hom=1;NGSD_het=470;NGSD_mosaic=0;NGSD_group=0%20/%2048;comment="DVD:%20Benign";gene_info=ADGRV1%20(inh%3DAR+AD%20oe_syn%3D1.02%20oe_mis%3D1.00%20oe_lof%3D0.44)	GT	1/0
chr5	90855813	.	C	G	1529	.	quality=DP%3D126%3BQD%3D12.13%3BAF%3D0.48%3BMQM%3D60%3BSAP%3D13%3BABP%3D3%3BSAR%3D22%3BSAF%3D39;gene=ADGRV1;variant_type=missense;coding_and_splicing=ADGRV1:ENST00000405460.9:missense_variant:MODERATE:exon82/90:c.17667C>G:p.His5889Gln:;OMIM=602851_[GENE%3DADGRV1_PHENOS%3DUsher%20syndrome%2C%20type%202C%2C%20605472%20(3)%2C%20Digenic%20dominant%2C%20Autosomal%20recessive%3B%20Usher%20syndrome%2C%20type%202C%2C%20GPR98/PDZD7%20digenic%2C%20605472%20(3)%2C%20Digenic%20dominant%2C%20Autosomal%20recessive%3B%20?Febrile%20seizures%2C%20familial%2C%204%2C%20604352%20(3)%2C%20Autosomal%20dominant];ClinVar=906693%20[uncertain%20significance%20DISEASE%3Dnot%20provided%2CUsher%20syndrome%20type%202C%20GENE%3DADGRV1]%3B;dbSNP=rs56382582;gnomAD=0.00004;gnomAD_sub=0.00000%2C0.00000%2C0.00000%2C0.00009%2C0.00000;gnomAD_hom_hemi=0%2C;gnomAD_het=6;gnomAD_wt=152300;phyloP=3.8870;CADD=23.20;REVEL=0.731;AlphaMissense=0.34;MaxEntScan=/0.3>8.4/0.0>0.0;SpliceAI=ADGRV1|0.32|0.00|0.00|0.00|1|-43|1|8;NGSD_hom=0;NGSD_het=13;NGSD_mosaic=0;NGSD_group=0%20/%201;gene_info=ADGRV1%20(inh%3DAR+AD%20oe_syn%3D1.02%20oe_mis%3D1.00%20oe_lof%3D0.44)	GT	1/0
chr5	127339238	.	C	G	628	.	quality=DP%3D68%3BQD%3D9.24%3BAF%3D0.44%3BMQM%3D60%3BSAP%3D52%3BABP%3D5%3BSAR%3D28%3BSAF%3D2;gene=MEGF10;variant_type=splice_region&intron;coding_and_splicing=MEGF10:ENST00000503335.7:splice_region_variant&intron_variant:LOW:intron3/24:c.218+17C>G::%2CMEGF10:ENST00000508365.5:splice_region_variant&intron_variant:LOW:intron3/13:c.218+17C>G::%2CMEGF10:ENST00000418761.6:splice_region_variant&intron_variant:LOW:intron4/14:c.218+17C>G::%2CMEGF10:ENST00000274473.6:splice_region_variant&intron_variant:LOW:intron4/25:c.218+17C>G::;regulatory=regulatory_region_variant:enhancer;OMIM=612453_[GENE%3DMEGF10_PHENOS%3DCongenital%20myopathy%2010A%2C%20severe%20variant%2C%20614399%20(3)%2C%20Autosomal%20recessive%3B%20Congenital%20myopathy%2010B%2C%20mild%20variant%2C%20620249%20(3)%2C%20Autosomal%20recessive];ClinVar=262070%20[benign/likely%20benign%20DISEASE%3DMEGF10-related%20myopathy%2Cnot%20specified%20GENE%3DMEGF10]%3B;dbSNP=rs72786483;gnomAD=0.00247;gnomAD_sub=0.00101%2C0.00321%2C0.00000%2C0.00380%2C0.00000;gnomAD_hom_hemi=1%2C;gnomAD_het=374;gnomAD_wt=151744;phyloP=-0.2310;CADD=0.28;MaxEntScan=/0.0>0.0/2.0>2.2;SpliceAI=MEGF10|0.00|0.00|0.00|0.00|-16|-25|-17|-2;PubMed=25741868;NGSD_hom=0;NGSD_het=161;NGSD_mosaic=0;NGSD_group=0%20/%2018;gene_info=MEGF10%20(inh%3DAR%20oe_syn%3D0.94%20oe_mis%3D0.89%20oe_lof%3D0.23)	GT	1/0
chr5	131988096	.	C	T	2785	.	quality=DP%3D248%3BQD%3D11.23%3BAF%3D0.48%3BMQM%3D60%3BSAP%3D35%3BABP%3D4%3BSAR%3D38%3BSAF%3D80;gene=ACSL6;variant_type=synonymous;coding_and_splicing=ACSL6:ENST00000651356.1:synonymous_variant:LOW:exon7/21:c.783G>A:p.Glu261%3D:PF00501%20[AMP-binding%20enzyme]%2CACSL6:ENST00000651883.2:synonymous_variant:LOW:exon7/21:c.783G>A:p.Glu261%3D:PF00501%20[AMP-binding%20enzyme]%2CACSL6:ENST00000357096.5:synonymous_variant:LOW:exon7/20:c.603G>A:p.Glu201%3D:PF00501%20[AMP-binding%20enzyme]%2CACSL6:ENST00000379255.5:synonymous_variant:LOW:exon7/20:c.603G>A:p.Glu201%3D:PF00501%20[AMP-binding%20enzyme]%2CACSL6:ENST00000379246.5:synonymous_variant:LOW:exon7/21:c.741G>A:p.Glu247%3D:PF00501%20[AMP-binding%20enzyme]%2CACSL6:ENST00000379244.5:synonymous_variant:LOW:exon7/21:c.708G>A:p.Glu236%3D:PF00501%20[AMP-binding%20enzyme]%2CACSL6:ENST00000651427.1:synonymous_variant:LOW:exon7/21:c.603G>A:p.Glu201%3D:PF00501%20[AMP-binding%20enzyme]%2CACSL6:ENST00000651250.1:synonymous_variant:LOW:exon7/21:c.678G>A:p.Glu226%3D:PF00501%20[AMP-binding%20enzyme]%2CACSL6:ENST00000650697.1:synonymous_variant:LOW:exon8/22:c.777G>A:p.Glu259%3D:PF00501%20[AMP-binding%20enzyme]%2CACSL6:ENST00000379240.5:synonymous_variant:LOW:exon7/21:c.708G>A:p.Glu236%3D:PF00501%20[AMP-binding%20enzyme]%2CACSL6:ENST00000296869.9:synonymous_variant:LOW:exon7/20:c.783G>A:p.Glu261%3D:PF00501%20[AMP-binding%20enzyme]%2CACSL6:ENST00000434099.6:synonymous_variant:LOW:exon7/21:c.678G>A:p.Glu226%3D:PF00501%20[AMP-binding%20enzyme]%2CACSL6:ENST00000543479.5:synonymous_variant:LOW:exon7/21:c.753G>A:p.Glu251%3D:PF00501%20[AMP-binding%20enzyme]%2CACSL6:ENST00000431707.5:synonymous_variant:LOW:exon7/21:c.648G>A:p.Glu216%3D:PF00501%20[AMP-binding%20enzyme];OMIM=604443_[GENE%3DACSL6_PHENOS%3DMyelodysplastic%20syndrome%20(3)%3B%20Myelogenous%20leukemia%2C%20acute%20(3)];dbSNP=rs72793264;gnomAD=0.00239;gnomAD_sub=0.00084%2C0.00301%2C0.00000%2C0.00369%2C0.00021;gnomAD_hom_hemi=2%2C;gnomAD_het=360;gnomAD_wt=151976;phyloP=0.3130;CADD=4.83;MaxEntScan=/0.0>0.0/0.0>0.0;SpliceAI=ACSL6|0.00|0.00|0.00|0.00|13|-18|-11|-18%2CCTB-127M13.1|0.00|0.00|0.00|0.00|13|-18|-11|-18;NGSD_hom=3;NGSD_het=229;NGSD_mosaic=1;NGSD_group=0%20/%2013;gene_info=ACSL6%20(inh%3Dn/a%20oe_syn%3D1.12%20oe_mis%3D0.76%20oe_lof%3D0.30)	GT	1/0
chr5	132589791	.	G	C	410	.	quality=DP%3D42%3BQD%3D9.76%3BAF%3D0.48%3BMQM%3D60%3BSAP%3D5%3BABP%3D3%3BSAR%3D12%3BSAF%3D8;gene=RAD50;variant_type=missense;coding_and_splicing=RAD50:ENST00000378823.8:missense_variant:MODERATE:exon9/25:c.1406G>C:p.Gly469Ala:;OMIM=604040_[GENE%3DRAD50_PHENOS%3DNijmegen%20breakage%20syndrome-like%20disorder%2C%20613078%20(3)%2C%20Autosomal%20recessive];ClinVar=216618%20[uncertain%20significance%20DISEASE%3DNijmegen%20breakage%20syndrome-like%20disorder%2CHereditary%20cancer-predisposing%20syndrome%20GENE%3DRAD50]%3B;dbSNP=rs55653181;gnomAD=0.00002;gnomAD_sub=0.00000%2C0.00000%2C0.00000%2C0.00004%2C0.00000;gnomAD_hom_hemi=0%2C;gnomAD_het=3;gnomAD_wt=152249;phyloP=6.4160;CADD=22.30;REVEL=0.264;AlphaMissense=0.22;MaxEntScan=/0.0>0.0/0.0>0.0;SpliceAI=RAD50|0.00|0.00|0.00|0.00|9|-10|46|43;PubMed=28202063;NGSD_hom=1;NGSD_het=15;NGSD_mosaic=0;NGSD_group=0%20/%201;gene_info=RAD50%20(inh%3DAR%20oe_syn%3D1.07%20oe_mis%3D0.86%20oe_lof%3D0.70)	GT	1/0
chr5	150405095	.	A	G	1493	.	quality=DP%3D171%3BQD%3D8.73%3BAF%3D0.38%3BMQM%3D60%3BSAP%3D13%3BABP%3D24%3BSAR%3D24%3BSAF%3D41;gene=CD74%2CTCOF1;variant_type=intron%2Cmissense%2Cdownstream_gene;coding_and_splicing=CD74:ENST00000377795.7:intron_variant:MODIFIER:intron4/5:c.441+1164T>C::%2CCD74:ENST00000009530.13:missense_variant:MODERATE:exon5/9:c.527T>C:p.Ile176Thr:PF08831%20[Class%20II%20MHC-associated%20invariant%20chain%20trimerisation%20domain]%2CCD74:ENST00000353334.11:missense_variant:MODERATE:exon5/8:c.527T>C:p.Ile176Thr:PF08831%20[Class%20II%20MHC-associated%20invariant%20chain%20trimerisation%20domain]%2CTCOF1:ENST00000377797.7:downstream_gene_variant:MODIFIER::::%2CTCOF1:ENST00000445265.6:downstream_gene_variant:MODIFIER::::%2CTCOF1:ENST00000323668.11:downstream_gene_variant:MODIFIER::::%2CTCOF1:ENST00000643257.2:downstream_gene_variant:MODIFIER::::%2CTCOF1:ENST00000427724.7:downstream_gene_variant:MODIFIER::::;regulatory=regulatory_region_variant:enhancer;OMIM=606847_[GENE%3DTCOF1_PHENOS%3DTreacher%20Collins%20syndrome%201%2C%20154500%20(3)%2C%20Autosomal%20dominant];dbSNP=rs72805941;gnomAD=0.00069;gnomAD_sub=0.00060%2C0.00098%2C0.00097%2C0.00051%2C0.00062;gnomAD_hom_hemi=0%2C;gnomAD_het=105;gnomAD_wt=152191;phyloP=0.2820;CADD=16.33;REVEL=0.164;AlphaMissense=0.06;MaxEntScan=/0.0>0.0/0.0>0.0;SpliceAI=CD74|0.00|0.00|0.00|0.00|49|-10|-10|-18;NGSD_hom=0;NGSD_het=67;NGSD_mosaic=0;NGSD_group=0%20/%206;gene_info=TCOF1%20(inh%3DAD%20oe_syn%3D1.09%20oe_mis%3D0.97%20oe_lof%3D0.19)%2C%20CD74%20(inh%3Dn/a%20oe_syn%3D0.93%20oe_mis%3D0.70%20oe_lof%3D0.25)	GT	1/0
chr5	178153531	.	C	T	1907	.	quality=DP%3D177%3BQD%3D10.77%3BAF%3D0.46%3BMQM%3D60%3BSAP%3D67%3BABP%3D6%3BSAR%3D16%3BSAF%3D65;gene=NHP2%2CRMND5B;variant_type=missense%2Cdownstream_gene;coding_and_splicing=NHP2:ENST00000314397.9:missense_variant:MODERATE:exon2/3:c.190G>A:p.Val64Met:%2CNHP2:ENST00000274606.8:missense_variant:MODERATE:exon2/4:c.190G>A:p.Val64Met:PF01248%20[Ribosomal%20protein%20L7Ae/L30e/S12e/Gadd45%20family]%2CRMND5B:ENST00000515098.5:downstream_gene_variant:MODIFIER::::%2CRMND5B:ENST00000313386.9:downstream_gene_variant:MODIFIER::::%2CRMND5B:ENST00000542098.2:downstream_gene_variant:MODIFIER::::;regulatory=regulatory_region_variant:open_chromatin_region;OMIM=606470_[GENE%3DNHP2_PHENOS%3DDyskeratosis%20congenita%2C%20autosomal%20recessive%202%2C%20613987%20(3)%2C%20Autosomal%20recessive];ClinVar=353025%20[uncertain%20significance%20DISEASE%3DDyskeratosis%20congenita%2Cnot%20provided%2CDyskeratosis%20congenita%2C%20autosomal%20recessive%201%2CDyskeratosis%20congenita%2C%20autosomal%20recessive%202%2Cnot%20specified%20GENE%3DNHP2]%3B;HGMD=CM2321242%20[CLASS%3DDM?%20MUT%3DALT%20PHEN%3D"Immunodeficiency%20common%20variable"%20GENE%3DNHP2]%3B;dbSNP=rs79031130;gnomAD=0.00038;gnomAD_sub=0.00012%2C0.00091%2C0.00000%2C0.00054%2C0.00000;gnomAD_hom_hemi=0%2C;gnomAD_het=58;gnomAD_wt=152292;phyloP=7.7870;CADD=26.90;REVEL=0.376;AlphaMissense=0.95;MaxEntScan=/0.0>0.0/0.0>0.0;SpliceAI=NHP2|0.00|0.00|0.00|0.00|18|12|-40|1;PubMed=25741868%2C31681265;NGSD_hom=1;NGSD_het=59;NGSD_mosaic=0;NGSD_group=0%20/%207;gene_info=RMND5B%20(inh%3DAR%20oe_syn%3D0.98%20oe_mis%3D0.87%20oe_lof%3D0.90)%2C%20NHP2%20(inh%3DAR%20oe_syn%3D1.00%20oe_mis%3D0.99%20oe_lof%3D0.42)	GT	1/0
chr5	180603322	.	C	T	2212	.	quality=DP%3D182%3BQD%3D12.15%3BAF%3D0.48%3BMQM%3D60%3BSAP%3D4%3BABP%3D4%3BSAR%3D40%3BSAF%3D47;gene=FLT4;variant_type=missense%2Cdownstream_gene;coding_and_splicing=FLT4:ENST00000261937.11:missense_variant:MODERATE:exon30/30:c.3962G>A:p.Arg1321Gln:%2CFLT4:ENST00000393347.7:downstream_gene_variant:MODIFIER::::%2CFLT4:ENST00000502649.5:downstream_gene_variant:MODIFIER::::;OMIM=136352_[GENE%3DFLT4_PHENOS%3DHemangioma%2C%20capillary%20infantile%2C%20somatic%2C%20602089%20(3)%3B%20Lymphatic%20malformation%201%2C%20153100%20(3)%2C%20Autosomal%20dominant%3B%20Congenital%20heart%20defects%2C%20multiple%20types%2C%207%2C%20618780%20(3)%2C%20Autosomal%20dominant];ClinVar=263055%20[benign/likely%20benign%20DISEASE%3Dnot%20provided%2Cnot%20specified%20GENE%3DFLT4]%3B;dbSNP=rs79620092;gnomAD=0.00927;gnomAD_sub=0.00281%2C0.00555%2C0.00000%2C0.01629%2C0.00393;gnomAD_hom_hemi=14%2C;gnomAD_het=1384;gnomAD_wt=150948;phyloP=0.7760;CADD=7.12;REVEL=0.080;AlphaMissense=0.08;MaxEntScan=/0.0>0.0/0.0>0.0;COSMIC=COSV56126176;SpliceAI=FLT4|0.00|0.00|0.00|0.00|-2|8|-2|-45;PubMed=25741868;NGSD_hom=7;NGSD_het=1109;NGSD_mosaic=1;NGSD_group=1%20/%20134;gene_info=FLT4%20(inh%3DAD%20oe_syn%3D1.11%20oe_mis%3D0.73%20oe_lof%3D0.07)	GT	1/0
chr5	180618911	.	G	A	2835	.	quality=DP%3D213%3BQD%3D13.31%3BAF%3D0.52%3BMQM%3D60%3BSAP%3D5%3BABP%3D4%3BSAR%3D60%3BSAF%3D50;gene=FLT4;variant_type=missense%2C3'UTR;coding_and_splicing=FLT4:ENST00000261937.11:missense_variant:MODERATE:exon21/30:c.2860C>T:p.Pro954Ser:PF07714%20[Protein%20tyrosine%20and%20serine/threonine%20kinase]%2CFLT4:ENST00000393347.7:missense_variant:MODERATE:exon21/30:c.2860C>T:p.Pro954Ser:PF07714%20[Protein%20tyrosine%20and%20serine/threonine%20kinase]%2CFLT4:ENST00000502649.5:missense_variant:MODERATE:exon21/30:c.2860C>T:p.Pro954Ser:PF07714%20[Protein%20tyrosine%20and%20serine/threonine%20kinase]%2CFLT4:ENST00000619105.4:3_prime_UTR_variant:MODIFIER:exon20/28:c.*1803C>T::;regulatory=regulatory_region_variant:open_chromatin_region;OMIM=136352_[GENE%3DFLT4_PHENOS%3DHemangioma%2C%20capillary%20infantile%2C%20somatic%2C%20602089%20(3)%3B%20Lymphatic%20malformation%201%2C%20153100%20(3)%2C%20Autosomal%20dominant%3B%20Congenital%20heart%20defects%2C%20multiple%20types%2C%207%2C%20618780%20(3)%2C%20Autosomal%20dominant];ClinVar=16264%20[benign%20DISEASE%3Dnot%20specified%2CColorectal%20cancer%2Cnot%20provided%2CCapillary%20infantile%20hemangioma%20GENE%3DFLT4]%3B;HGMD=CM1710317%20[CLASS%3DDM?%20MUT%3DALT%20PHEN%3D"Vascular%20anomalies"%20GENE%3DFLT4]%3B;dbSNP=rs34255532;gnomAD=0.00346;gnomAD_sub=0.00118%2C0.00216%2C0.00000%2C0.00619%2C0.00228;gnomAD_hom_hemi=4%2C;gnomAD_het=519;gnomAD_wt=151771;phyloP=3.7870;CADD=22.10;REVEL=0.157;AlphaMissense=0.09;MaxEntScan=/0.0>0.0/0.0>0.0;COSMIC=COSV56128641;SpliceAI=FLT4|0.01|0.00|0.00|0.00|25|6|6|25;PubMed=25741868%2C11807987%2C36656337;NGSD_hom=3;NGSD_het=405;NGSD_mosaic=0;NGSD_group=0%20/%2051;gene_info=FLT4%20(inh%3DAD%20oe_syn%3D1.11%20oe_mis%3D0.73%20oe_lof%3D0.07)	GT	1/0
chr6	7542020	.	G	A	1573	.	quality=DP%3D149%3BQD%3D10.56%3BAF%3D0.44%3BMQM%3D60%3BSAP%3D22%3BABP%3D7%3BSAR%3D45%3BSAF%3D21;gene=DSP-AS1%2CDSP;variant_type=intron&non_coding_transcript%2Csynonymous%2Cupstream_gene;coding_and_splicing=DSP-AS1:ENST00000690863.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/1:n.344+751C>T::%2CDSP:ENST00000418664.3:synonymous_variant:LOW:exon1/24:c.105G>A:p.Gly35%3D:%2CDSP:ENST00000710359.2:synonymous_variant:LOW:exon1/24:c.105G>A:p.Gly35%3D:%2CDSP:ENST00000713909.1:synonymous_variant:LOW:exon1/23:c.105G>A:p.Gly35%3D:%2CDSP:ENST00000713910.1:synonymous_variant:LOW:exon1/11:c.105G>A:p.Gly35%3D:%2CDSP:ENST00000713918.1:synonymous_variant:LOW:exon1/1:c.105G>A:p.Gly35%3D:%2CDSP:ENST00000683682.2:synonymous_variant:LOW:exon1/2:c.105G>A:p.Gly35%3D:%2CDSP:ENST00000379802.8:synonymous_variant:LOW:exon1/24:c.105G>A:p.Gly35%3D:%2CDSP-AS1:ENST00000687028.2:upstream_gene_variant:MODIFIER::::%2CDSP:ENST00000713904.1:upstream_gene_variant:MODIFIER::::;regulatory=regulatory_region_variant:promoter;OMIM=125647_[GENE%3DDSP_PHENOS%3DArrhythmogenic%20right%20ventricular%20dysplasia%208%2C%20607450%20(3)%2C%20Autosomal%20dominant%3B%20Epidermolysis%20bullosa%2C%20lethal%20acantholytic%2C%20609638%20(3)%2C%20Autosomal%20recessive%3B%20Keratosis%20palmoplantaris%20striata%20II%2C%20612908%20(3)%2C%20Autosomal%20dominant%3B%20Dilated%20cardiomyopathy%20with%20woolly%20hair%2C%20keratoderma%2C%20and%20tooth%20agenesis%2C%20615821%20(3)%2C%20Autosomal%20dominant%3B%20Cardiomyopathy%2C%20dilated%2C%20with%20woolly%20hair%20and%20keratoderma%2C%20605676%20(3)%2C%20Autosomal%20recessive];ClinVar=36016%20[benign/likely%20benign%20DISEASE%3DCardiomyopathy%2Cnot%20specified%2CArrhythmogenic%20right%20ventricular%20dysplasia%208%2CArrhythmogenic%20cardiomyopathy%20with%20wooly%20hair%20and%20keratoderma%2CCardiomyopathy%2C%20dilated%2C%20with%20wooly%20hair%2C%20keratoderma%2C%20and%20tooth%20agenesis%2CLethal%20acantholytic%20epidermolysis%20bullosa%2CWoolly%20hair-skin%20fragility%20syndrome%2CKeratosis%20palmoplantaris%20striata%202%2Cnot%20provided%20GENE%3DDSP]%3B;dbSNP=rs77445784;gnomAD=0.00575;gnomAD_sub=0.00176%2C0.01065%2C0.00000%2C0.00870%2C0.00041;gnomAD_hom_hemi=4%2C;gnomAD_het=868;gnomAD_wt=151436;phyloP=-0.4890;CADD=9.73;MaxEntScan=/0.0>0.0/0.4>1.0%2C/0.0>0.0/0.0>0.0;SpliceAI=DSP|0.00|0.00|0.00|0.00|-41|12|14|-18;PubMed=24033266%2C18414213%2C21606396;NGSD_hom=4;NGSD_het=607;NGSD_mosaic=1;NGSD_group=0%20/%2075;classification=2;classification_comment="[2]%20old%20entry%20-%20no%20details%20available";gene_info=DSP-AS1%20(inh%3Dn/a%20oe_syn%3Dn/a%20oe_mis%3Dn/a%20oe_lof%3Dn/a)%2C%20DSP%20(inh%3DAR+AD%20oe_syn%3D1.05%20oe_mis%3D0.96%20oe_lof%3D0.18)	GT	1/0
chr6	30923211	.	G	A	2817	.	quality=DP%3D243%3BQD%3D11.59%3BAF%3D0.47%3BMQM%3D60%3BSAP%3D25%3BABP%3D5%3BSAR%3D74%3BSAF%3D40;gene=VARS2;variant_type=missense;coding_and_splicing=VARS2:ENST00000672801.1:missense_variant:MODERATE:exon23/29:c.2287G>A:p.Val763Met:%2CVARS2:ENST00000321897.9:missense_variant:MODERATE:exon23/29:c.2293G>A:p.Val765Met:%2CVARS2:ENST00000625423.2:missense_variant:MODERATE:exon23/29:c.1873G>A:p.Val625Met:%2CVARS2:ENST00000676266.1:missense_variant:MODERATE:exon24/30:c.2293G>A:p.Val765Met:%2CVARS2:ENST00000541562.6:missense_variant:MODERATE:exon24/30:c.2293G>A:p.Val765Met:;OMIM=612802_[GENE%3DVARS2_PHENOS%3DCombined%20oxidative%20phosphorylation%20deficiency%2020%2C%20615917%20(3)%2C%20Autosomal%20recessive];ClinVar=377004%20[likely%20benign(replaced%20by%20megSAP%20based%20on%20classifications:2x1%2C1x2%2C1x3)%20DISEASE%3Dnot%20provided%20GENE%3DVARS2]%3B;dbSNP=rs55865499;gnomAD=0.00258;gnomAD_sub=0.00055%2C0.00104%2C0.00019%2C0.00342%2C0.00000;gnomAD_hom_hemi=2%2C;gnomAD_het=389;gnomAD_wt=151947;phyloP=-0.2490;CADD=14.59;REVEL=0.022;AlphaMissense=0.09;MaxEntScan=/0.8>0.4/0.0>0.0;COSMIC=COSV58913391;SpliceAI=VARS2|0.00|0.00|0.00|0.00|-17|-11|-30|36;PubMed=25741868;NGSD_hom=0;NGSD_het=186;NGSD_mosaic=0;NGSD_group=0%20/%2018;gene_info=VARS2%20(inh%3DAR%20oe_syn%3D0.84%20oe_mis%3D0.73%20oe_lof%3D0.53)	GT	1/0
chr6	31269478	.	G	A	1990	.	quality=DP%3D159%3BQD%3D12.52%3BAF%3D0.50%3BMQM%3D59%3BSAP%3D3%3BABP%3D3%3BSAR%3D40%3BSAF%3D39;gene=HLA-C;variant_type=splice_region&intron;coding_and_splicing=HLA-C:ENST00000383329.7:splice_region_variant&intron_variant:LOW:intron6/7:c.1066+15C>T::%2CHLA-C:ENST00000376228.10:splice_region_variant&intron_variant:LOW:intron6/7:c.1048+15C>T::;regulatory=regulatory_region_variant:open_chromatin_region;OMIM=142840_[GENE%3DHLA-C_PHENOS%3D{Psoriasis%20susceptibility%201}%2C%20177900%20(3)%2C%20Multifactorial%3B%20{HIV-1%20viremia%2C%20susceptibility%20to}%2C%20609423%20(3)];dbSNP=rs2523609;gnomAD=0.00814;gnomAD_sub=0.01024%2C0.00651%2C0.01261%2C0.00701%2C0.02804;gnomAD_hom_hemi=18%2C;gnomAD_het=369;gnomAD_wt=49367;phyloP=-3.2160;CADD=0.51;MaxEntScan=/0.0>0.0/0.0>4.7;COSMIC=COSV66111860;SpliceAI=HLA-C|0.00|0.00|0.04|0.00|21|47|2|-12;NGSD_hom=13442;NGSD_het=12676;NGSD_mosaic=14;NGSD_group=1289%20/%201366;gene_info=HLA-C%20(inh%3Dn/a%20oe_syn%3D0.98%20oe_mis%3D0.97%20oe_lof%3D0.63)	GT	1/0
chr6	31269546	.	A	G	1543	.	quality=DP%3D104%3BQD%3D14.84%3BAF%3D0.58%3BMQM%3D60%3BSAP%3D36%3BABP%3D8%3BSAR%3D45%3BSAF%3D15;gene=HLA-C;variant_type=splice_region&intron%2Cintron;coding_and_splicing=HLA-C:ENST00000383329.7:splice_region_variant&intron_variant:LOW:intron5/7:c.1016-3T>C::%2CHLA-C:ENST00000376228.10:intron_variant:MODIFIER:intron5/7:c.1016-21T>C::;regulatory=regulatory_region_variant:open_chromatin_region;OMIM=142840_[GENE%3DHLA-C_PHENOS%3D{Psoriasis%20susceptibility%201}%2C%20177900%20(3)%2C%20Multifactorial%3B%20{HIV-1%20viremia%2C%20susceptibility%20to}%2C%20609423%20(3)];dbSNP=rs68094471;gnomAD=0.00423;gnomAD_sub=0.00603%2C0.00257%2C0.00658%2C0.00401%2C0.00231;gnomAD_hom_hemi=2%2C;gnomAD_het=213;gnomAD_wt=51109;phyloP=1.1810;CADD=10.14;MaxEntScan=5.3>6.0/5.3>6.0/0.0>0.0%2C/5.3>6.0/0.0>0.0;COSMIC=COSV66111865;SpliceAI=HLA-C|0.00|0.00|0.00|0.00|-21|-3|-47|-21;NGSD_hom=15353;NGSD_het=11674;NGSD_mosaic=7;NGSD_group=1499%20/%201265;gene_info=HLA-C%20(inh%3Dn/a%20oe_syn%3D0.98%20oe_mis%3D0.97%20oe_lof%3D0.63)	GT	1/0
chr6	31269556	.	T	A	1539	.	quality=DP%3D101%3BQD%3D15.24%3BAF%3D0.59%3BMQM%3D60%3BSAP%3D50%3BABP%3D11%3BSAR%3D48%3BSAF%3D12;gene=HLA-C;variant_type=splice_region&intron%2Cintron;coding_and_splicing=HLA-C:ENST00000383329.7:splice_region_variant&intron_variant:LOW:intron5/7:c.1016-13A>T::%2CHLA-C:ENST00000376228.10:intron_variant:MODIFIER:intron5/7:c.1016-31A>T::;regulatory=regulatory_region_variant:open_chromatin_region;OMIM=142840_[GENE%3DHLA-C_PHENOS%3D{Psoriasis%20susceptibility%201}%2C%20177900%20(3)%2C%20Multifactorial%3B%20{HIV-1%20viremia%2C%20susceptibility%20to}%2C%20609423%20(3)];dbSNP=rs66772001;gnomAD=0.00320;gnomAD_sub=0.00475%2C0.00170%2C0.00395%2C0.00290%2C0.00287;gnomAD_hom_hemi=1%2C;gnomAD_het=164;gnomAD_wt=51778;phyloP=-1.1030;CADD=0.61;MaxEntScan=5.3>10.9/7.7>10.9/0.0>0.0%2C/7.7>10.9/0.0>0.0;COSMIC=COSV66111868;SpliceAI=HLA-C|0.14|0.00|0.00|0.00|-13|-2|-30|50;NGSD_hom=15353;NGSD_het=11667;NGSD_mosaic=9;NGSD_group=1499%20/%201265;gene_info=HLA-C%20(inh%3Dn/a%20oe_syn%3D0.98%20oe_mis%3D0.97%20oe_lof%3D0.63)	GT	1/0
chr6	31269946	.	G	A	1804	.	quality=DP%3D200%3BQD%3D9.02%3BAF%3D0.40%3BMQM%3D53%3BSAP%3D16%3BABP%3D20%3BSAR%3D29%3BSAF%3D51;gene=HLA-C;variant_type=splice_region&intron;coding_and_splicing=HLA-C:ENST00000383329.7:splice_region_variant&intron_variant:LOW:intron5/7:c.1015+20C>T::%2CHLA-C:ENST00000376228.10:splice_region_variant&intron_variant:LOW:intron5/7:c.1015+20C>T::;regulatory=regulatory_region_variant:promoter;OMIM=142840_[GENE%3DHLA-C_PHENOS%3D{Psoriasis%20susceptibility%201}%2C%20177900%20(3)%2C%20Multifactorial%3B%20{HIV-1%20viremia%2C%20susceptibility%20to}%2C%20609423%20(3)];dbSNP=rs9264610;gnomAD=0.00024;gnomAD_sub=0.00045%2C0.00000%2C0.00000%2C0.00018%2C0.00188;gnomAD_hom_hemi=2%2C;gnomAD_het=10;gnomAD_wt=58324;phyloP=-2.2250;CADD=5.34;MaxEntScan=/0.0>0.0/0.0>0.0;COSMIC=COSV66113871;SpliceAI=HLA-C|0.00|0.00|0.00|0.00|10|33|20|-43;NGSD_hom=15351;NGSD_het=11633;NGSD_mosaic=12;NGSD_group=1499%20/%201264;gene_info=HLA-C%20(inh%3Dn/a%20oe_syn%3D0.98%20oe_mis%3D0.97%20oe_lof%3D0.63)	GT	1/0
chr6	31269950	.	T	C	1804	.	quality=DP%3D200%3BQD%3D9.02%3BAF%3D0.40%3BMQM%3D53%3BSAP%3D16%3BABP%3D20%3BSAR%3D29%3BSAF%3D51;gene=HLA-C;variant_type=splice_region&intron;coding_and_splicing=HLA-C:ENST00000383329.7:splice_region_variant&intron_variant:LOW:intron5/7:c.1015+16A>G::%2CHLA-C:ENST00000376228.10:splice_region_variant&intron_variant:LOW:intron5/7:c.1015+16A>G::;regulatory=regulatory_region_variant:promoter;OMIM=142840_[GENE%3DHLA-C_PHENOS%3D{Psoriasis%20susceptibility%201}%2C%20177900%20(3)%2C%20Multifactorial%3B%20{HIV-1%20viremia%2C%20susceptibility%20to}%2C%20609423%20(3)];dbSNP=rs2074497;gnomAD=0.00019;gnomAD_sub=0.00045%2C0.00000%2C0.00000%2C0.00012%2C0.00129;gnomAD_hom_hemi=2%2C;gnomAD_het=7;gnomAD_wt=57943;phyloP=-3.5280;CADD=5.66;REVEL=0.002;MaxEntScan=/0.0>0.0/0.0>5.5;COSMIC=COSV66117765;SpliceAI=HLA-C|0.00|0.00|0.02|0.00|5|6|5|12;NGSD_hom=15353;NGSD_het=11631;NGSD_mosaic=12;NGSD_group=1499%20/%201264;gene_info=HLA-C%20(inh%3Dn/a%20oe_syn%3D0.98%20oe_mis%3D0.97%20oe_lof%3D0.63)	GT	1/0
chr6	31270009	.	A	T	2028	.	quality=DP%3D256%3BQD%3D7.92%3BAF%3D0.36%3BMQM%3D57%3BSAP%3D5%3BABP%3D45%3BSAR%3D42%3BSAF%3D51;gene=HLA-C;variant_type=synonymous;coding_and_splicing=HLA-C:ENST00000383329.7:synonymous_variant:LOW:exon5/8:c.972T>A:p.Leu324%3D:%2CHLA-C:ENST00000376228.10:synonymous_variant:LOW:exon5/8:c.972T>A:p.Leu324%3D:;regulatory=regulatory_region_variant:promoter;OMIM=142840_[GENE%3DHLA-C_PHENOS%3D{Psoriasis%20susceptibility%201}%2C%20177900%20(3)%2C%20Multifactorial%3B%20{HIV-1%20viremia%2C%20susceptibility%20to}%2C%20609423%20(3)];dbSNP=rs41556617;gnomAD=0.00014;gnomAD_sub=0.00018%2C0.00000%2C0.00000%2C0.00015%2C0.00000;gnomAD_hom_hemi=0%2C;gnomAD_het=8;gnomAD_wt=58452;phyloP=-0.8990;CADD=0.46;MaxEntScan=/0.0>0.2/0.0>0.0;COSMIC=COSV66110697;SpliceAI=HLA-C|0.01|0.00|0.00|0.00|7|-33|-23|-43;PubMed=29138264;NGSD_hom=15348;NGSD_het=11665;NGSD_mosaic=9;NGSD_group=1498%20/%201266;gene_info=HLA-C%20(inh%3Dn/a%20oe_syn%3D0.98%20oe_mis%3D0.97%20oe_lof%3D0.63)	GT	1/0
chr6	31270025	.	A	G	2383	.	quality=DP%3D274%3BQD%3D8.70%3BAF%3D0.38%3BMQM%3D58%3BSAP%3D4%3BABP%3D38%3BSAR%3D55%3BSAF%3D49;gene=HLA-C;variant_type=missense;coding_and_splicing=HLA-C:ENST00000383329.7:missense_variant:MODERATE:exon5/8:c.956T>C:p.Val319Ala:%2CHLA-C:ENST00000376228.10:missense_variant:MODERATE:exon5/8:c.956T>C:p.Val319Ala:;regulatory=regulatory_region_variant:promoter;OMIM=142840_[GENE%3DHLA-C_PHENOS%3D{Psoriasis%20susceptibility%201}%2C%20177900%20(3)%2C%20Multifactorial%3B%20{HIV-1%20viremia%2C%20susceptibility%20to}%2C%20609423%20(3)];dbSNP=rs1050147;gnomAD=0.00012;gnomAD_sub=0.00009%2C0.00019%2C0.00000%2C0.00015%2C0.00000;gnomAD_hom_hemi=0%2C;gnomAD_het=7;gnomAD_wt=58987;phyloP=0.0520;CADD=0.20;REVEL=0.007;AlphaMissense=0.07;MaxEntScan=/5.4>5.7/0.0>0.0;COSMIC=COSV66111096;SpliceAI=HLA-C|0.00|0.00|0.00|0.00|9|-9|-39|-9;PubMed=35743738;NGSD_hom=15339;NGSD_het=11669;NGSD_mosaic=14;NGSD_group=1499%20/%201265;gene_info=HLA-C%20(inh%3Dn/a%20oe_syn%3D0.98%20oe_mis%3D0.97%20oe_lof%3D0.63)	GT	1/0
chr6	31270056	.	T	C	2176	.	quality=DP%3D284%3BQD%3D7.66%3BAF%3D0.35%3BMQM%3D56%3BSAP%3D14%3BABP%3D57%3BSAR%3D61%3BSAF%3D39;gene=HLA-C;variant_type=missense;coding_and_splicing=HLA-C:ENST00000383329.7:missense_variant:MODERATE:exon5/8:c.925A>G:p.Met309Val:%2CHLA-C:ENST00000376228.10:missense_variant:MODERATE:exon5/8:c.925A>G:p.Met309Val:;regulatory=regulatory_region_variant:promoter;OMIM=142840_[GENE%3DHLA-C_PHENOS%3D{Psoriasis%20susceptibility%201}%2C%20177900%20(3)%2C%20Multifactorial%3B%20{HIV-1%20viremia%2C%20susceptibility%20to}%2C%20609423%20(3)];dbSNP=rs1050180;gnomAD=0.00017;gnomAD_sub=0.00018%2C0.00019%2C0.00000%2C0.00015%2C0.00000;gnomAD_hom_hemi=0%2C;gnomAD_het=10;gnomAD_wt=58760;phyloP=-3.0410;CADD=0.03;REVEL=0.022;AlphaMissense=0.06;MaxEntScan=/0.0>0.0/0.0>0.0;COSMIC=COSV66110429%2CCOSV66114266;SpliceAI=HLA-C|0.00|0.00|0.00|0.00|29|-40|1|-40;NGSD_hom=14724;NGSD_het=12061;NGSD_mosaic=13;NGSD_group=1444%20/%201296;gene_info=HLA-C%20(inh%3Dn/a%20oe_syn%3D0.98%20oe_mis%3D0.97%20oe_lof%3D0.63)	GT	1/0
chr6	31270081	.	T	C	1972	.	quality=DP%3D269%3BQD%3D7.33%3BAF%3D0.35%3BMQM%3D56%3BSAP%3D40%3BABP%3D56%3BSAR%3D67%3BSAF%3D27;gene=HLA-C;variant_type=synonymous;coding_and_splicing=HLA-C:ENST00000383329.7:synonymous_variant:LOW:exon5/8:c.900A>G:p.Pro300%3D:%2CHLA-C:ENST00000376228.10:synonymous_variant:LOW:exon5/8:c.900A>G:p.Pro300%3D:;regulatory=regulatory_region_variant:promoter;OMIM=142840_[GENE%3DHLA-C_PHENOS%3D{Psoriasis%20susceptibility%201}%2C%20177900%20(3)%2C%20Multifactorial%3B%20{HIV-1%20viremia%2C%20susceptibility%20to}%2C%20609423%20(3)];dbSNP=rs34794906;gnomAD=0.00011;gnomAD_sub=0.00025%2C0.00000%2C0.00000%2C0.00006%2C0.00000;gnomAD_hom_hemi=1%2C;gnomAD_het=5;gnomAD_wt=62207;phyloP=-5.7180;CADD=6.97;MaxEntScan=/0.0>0.1/0.0>0.0;COSMIC=COSV66110447;SpliceAI=HLA-C|0.01|0.00|0.00|0.00|2|31|-15|38;PubMed=34021172%2C27863252;NGSD_hom=3092;NGSD_het=12546;NGSD_mosaic=11;NGSD_group=288%20/%201307;gene_info=HLA-C%20(inh%3Dn/a%20oe_syn%3D0.98%20oe_mis%3D0.97%20oe_lof%3D0.63)	GT	1/0
chr6	31270099	.	A	G	1951	.	quality=DP%3D247%3BQD%3D7.90%3BAF%3D0.36%3BMQM%3D55%3BSAP%3D22%3BABP%3D42%3BSAR%3D59%3BSAF%3D31;gene=HLA-C;variant_type=splice_region&intron;coding_and_splicing=HLA-C:ENST00000383329.7:splice_region_variant&intron_variant:LOW:intron4/7:c.896-14T>C::%2CHLA-C:ENST00000376228.10:splice_region_variant&intron_variant:LOW:intron4/7:c.896-14T>C::;regulatory=regulatory_region_variant:promoter;OMIM=142840_[GENE%3DHLA-C_PHENOS%3D{Psoriasis%20susceptibility%201}%2C%20177900%20(3)%2C%20Multifactorial%3B%20{HIV-1%20viremia%2C%20susceptibility%20to}%2C%20609423%20(3)];dbSNP=rs9264622;gnomAD=0.00033;gnomAD_sub=0.00073%2C0.00057%2C0.00068%2C0.00012%2C0.00064;gnomAD_hom_hemi=1%2C;gnomAD_het=17;gnomAD_wt=57921;phyloP=0.2030;CADD=9.38;MaxEntScan=10.8>11.3/10.8>11.3/0.0>0.0;COSMIC=COSV66117787;SpliceAI=HLA-C|0.00|0.03|0.00|0.00|-28|-14|40|-16;NGSD_hom=15348;NGSD_het=11658;NGSD_mosaic=11;NGSD_group=1498%20/%201266;gene_info=HLA-C%20(inh%3Dn/a%20oe_syn%3D0.98%20oe_mis%3D0.97%20oe_lof%3D0.63)	GT	1/0
chr6	31270252	.	T	C	124	.	quality=DP%3D235%3BQD%3D0.53%3BAF%3D0.17%3BMQM%3D52%3BSAP%3D42%3BABP%3D219%3BSAR%3D7%3BSAF%3D34;gene=HLA-C;variant_type=missense;coding_and_splicing=HLA-C:ENST00000383329.7:missense_variant:MODERATE:exon4/8:c.853A>G:p.Met285Val:PF07654%20[Immunoglobulin%20C1-set%20domain]%2CHLA-C:ENST00000376228.10:missense_variant:MODERATE:exon4/8:c.853A>G:p.Met285Val:PF07654%20[Immunoglobulin%20C1-set%20domain];OMIM=142840_[GENE%3DHLA-C_PHENOS%3D{Psoriasis%20susceptibility%201}%2C%20177900%20(3)%2C%20Multifactorial%3B%20{HIV-1%20viremia%2C%20susceptibility%20to}%2C%20609423%20(3)];dbSNP=rs2308622;gnomAD=0.00268;gnomAD_sub=0.00810%2C0.00212%2C0.00140%2C0.00130%2C0.00065;gnomAD_hom_hemi=5%2C;gnomAD_het=142;gnomAD_wt=56550;phyloP=2.8770;CADD=2.17;REVEL=0.141;AlphaMissense=0.04;MaxEntScan=/4.3>4.8/0.0>0.0;COSMIC=COSV66110598;SpliceAI=HLA-C|0.00|0.00|0.00|0.00|1|0|-42|8;PubMed=30886520%2C28845244;NGSD_hom=15336;NGSD_het=10744;NGSD_mosaic=469;NGSD_group=1498%20/%201201;gene_info=HLA-C%20(inh%3Dn/a%20oe_syn%3D0.98%20oe_mis%3D0.97%20oe_lof%3D0.63)	GT	1/0
chr6	31270276	.	G	C	554	.	quality=DP%3D216%3BQD%3D2.56%3BAF%3D0.22%3BMQM%3D52%3BSAP%3D49%3BABP%3D148%3BSAR%3D8%3BSAF%3D40;gene=HLA-C;variant_type=missense;coding_and_splicing=HLA-C:ENST00000383329.7:missense_variant:MODERATE:exon4/8:c.829C>G:p.Gln277Glu:PF07654%20[Immunoglobulin%20C1-set%20domain]%2CHLA-C:ENST00000376228.10:missense_variant:MODERATE:exon4/8:c.829C>G:p.Gln277Glu:PF07654%20[Immunoglobulin%20C1-set%20domain];OMIM=142840_[GENE%3DHLA-C_PHENOS%3D{Psoriasis%20susceptibility%201}%2C%20177900%20(3)%2C%20Multifactorial%3B%20{HIV-1%20viremia%2C%20susceptibility%20to}%2C%20609423%20(3)];dbSNP=rs707908;gnomAD=0.00019;gnomAD_sub=0.00018%2C0.00019%2C0.00072%2C0.00013%2C0.00066;gnomAD_hom_hemi=1%2C;gnomAD_het=9;gnomAD_wt=56759;phyloP=-1.3940;CADD=0.09;REVEL=0.023;AlphaMissense=0.05;MaxEntScan=/0.0>0.0/0.0>0.0;COSMIC=COSV66110239;SpliceAI=HLA-C|0.00|0.00|0.00|0.00|30|-9|-10|29;PubMed=35958581%2C30123242;NGSD_hom=14674;NGSD_het=11859;NGSD_mosaic=51;NGSD_group=1441%20/%201288;gene_info=HLA-C%20(inh%3Dn/a%20oe_syn%3D0.98%20oe_mis%3D0.97%20oe_lof%3D0.63)	GT	1/0
chr6	31270291	.	C	T	1006	.	quality=DP%3D217%3BQD%3D4.64%3BAF%3D0.28%3BMQM%3D53%3BSAP%3D50%3BABP%3D97%3BSAR%3D12%3BSAF%3D48;gene=HLA-C;variant_type=missense;coding_and_splicing=HLA-C:ENST00000383329.7:missense_variant:MODERATE:exon4/8:c.814G>A:p.Val272Met:PF07654%20[Immunoglobulin%20C1-set%20domain]%2CHLA-C:ENST00000376228.10:missense_variant:MODERATE:exon4/8:c.814G>A:p.Val272Met:PF07654%20[Immunoglobulin%20C1-set%20domain];OMIM=142840_[GENE%3DHLA-C_PHENOS%3D{Psoriasis%20susceptibility%201}%2C%20177900%20(3)%2C%20Multifactorial%3B%20{HIV-1%20viremia%2C%20susceptibility%20to}%2C%20609423%20(3)];dbSNP=rs1050276;gnomAD=0.00005;gnomAD_sub=0.00008%2C0.00000%2C0.00064%2C0.00003%2C0.00000;gnomAD_hom_hemi=0%2C;gnomAD_het=3;gnomAD_wt=64969;phyloP=0.2840;CADD=20.20;REVEL=0.054;AlphaMissense=0.15;MaxEntScan=/0.0>0.0/0.0>1.2;SpliceAI=HLA-C|0.00|0.00|0.00|0.00|32|15|-2|41;PubMed=37704211;NGSD_hom=66;NGSD_het=2525;NGSD_mosaic=4;NGSD_group=5%20/%20260;gene_info=HLA-C%20(inh%3Dn/a%20oe_syn%3D0.98%20oe_mis%3D0.97%20oe_lof%3D0.63)	GT	1/0
chr6	31270378	.	G	A	3090	.	quality=DP%3D289%3BQD%3D10.69%3BAF%3D0.45%3BMQM%3D49%3BSAP%3D15%3BABP%3D10%3BSAR%3D51%3BSAF%3D78;gene=HLA-C;variant_type=missense;coding_and_splicing=HLA-C:ENST00000383329.7:missense_variant:MODERATE:exon4/8:c.727C>T:p.Arg243Trp:PF07654%20[Immunoglobulin%20C1-set%20domain]%2CHLA-C:ENST00000376228.10:missense_variant:MODERATE:exon4/8:c.727C>T:p.Arg243Trp:PF07654%20[Immunoglobulin%20C1-set%20domain];OMIM=142840_[GENE%3DHLA-C_PHENOS%3D{Psoriasis%20susceptibility%201}%2C%20177900%20(3)%2C%20Multifactorial%3B%20{HIV-1%20viremia%2C%20susceptibility%20to}%2C%20609423%20(3)];dbSNP=rs1050328;gnomAD=0.00187;gnomAD_sub=0.00368%2C0.00220%2C0.00276%2C0.00101%2C0.00179;gnomAD_hom_hemi=1%2C;gnomAD_het=112;gnomAD_wt=60988;phyloP=-0.2870;CADD=20.20;REVEL=0.054;AlphaMissense=0.12;MaxEntScan=/2.5>1.8/0.0>0.0;COSMIC=COSV66117576;SpliceAI=HLA-C|0.01|0.00|0.00|0.00|0|18|50|-46;PubMed=34506591;NGSD_hom=2830;NGSD_het=12086;NGSD_mosaic=6;NGSD_group=270%20/%201265;gene_info=HLA-C%20(inh%3Dn/a%20oe_syn%3D0.98%20oe_mis%3D0.97%20oe_lof%3D0.63)	GT	1/0
chr6	31270482	.	G	T	2627	.	quality=DP%3D289%3BQD%3D9.09%3BAF%3D0.39%3BMQM%3D59%3BSAP%3D49%3BABP%3D33%3BSAR%3D81%3BSAF%3D32;gene=HLA-C;variant_type=missense;coding_and_splicing=HLA-C:ENST00000383329.7:missense_variant:MODERATE:exon4/8:c.623C>A:p.Pro208His:%2CHLA-C:ENST00000376228.10:missense_variant:MODERATE:exon4/8:c.623C>A:p.Pro208His:;regulatory=regulatory_region_variant:promoter;OMIM=142840_[GENE%3DHLA-C_PHENOS%3D{Psoriasis%20susceptibility%201}%2C%20177900%20(3)%2C%20Multifactorial%3B%20{HIV-1%20viremia%2C%20susceptibility%20to}%2C%20609423%20(3)];dbSNP=rs1131096;gnomAD=0.00108;gnomAD_sub=0.00127%2C0.00180%2C0.00280%2C0.00085%2C0.00317;gnomAD_hom_hemi=0%2C;gnomAD_het=61;gnomAD_wt=56605;phyloP=0.5280;CADD=15.45;REVEL=0.174;AlphaMissense=0.13;MaxEntScan=/0.0>0.0/0.0>0.0;COSMIC=COSV66109964%2CCOSV66111751;SpliceAI=HLA-C|0.00|0.00|0.00|0.00|-44|-8|-13|9;PubMed=29760565%2C36292921;NGSD_hom=14646;NGSD_het=11960;NGSD_mosaic=8;NGSD_group=1444%20/%201296;gene_info=HLA-C%20(inh%3Dn/a%20oe_syn%3D0.98%20oe_mis%3D0.97%20oe_lof%3D0.63)	GT	1/0
chr6	31271853	.	C	T	2079	.	quality=DP%3D303%3BQD%3D6.86%3BAF%3D0.34%3BMQM%3D46%3BSAP%3D12%3BABP%3D73%3BSAR%3D61%3BSAF%3D41;gene=HLA-C%2CUSP8P1;variant_type=missense%2Cupstream_gene;coding_and_splicing=HLA-C:ENST00000383329.7:missense_variant:MODERATE:exon2/8:c.89G>A:p.Arg30Lys:PF00129%20[Class%20I%20Histocompatibility%20antigen%20domains%20alpha%201%20and%202]%2CHLA-C:ENST00000376228.10:missense_variant:MODERATE:exon2/8:c.89G>A:p.Arg30Lys:PF00129%20[Class%20I%20Histocompatibility%20antigen%20domains%20alpha%201%20and%202]%2CUSP8P1:ENST00000494673.1:upstream_gene_variant:MODIFIER::::;regulatory=TF_binding_site_variant;OMIM=142840_[GENE%3DHLA-C_PHENOS%3D{Psoriasis%20susceptibility%201}%2C%20177900%20(3)%2C%20Multifactorial%3B%20{HIV-1%20viremia%2C%20susceptibility%20to}%2C%20609423%20(3)];dbSNP=rs1131151;gnomAD=0.00704;gnomAD_sub=0.00116%2C0.00814%2C0.03337%2C0.00820%2C0.00648;gnomAD_hom_hemi=13%2C;gnomAD_het=571;gnomAD_wt=84165;phyloP=0.4810;CADD=14.70;REVEL=0.143;AlphaMissense=0.17;MaxEntScan=/0.0>1.3/7.6>0.9;COSMIC=COSV66111479;SpliceAI=HLA-C|0.00|0.00|0.00|0.00|15|-1|-2|0;PubMed=20604894%2C35122707%2C23495851%2C37704211;NGSD_hom=64;NGSD_het=2532;NGSD_mosaic=2;NGSD_group=5%20/%20259;gene_info=HLA-C%20(inh%3Dn/a%20oe_syn%3D0.98%20oe_mis%3D0.97%20oe_lof%3D0.63)%2C%20USP8P1%20(inh%3Dn/a%20oe_syn%3Dn/a%20oe_mis%3Dn/a%20oe_lof%3Dn/a)	GT	1/0
chr6	31558196	.	G	A	1022	.	quality=DP%3D82%3BQD%3D12.46%3BAF%3D0.50%3BMQM%3D60%3BSAP%3D7%3BABP%3D3%3BSAR%3D25%3BSAF%3D16;gene=NFKBIL1;variant_type=missense%2Cdownstream_gene;coding_and_splicing=NFKBIL1:ENST00000376148.9:missense_variant:MODERATE:exon4/4:c.731G>A:p.Arg244Gln:%2CNFKBIL1:ENST00000376145.8:missense_variant:MODERATE:exon4/4:c.686G>A:p.Arg229Gln:%2CNFKBIL1:ENST00000496233.1:downstream_gene_variant:MODIFIER::::;OMIM=601022_[GENE%3DNFKBIL1_PHENOS%3D{Rheumatoid%20arthritis%2C%20susceptibility%20to}%2C%20180300%20(3)];ClinVar=2371518%20[uncertain%20significance%20DISEASE%3Dnot%20specified%20GENE%3DNFKBIL1]%3B;dbSNP=rs72847261;gnomAD=0.00007;gnomAD_sub=0.00000%2C0.00000%2C0.00000%2C0.00015%2C0.00000;gnomAD_hom_hemi=0%2C;gnomAD_het=11;gnomAD_wt=152327;phyloP=1.2420;CADD=20.80;REVEL=0.143;AlphaMissense=0.09;MaxEntScan=/0.0>0.0/0.0>0.0;SpliceAI=NFKBIL1|0.00|0.00|0.00|0.00|2|10|41|39;NGSD_hom=0;NGSD_het=21;NGSD_mosaic=0;NGSD_group=0%20/%201;gene_info=NFKBIL1%20(inh%3Dn/a%20oe_syn%3D0.68%20oe_mis%3D0.57%20oe_lof%3D0.31)	GT	1/0
chr6	31762197	.	G	A	1549	.	quality=DP%3D134%3BQD%3D11.56%3BAF%3D0.49%3BMQM%3D60%3BSAP%3D4%3BABP%3D3%3BSAR%3D35%3BSAF%3D30;gene=MSH5%2CMSH5-SAPCD1%2CSAPCD1%2CSAPCD1-AS1%2CVWA7;variant_type=splice_region&intron%2Cupstream_gene%2Cdownstream_gene;coding_and_splicing=MSH5:ENST00000375755.8:splice_region_variant&intron_variant:LOW:intron24/24:c.2393+12G>A::%2CMSH5:ENST00000375750.9:splice_region_variant&intron_variant:LOW:intron24/24:c.2393+12G>A::%2CMSH5-SAPCD1:ENST00000493662.6:splice_region_variant&intron_variant:LOW:intron24/28:c.2444+12G>A::%2CMSH5:ENST00000375703.7:splice_region_variant&intron_variant:LOW:intron24/24:c.2396+12G>A::%2CMSH5:ENST00000375740.7:splice_region_variant&intron_variant:LOW:intron24/24:c.2357+12G>A::%2CSAPCD1:ENST00000415669.4:upstream_gene_variant:MODIFIER::::%2CSAPCD1:ENST00000425424.4:upstream_gene_variant:MODIFIER::::%2CSAPCD1-AS1:ENST00000419679.1:downstream_gene_variant:MODIFIER::::%2CVWA7:ENST00000375688.5:downstream_gene_variant:MODIFIER::::;OMIM=603382_[GENE%3DMSH5_PHENOS%3D?Premature%20ovarian%20failure%2013%2C%20617442%20(3)%2C%20Autosomal%20recessive%3B%20Spermatogenic%20failure%2074%2C%20619937%20(3)%2C%20Autosomal%20recessive];dbSNP=rs28399985;gnomAD=0.00401;gnomAD_sub=0.00060%2C0.00249%2C0.00000%2C0.00532%2C0.00041;gnomAD_hom_hemi=2%2C;gnomAD_het=607;gnomAD_wt=151605;phyloP=0.4100;CADD=4.89;MaxEntScan=/2.5>1.9/0.0>0.0;SpliceAI=MSH5-SAPCD1|0.00|0.00|0.00|0.00|7|-10|-6|-8%2CMSH5|0.00|0.00|0.00|0.00|7|-28|-12|-8;NGSD_hom=1;NGSD_het=357;NGSD_mosaic=0;NGSD_group=0%20/%2046;gene_info=MSH5%20(inh%3DAR%20oe_syn%3D0.79%20oe_mis%3D0.77%20oe_lof%3D0.50)%2C%20MSH5-SAPCD1%20(inh%3DAR%20oe_syn%3Dn/a%20oe_mis%3Dn/a%20oe_lof%3Dn/a)%2C%20SAPCD1%20(inh%3Dn/a%20oe_syn%3D0.84%20oe_mis%3D0.92%20oe_lof%3D1.06)%2C%20SAPCD1-AS1%20(inh%3Dn/a%20oe_syn%3Dn/a%20oe_mis%3Dn/a%20oe_lof%3Dn/a)%2C%20VWA7%20(inh%3Dn/a%20oe_syn%3D0.85%20oe_mis%3D0.87%20oe_lof%3D0.61)	GT	1/0
chr6	31972121	.	C	T	1995	.	quality=DP%3D156%3BQD%3D12.79%3BAF%3D0.50%3BMQM%3D60%3BSAP%3D14%3BABP%3D3%3BSAR%3D49%3BSAF%3D29;gene=DXO%2CSTK19%2CSKIC2;variant_type=5'UTR%2Cmissense%2Cdownstream_gene%2Cupstream_gene;coding_and_splicing=DXO:ENST00000375349.7:5_prime_UTR_variant:MODIFIER:exon1/7:c.-243G>A::%2CDXO:ENST00000337523.10:5_prime_UTR_variant:MODIFIER:exon1/7:c.-199G>A::%2CSTK19:ENST00000466132.6:5_prime_UTR_variant:MODIFIER:exon2/8:c.-291C>T::%2CSTK19:ENST00000460018.3:missense_variant:MODERATE:exon2/9:c.125C>T:p.Ala42Val:%2CSTK19:ENST00000375331.8:missense_variant:MODERATE:exon1/8:c.125C>T:p.Ala42Val:%2CSTK19:ENST00000492583.6:5_prime_UTR_variant:MODIFIER:exon1/7:c.-291C>T::%2CSTK19:ENST00000375333.4:missense_variant:MODERATE:exon1/8:c.125C>T:p.Ala42Val:%2CSKIC2:ENST00000697831.1:downstream_gene_variant:MODIFIER::::%2CSKIC2:ENST00000491994.2:downstream_gene_variant:MODIFIER::::%2CSKIC2:ENST00000697838.1:downstream_gene_variant:MODIFIER::::%2CSKIC2:ENST00000697840.1:downstream_gene_variant:MODIFIER::::%2CSKIC2:ENST00000375394.7:downstream_gene_variant:MODIFIER::::%2CDXO:ENST00000375356.7:upstream_gene_variant:MODIFIER::::%2CSTK19:ENST00000685781.1:upstream_gene_variant:MODIFIER::::%2CSTK19:ENST00000491861.6:upstream_gene_variant:MODIFIER::::;regulatory=regulatory_region_variant:promoter%2CTF_binding_site_variant;OMIM=600478_[GENE%3DSKIC2_PHENOS%3DTrichohepatoenteric%20syndrome%202%2C%20614602%20(3)%2C%20Autosomal%20recessive];ClinVar=2656433%20[likely%20benign%20DISEASE%3Dnot%20provided%20GENE%3DDXO]%3B;dbSNP=rs80001134;gnomAD=0.00368;gnomAD_sub=0.00053%2C0.00274%2C0.00000%2C0.00545%2C0.00083;gnomAD_hom_hemi=1%2C;gnomAD_het=559;gnomAD_wt=151785;phyloP=-0.0310;CADD=11.51;REVEL=0.069;AlphaMissense=0.09;MaxEntScan=/0.0>0.0/0.0>1.8%2C/0.0>0.1/0.0>0.0;SpliceAI=DXO|0.00|0.00|0.00|0.00|38|2|-13|38%2CSTK19|0.00|0.00|0.00|0.00|21|9|29|-46;NGSD_hom=2;NGSD_het=396;NGSD_mosaic=0;NGSD_group=0%20/%2055;gene_info=SKIC2%20(inh%3DAR%20oe_syn%3D0.79%20oe_mis%3D0.81%20oe_lof%3D0.68)%2C%20DXO%20(inh%3Dn/a%20oe_syn%3D0.81%20oe_mis%3D0.84%20oe_lof%3D0.86)%2C%20STK19%20(inh%3Dn/a%20oe_syn%3D0.79%20oe_mis%3D0.95%20oe_lof%3D0.77)	GT	1/0
chr6	32637548	.	C	T	562	.	quality=DP%3D100%3BQD%3D5.62%3BAF%3D0.32%3BMQM%3D60%3BSAP%3D42%3BABP%3D31%3BSAR%3D28%3BSAF%3D4;gene=HLA-DQA1;variant_type=splice_region&intron;coding_and_splicing=HLA-DQA1:ENST00000395363.5:splice_region_variant&intron_variant:LOW:intron1/4:c.82+8C>T::%2CHLA-DQA1:ENST00000343139.11:splice_region_variant&intron_variant:LOW:intron1/4:c.82+8C>T::%2CHLA-DQA1:ENST00000374949.2:splice_region_variant&intron_variant:LOW:intron1/3:c.82+8C>T::;regulatory=regulatory_region_variant:open_chromatin_region%2CTF_binding_site_variant;OMIM=146880_[GENE%3DHLA-DQA1_PHENOS%3D{Celiac%20disease%2C%20susceptibility%20to}%2C%20212750%20(3)%2C%20Multifactorial%2C%20Autosomal%20recessive];dbSNP=rs9272434;gnomAD=0.00151;gnomAD_sub=0.00109%2C0.00162%2C0.00282%2C0.00189%2C0.00131;gnomAD_hom_hemi=3%2C;gnomAD_het=138;gnomAD_wt=95458;phyloP=-0.3510;CADD=10.38;MaxEntScan=/0.0>0.0/0.0>0.7;SpliceAI=HLA-DQA1|0.00|0.00|0.13|0.00|-2|0|-23|-8;NGSD_hom=2282;NGSD_het=11137;NGSD_mosaic=29;NGSD_group=253%20/%201191;gene_info=HLA-DQA1%20(inh%3DAR%20oe_syn%3D0.72%20oe_mis%3D0.60%20oe_lof%3D0.42)	GT	1/0
chr6	32642668	.	G	A	2088	.	quality=DP%3D324%3BQD%3D6.44%3BAF%3D0.34%3BMQM%3D42%3BSAP%3D3%3BABP%3D73%3BSAR%3D56%3BSAF%3D55;gene=HLA-DQA1;variant_type=synonymous;coding_and_splicing=HLA-DQA1:ENST00000395363.5:synonymous_variant:LOW:exon4/5:c.672G>A:p.Gly224%3D:%2CHLA-DQA1:ENST00000343139.11:synonymous_variant:LOW:exon4/5:c.672G>A:p.Gly224%3D:%2CHLA-DQA1:ENST00000374949.2:synonymous_variant:LOW:exon4/4:c.672G>A:p.Gly224%3D:;regulatory=regulatory_region_variant:open_chromatin_region;OMIM=146880_[GENE%3DHLA-DQA1_PHENOS%3D{Celiac%20disease%2C%20susceptibility%20to}%2C%20212750%20(3)%2C%20Multifactorial%2C%20Autosomal%20recessive];dbSNP=rs1048381;gnomAD=0.00713;gnomAD_sub=0.01270%2C0.00788%2C0.00984%2C0.00310%2C0.00570;gnomAD_hom_hemi=4%2C;gnomAD_het=741;gnomAD_wt=104283;phyloP=-0.6100;CADD=1.48;MaxEntScan=/0.9>1.1/0.0>0.0;COSMIC=COSV58239552;SpliceAI=HLA-DQA1|0.00|0.00|0.00|0.00|2|-22|27|-15;PubMed=20095854%2C33204752%2C37046283;NGSD_hom=603;NGSD_het=6957;NGSD_mosaic=5;NGSD_group=61%20/%20753;gene_info=HLA-DQA1%20(inh%3DAR%20oe_syn%3D0.72%20oe_mis%3D0.60%20oe_lof%3D0.42)	GT	1/0